| 1 |
Ballul T, Mageau A, Roland Nicaise P, Ajzenberg N, Strukov A, Dossier A, Rouzaud D, Papo T, Sacré K. Recurrent thrombotic events after disappearance of antiphospholipid autoantibodies: A long-term longitudinal study in patients with antiphospholipid syndrome. Thromb Res 2023;224:1-3. [PMID: 36774700 DOI: 10.1016/j.thromres.2023.02.005] [Reference Citation Analysis]
|
| 2 |
Mittal P, Quattrocchi G, Tohidi-Esfahani I, Sayar Z, Chandratheva A, Cohen H. Antiphospholipid syndrome, antiphospholipid antibodies, and stroke. Int J Stroke 2023;18:383-91. [PMID: 36571450 DOI: 10.1177/17474930221150349] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 3 |
Álvarez D, Morales-Prieto DM, Cadavid ÁP. Interaction between endothelial cell-derived extracellular vesicles and monocytes: A potential link between vascular thrombosis and pregnancy-related morbidity in antiphospholipid syndrome. Autoimmun Rev 2023;22:103274. [PMID: 36649876 DOI: 10.1016/j.autrev.2023.103274] [Reference Citation Analysis]
|
| 4 |
Talon L, Fourneyron V, Senectaire S, Tardieu M, Tillier M, Trapani A, Trayaud A, Vaissade A, Sapin AF, Lebreton A, Sinegre T. Lupus anticoagulant laboratory diagnosis by applying the 2020 ISTH-SSC guidelines. Thromb Res 2023;224:38-45. [PMID: 36827954 DOI: 10.1016/j.thromres.2023.02.009] [Reference Citation Analysis]
|
| 5 |
Pines M, Meyer R, Grabowski EF, Flynn P, Kucine N. De novo antiphospholipid antibody syndrome in two infants. Pediatr Blood Cancer 2023;70:e30129. [PMID: 36495261 DOI: 10.1002/pbc.30129] [Reference Citation Analysis]
|
| 6 |
Arachchillage DRJ, Pericleous C. Evolution of Antiphospholipid Syndrome. Semin Thromb Hemost 2023;49:295-304. [PMID: 36646109 DOI: 10.1055/s-0042-1760333] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 7 |
Gehlen R, Vandevelde A, de Laat B, Devreese KMJ. Application of the thrombin generation assay in patients with antiphospholipid syndrome: A systematic review of the literature. Front Cardiovasc Med 2023;10. [DOI: 10.3389/fcvm.2023.1075121] [Reference Citation Analysis]
|
| 8 |
Eviatar T, Niznik S, Elkayam O, Ben-gal Y, Shavit R, Raanani E, Agmon-levin N, Paran D. Heart Valve Surgery in Antiphospholipid Syndrome Patients—Morbidity and Mortality. Life 2023;13:891. [DOI: 10.3390/life13040891] [Reference Citation Analysis]
|
| 9 |
Tincani A, Fontana G, Mackworth-Young C. The history of antiphospholipid syndrome. Reumatismo 2023;74. [PMID: 36942979 DOI: 10.4081/reumatismo.2022.1556] [Reference Citation Analysis]
|
| 10 |
El Hasbani G, Uthman I. Lupus, antiphospholipid syndrome, and stroke: An attempt to crossmatch. Lupus 2023;:9612033231165151. [PMID: 36940089 DOI: 10.1177/09612033231165151] [Reference Citation Analysis]
|
| 11 |
Zubiaur J, Herrero-Morant A, Margarida de Castro A, Pérez-Barquín R, Ferraz-Amaro I, Loricera J, Castañeda S, Blanco R. Association between cumulative dose of hydroxychloroquine and electrocardiographic abnormalities in patients with systemic lupus erythematosus. Eur J Intern Med 2023:S0953-6205(23)00086-9. [PMID: 36948977 DOI: 10.1016/j.ejim.2023.03.014] [Reference Citation Analysis]
|
| 12 |
Radin M, Cecchi I, Arbrile M, Montin D, Farinasso L, Cioffi M, Foddai SG, Barinotti A, Menegatti E, Baldovino S, Sciascia S, Roccatello D. Pediatric Presentation of Antiphospholipid Syndrome: A Review of Recent Literature With Estimation of Local Prevalence. Semin Thromb Hemost 2023. [PMID: 36940717 DOI: 10.1055/s-0043-1764472] [Reference Citation Analysis]
|
| 13 |
Luo Y, Jin J, Yan Y, Zhang M, Hou L, Hou Y, Pei Q, Li C. Hemorrhage complications in obstetric antiphospholipid syndrome: Risk factors and association with adverse pregnancy outcomes. Front Immunol 2023;14. [DOI: 10.3389/fimmu.2023.1145146] [Reference Citation Analysis]
|
| 14 |
Liu J, Zhang Y, Li Z, Li J, Zhang L, Song Y, Lyu Z, Wang C, Gou L, Quan M, Xiao J, Song H. The effect of antinuclear antibody titre and its variation on outcomes in children with primary immune thrombocytopenia. Br J Haematol 2023. [PMID: 36929463 DOI: 10.1111/bjh.18732] [Reference Citation Analysis]
|
| 15 |
Carlos AF, Graff-Radford J, Crum BA, Machulda MM, Pham NTT, Lowe VJ, Whitwell JL, Josephs KA. Antiphospholipid syndrome mimicking posterior cortical atrophy and the "railroad track" sign on brain fluorodeoxyglucose-positron emission tomography. J Neurol Sci 2023;:120615. [PMID: 36959061 DOI: 10.1016/j.jns.2023.120615] [Reference Citation Analysis]
|
| 16 |
Ott O, Herrmann E, Schulz A, Lindhoff-last E. The APSANTICO Study: A Prospective Observational Study to Evaluate Antiphospholipid Antibody Profiles in Patients with Thromboembolic Antiphospholipid Syndrome (APS) after COVID-19 Infection and/or Vaccination. IJMS 2023;24:5644. [DOI: 10.3390/ijms24065644] [Reference Citation Analysis]
|
| 17 |
Han Z, Qi H. Carotid Artery Thrombus in Antiphospholipid Antibody Syndrome. Radiology 2023;:221836. [PMID: 36916895 DOI: 10.1148/radiol.221836] [Reference Citation Analysis]
|
| 18 |
Khalil DN, Prieto González-Albo I, Rosen L, Lillie T, Stacey A, Parfitt L, Soff GA. A tumor-selective adenoviral vector platform induces transient antiphospholipid antibodies, without increased risk of thrombosis, in phase 1 clinical studies. Invest New Drugs 2023;:1-7. [PMID: 36897458 DOI: 10.1007/s10637-023-01345-8] [Reference Citation Analysis]
|
| 19 |
Schäfer-graf U, Bader B, Schmidt M. Leitlinie: Nierenerkrankungen und Schwangerschaft. Gynäkologie 2023. [DOI: 10.1007/s00129-023-05069-x] [Reference Citation Analysis]
|
| 20 |
Mokbel A, Attia DH, Zayed HS, Eesa Naeem N, Mahmoud G, Riad R, Abou Elewa S, Youssef M, Haggag H, Mohamed SS. Pregnancy outcomes among Egyptian women with systemic lupus erythematosus: A prospective cohort study. Lupus 2023;:9612033231159468. [PMID: 36889920 DOI: 10.1177/09612033231159468] [Reference Citation Analysis]
|
| 21 |
Zhang Y, Yu Y, Gao AT. Systemic lupus erythematosus and antiphospholipid syndrome with retiform purpura as the initial skin lesion: A case study. Lupus 2023;:9612033231162199. [PMID: 36888900 DOI: 10.1177/09612033231162199] [Reference Citation Analysis]
|
| 22 |
Wantha O, Mahakkanukrauh A, Tuydaung K, Donsrichan W, Yingyaun K, Kaewmeun S, Suwannaroj S, Foocharoen C. Attitudes and factors affecting decision-making regarding COVID-19 vaccination among autoimmune rheumatic disease patients. Int J Rheum Dis 2023. [PMID: 36872073 DOI: 10.1111/1756-185X.14644] [Reference Citation Analysis]
|
| 23 |
Mondy VC, Valakkada J, Ayappan A. A Curious Case of Multiple Intracardiac Masses: Antiphospholipid Syndrome Manifesting as Multiple Intracardiac Thrombi. Indian J Radiol Imaging 2023. [DOI: 10.1055/s-0043-1762933] [Reference Citation Analysis]
|
| 24 |
Ambati A, Knight JS, Zuo Y. Antiphospholipid syndrome management: a 2023 update and practical algorithm-based approach. Curr Opin Rheumatol 2023. [PMID: 36866678 DOI: 10.1097/BOR.0000000000000932] [Reference Citation Analysis]
|
| 25 |
Suzuki J, Furuta S, Sugiyama T, Iwamoto T, Ikeda K, Suzuki K, Nakajima H. Antiphospholipid antibody positivity and the thrombotic risk in Japanese patients with anti-neutrophil cytoplasmic antibody-associated vasculitis. Mod Rheumatol 2023;33:346-51. [PMID: 35411394 DOI: 10.1093/mr/roac031] [Reference Citation Analysis]
|
| 26 |
Vrotniakaite-Bajerciene K, Tritschler T, Jalowiec KA, Broughton H, Schmidli F, Schneider JS, Haynes A, Rovo A, Hovinga JAK, Aujesky D, Angelillo-Scherrer A. Adherence to thrombophilia testing guidelines and its influence on anticoagulation therapy: A single-center cross-sectional study. Thromb Res 2023;223:87-94. [PMID: 36724651 DOI: 10.1016/j.thromres.2022.12.001] [Reference Citation Analysis]
|
| 27 |
Morris G, Talaulikar V. Hormone replacement therapy in women with history of thrombosis or a thrombophilia. Post Reprod Health 2023;29:33-41. [PMID: 36573625 DOI: 10.1177/20533691221148036] [Reference Citation Analysis]
|
| 28 |
Kitada A, Nakai T, Fukui S, Rokutanda R, Okada M, Kusaoi M, Yamaji K, Tamura N. Safety of tacrolimus use during pregnancy and related pregnancy outcomes in patients with systemic lupus erythematosus: A retrospective single-center analysis in Japan. Lupus 2023;32:352-62. [PMID: 36633400 DOI: 10.1177/09612033221148334] [Reference Citation Analysis]
|
| 29 |
Andreoli L, Chighizola CB, Iaccarino L, Botta A, Gerosa M, Ramoni V, Tani C, Bermas B, Brucato A, Buyon J, Cetin I, Chambers CD, Clowse MEB, Costedoat-Chalumeau N, Cutolo M, De Carolis S, Dolhain R, Fazzi EM, Förger F, Giles I, Haase I, Khamashta M, Levy RA, Meroni PL, Mosca M, Nelson-Piercy C, Raio L, Salmon J, Villiger P, Wahren-Herlenius M, Wallenius M, Zanardini C, Shoenfeld Y, Tincani A. Immunology of pregnancy and reproductive health in autoimmune rheumatic diseases. Update from the 11(th) International Conference on Reproduction, Pregnancy and Rheumatic Diseases. Autoimmun Rev 2023;22:103259. [PMID: 36549355 DOI: 10.1016/j.autrev.2022.103259] [Reference Citation Analysis]
|
| 30 |
Nevras V, Milaras N, Katsioulis C, Sotiriou Z, Tsalamandris S, Gkounti G, Skevos S. Acute Coronary Syndromes in Antiphospholipid Syndrome-above Suspicion: A Systematic Review. Curr Probl Cardiol 2023;48:101503. [PMID: 36402221 DOI: 10.1016/j.cpcardiol.2022.101503] [Reference Citation Analysis]
|
| 31 |
Shimomura A, Smith S, Darki A, Kamberos N, Charous S. Between a Rock and a Hard Place: Anticoagulating an Adolescent with Post-Tonsillectomy Massive PE: A Case Report. Ann Otol Rhinol Laryngol 2023;132:346-50. [PMID: 35373621 DOI: 10.1177/00034894221088178] [Reference Citation Analysis]
|
| 32 |
Suenaga A, Sawa N, Oshima Y, Ikuma D, Oba Y, Yamanouchi M, Hasegawa E, Mizuno H, Sekine A, Suwabe T, Kono K, Kinowaki K, Ohashi K, Takemura T, Yamaguchi Y, Miyazono M, Atsumi T, Ubara Y. Antiphospholipid Syndrome Nephropathy Related Disease Diagnosed by Assessing Phosphatidylserine-dependent Antiprothrombin Antibodies. Intern Med 2023;62:757-61. [PMID: 35908966 DOI: 10.2169/internalmedicine.0302-22] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 33 |
Bruck H, von Kiel C. [Autoimmune diagnostics in nephrology and rheumatology]. Dtsch Med Wochenschr 2023;148:230-40. [PMID: 36848886 DOI: 10.1055/a-1844-9568] [Reference Citation Analysis]
|
| 34 |
Silver R, Craigo S, Porter F, Osmundson SS, Kuller JA, Norton ME; Society for Maternal-Fetal Medicine (SMFM). Electronic address: pubs@smfm.org. Society for Maternal-Fetal Medicine Consult Series #64: Systemic lupus erythematosus in pregnancy. Am J Obstet Gynecol 2023;228:B41-60. [PMID: 36084704 DOI: 10.1016/j.ajog.2022.09.001] [Reference Citation Analysis]
|
| 35 |
Motomura K, Hara M, Ito I, Morita H, Matsumoto K. Roles of human trophoblasts' pattern recognition receptors in host defense and pregnancy complications. J Reprod Immunol 2023;156:103811. [PMID: 36669386 DOI: 10.1016/j.jri.2023.103811] [Reference Citation Analysis]
|
| 36 |
Yokote R, Kuwabara Y, Kasano S, Yonezawa M, Ouchi N, Ichikawa T, Suzuki S, Takeshita T. Risk factors for persistent positive anticardiolipin antibodies in women with recurrent pregnancy loss. J Reprod Immunol 2023;156:103920. [PMID: 36863074 DOI: 10.1016/j.jri.2023.103920] [Reference Citation Analysis]
|
| 37 |
El Hasbani G, Saliba AN, Uthman I, Taher AT. Hematological manifestations of antiphospholipid syndrome: Going beyond thrombosis. Blood Rev 2023;58:101015. [PMID: 36175215 DOI: 10.1016/j.blre.2022.101015] [Reference Citation Analysis]
|
| 38 |
Guedon AF, Ricard L, Laurent C, De Moreuil C, Urbanski G, Deriaz S, Gerotziafas G, Elalamy I, Audemard A, Chasset F, Alamowitch S, Sellam J, Boffa JJ, Cohen A, Wahl C, Abisror N, Maillot F, Fain O, Mekinian A. Identifying high-risk profile in primary antiphospholipid syndrome through cluster analysis: French multicentric cohort study. RMD Open 2023;9. [PMID: 36894193 DOI: 10.1136/rmdopen-2022-002881] [Reference Citation Analysis]
|
| 39 |
Pires da Rosa G, Ferreira E, Sousa-Pinto B, Bettencourt P, Espinosa G, Cervera R. Patients with laboratory criteria of anti-phospholipid syndrome and 'non-criteria' manifestations: a multicenter cohort. Scand J Rheumatol 2023;52:190-5. [PMID: 35723613 DOI: 10.1080/03009742.2022.2082114] [Reference Citation Analysis]
|
| 40 |
Khayata M, Wang TKM, Chan N, Alkharabsheh S, Verma BR, Oliveira GH, Klein AL, Littlejohn E, Xu B. Multimodality Cardiac Imaging in Patients with Systemic Lupus Erythematosus. Curr Probl Cardiol 2023;48:101048. [PMID: 34774920 DOI: 10.1016/j.cpcardiol.2021.101048] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 41 |
Knight JS, Branch DW, Ortel TL. Antiphospholipid syndrome: advances in diagnosis, pathogenesis, and management. BMJ 2023;380:e069717. [PMID: 36849186 DOI: 10.1136/bmj-2021-069717] [Reference Citation Analysis]
|
| 42 |
Biggart R, Davies C, Joshi N. A Review of Systemic Hematological Manifestations and Stent Thrombosis. Cardiol Rev 2023:e000535. [PMID: 36825903 DOI: 10.1097/CRD.0000000000000535] [Reference Citation Analysis]
|
| 43 |
Karakasis P, Lefkou E, Pamporis K, Nevras V, Bougioukas KI, Haidich AB, Fragakis N. Risk of Subclinical Atherosclerosis in Patients with Antiphospholipid Syndrome and Subjects With Antiphospholipid Antibody Positivity: A Systematic Review and Meta-analysis. Curr Probl Cardiol 2023;48:101672. [PMID: 36841314 DOI: 10.1016/j.cpcardiol.2023.101672] [Reference Citation Analysis]
|
| 44 |
Estévez MÁ, Lanio N, Molina Á, Jiménez-León MR, Picado MJ, Esteban E, Sánchez S, Pallarés L, Julià MR. Extra-criteria antiphospholipid antibodies in patients with small vessel brain lesions and clinical manifestations associated with antiphospholipid syndrome. J Stroke Cerebrovasc Dis 2023;32:107034. [PMID: 36842350 DOI: 10.1016/j.jstrokecerebrovasdis.2023.107034] [Reference Citation Analysis]
|
| 45 |
Shi Y, Jiang H, Zhao Y, Zhao J, Li M, Zeng X. Immune Thrombocytopenia Could be an Independent Clinical Phenotype of Antiphospholipid Syndrome: A Prospective Cohort Study. Rheumatol Ther 2023. [PMID: 36807880 DOI: 10.1007/s40744-023-00538-0] [Reference Citation Analysis]
|
| 46 |
Yamamoto T, Matsushita S, Endo D, Shimada A, Dohi S, Kajimoto K, Yokoyama Y, Sato Y, Machida Y, Asai T, Amano A. Management of cardiovascular surgery in patients with systemic lupus erythematosus including thromboembolism and multiple organ failure prevention: A retrospective observational study. Medicine (Baltimore) 2023;102:e32979. [PMID: 36800570 DOI: 10.1097/MD.0000000000032979] [Reference Citation Analysis]
|
| 47 |
Ibrahim AAG, Shadi HWE, Elamin AAY, Draz HE. Retrospective cohort study of thromboembolic events in systemic lupus erythematosus with or without secondary antiphospholipid syndrome and their correlation to lupus activity and dyslipidemia. Egypt Rheumatol Rehabil 2023;50:10. [DOI: 10.1186/s43166-023-00175-z] [Reference Citation Analysis]
|
| 48 |
Cheldieva FA, Reshetnyak TM, Shumilova AA, Nurbaeva KS, Cherkasova MV, Samarkina EY, Lila AM. Global Antiphospholipid Syndrome Score (GAPSS) in patients with primary antiphospholipid syndrome. Sovremennaâ revmatologiâ 2023;17:31-37. [DOI: 10.14412/1996-7012-2023-1-31-37] [Reference Citation Analysis]
|
| 49 |
Peng X, Tan X, Xing A. An advanced understanding of the heterogeneous clinical features of "non-criteria" obstetric antiphospholipid syndrome: Two case reports and a literature review. Front Immunol 2023;14:1122127. [PMID: 36865564 DOI: 10.3389/fimmu.2023.1122127] [Reference Citation Analysis]
|
| 50 |
Stammler R, Nguyen Y, Yelnik C, Le Guern V, Lambert M, Paule R, Hachulla E, Mouthon L, Dupré A, Ackermann F, Dufrost V, Wahl D, Godeau B, Leroux G, Benhamou Y, Lazaro E, Daugas E, Bezanahary H, Mekinian A, Piette JC, Morel N, Costedoat-Chalumeau N. Precipitating factors of catastrophic antiphospholipid syndrome: the role of anticoagulant treatment in a series of 112 patients. J Thromb Haemost 2023:S1538-7836(23)00146-0. [PMID: 36792010 DOI: 10.1016/j.jtha.2023.02.007] [Reference Citation Analysis]
|
| 51 |
Hasan H, Surjancev I, Arnason JA, Garg S, Rose WN. Corticosteroids, Plasmapheresis, Argatroban, Rituximab, and Sirolimus Provided Clinical Benefit for Catastrophic Antiphospholipid Syndrome in a Patient with a History of Heparin-Induced Thrombocytopenia. Case Rep Rheumatol 2023;2023:3226278. [PMID: 36816449 DOI: 10.1155/2023/3226278] [Reference Citation Analysis]
|
| 52 |
Drosos GC, Konstantonis G, Sfikakis PP, Tektonidou MG. Lipid management in systemic lupus erythematosus according to risk classifiers suggested by the European Society of Cardiology and disease-related risk factors reported by the EULAR recommendations. RMD Open 2023;9. [PMID: 36759009 DOI: 10.1136/rmdopen-2022-002767] [Reference Citation Analysis]
|
| 53 |
Li J, Hou Y, Zhang L, Li F, Liu Q, Li Y, Shen H, Xiong Z, Huang L, Qiao C. Clinical phenotype, treatment strategy and pregnancy outcome of non-criteria obstetric antiphospholipid syndrome. Am J Reprod Immunol 2023;:e13684. [PMID: 36756665 DOI: 10.1111/aji.13684] [Reference Citation Analysis]
|
| 54 |
D'Ippolito S, Barbaro G, Paciullo C, Tersigni C, Scambia G, Di Simone N. Antiphospholipid Syndrome in Pregnancy: New and Old Pathogenetic Mechanisms. Int J Mol Sci 2023;24. [PMID: 36834614 DOI: 10.3390/ijms24043195] [Reference Citation Analysis]
|
| 55 |
Pastori D, Cormaci VM, Marucci S, Franchino G, Del Sole F, Capozza A, Fallarino A, Corso C, Valeriani E, Menichelli D, Pignatelli P. A Comprehensive Review of Risk Factors for Venous Thromboembolism: From Epidemiology to Pathophysiology. Int J Mol Sci 2023;24. [PMID: 36834580 DOI: 10.3390/ijms24043169] [Reference Citation Analysis]
|
| 56 |
Franco AMM, Makita LS, Perrut VC, Balbi GGM, Barros AM, Medina FMC, Signorelli F. Ocular involvement in primary antiphospholipid syndrome: results of an extensive ophthalmological evaluation performed in the APS-Rio cohort. Lupus 2023;32:180-8. [PMID: 36444940 DOI: 10.1177/09612033221143294] [Reference Citation Analysis]
|
| 57 |
Magro-Checa C, Ramiro S, Rúa-Figueroa I, Jimenez N, Del Campo-Pérez V, Martinez-Barrio J, Galindo-Izquierdo M, Calvo-Alén J, Uriarte-Isacelaya E, Tomero-Muriel E, Freire-González M, Martínez-Taboada V, Salgado E, Vela P, Mena-Vázquez N, Olivé A, Narváez J, Menor-Almagro R, Santos-Soler G, Hernández-Beriaín JA, Manero-Ruiz J, Aurrecoechea-Aguinaga E, Ibarguengoitia O, Montilla-Morales C, Bonilla-Hernán G, Torrente-Segarra V, Salman-Monte T, Ros-Vilamajo I, García-Villanueva MJ, Moriano-Morales C, Fito-Manteca C, Lozano-Rivas N, Bohórquez C, Pego-Reigosa JM. Central nervous system involvement in systemic lupus erythematosus: Data from the Spanish Society of Rheumatology Lupus Register (RELESSER). Semin Arthritis Rheum 2023;58:152121. [PMID: 36375359 DOI: 10.1016/j.semarthrit.2022.152121] [Reference Citation Analysis]
|
| 58 |
Raghunath S, Glikmann-Johnston Y, Golder V, Kandane-Rathnayake R, Morand EF, Stout JC, Hoi A. Clinical associations of cognitive dysfunction in systemic lupus erythematosus. Lupus Sci Med 2023;10. [PMID: 36854540 DOI: 10.1136/lupus-2022-000835] [Reference Citation Analysis]
|
| 59 |
Manukyan G, Kriegova E, Slavik L, Mikulkova Z, Ulehlova J, Martirosyan A, Papajik T. Antiphospholipid antibody-mediated NK cell cytotoxicity. J Reprod Immunol 2023;155:103791. [PMID: 36621092 DOI: 10.1016/j.jri.2022.103791] [Reference Citation Analysis]
|
| 60 |
Lopez-Pedrera C, Patiño-Trives AM, Cerdó T, Ortega-Castro R, Sanchez-Pareja I, Ibañez-Costa A, Muñoz-Barrera L, Ábalos-Aguilera MC, Ruiz-Vilchez D, Seguí Azpilcueta P, Espinosa M, Barbarroja N, Escudero-Contreras A, Castaño JP, Luque RM, Ortega R, Aguirre MA, Perez-Sanchez C. Splicing machinery is profoundly altered in systemic lupus erythematosus and antiphospholipid syndrome and directly linked to key clinical features. J Autoimmun 2023;135:102990. [PMID: 36621176 DOI: 10.1016/j.jaut.2022.102990] [Reference Citation Analysis]
|
| 61 |
Álvarez-López S, Ariza-Gómez MF, López-Montoya V, Cataño-Bedoya JU, Giraldo-Mendez D, Jaimes F. Demographic, Clinical, and Serological Characteristics of Antiphospholipid Syndrome Patients From the Anticoagulation Clinic of Hospital Universitario San Vicente Fundación, Medellín, Colombia. Cureus 2023;15:e35114. [PMID: 36945288 DOI: 10.7759/cureus.35114] [Reference Citation Analysis]
|
| 62 |
Arcani R, Cauchois R, Suchon P, Weber S, Jean R, Jarrot PA, Rey L, Venton G, Koubi M, Muller R, Bertin D, Mège JL, Kaplanski G, Bardin N. "True" Antiphospholipid Syndrome in COVID-19: Contribution of the Follow-up of Antiphospholipid Autoantibodies. Semin Thromb Hemost 2023;49:97-102. [PMID: 36335917 DOI: 10.1055/s-0042-1758118] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 63 |
Yee CS, Gordon C, Akil M, Lanyon P, Edwards CJ, Isenberg DA, Rahman A, Teh LS, Tosounidou S, Stevens R, Prabu A, Griffiths B, McHugh N, Bruce IN, Ahmad Y, Khamashta MA, Farewell VT. The BILAG-2004 index is associated with development of new damage in SLE. Rheumatology (Oxford) 2023;62:668-75. [PMID: 35686924 DOI: 10.1093/rheumatology/keac334] [Reference Citation Analysis]
|
| 64 |
Zhang Y, Su Y, Guo H, Wang L, Li A, Wang C, Zhang J, Qiao R. Anti-phosphatidylserine/prothrombin complex antibodies (aPS/PT) increase the risk for thrombosis based on lupus anticoagulant positivity. Clin Biochem 2023;112:17-23. [PMID: 36535385 DOI: 10.1016/j.clinbiochem.2022.12.007] [Reference Citation Analysis]
|
| 65 |
Nawroth F, Toth B. Diagnostik und Therapie wiederholter Spontanaborte gemäß S2k-Leitlinie. Gynäkologie 2023;56:115-126. [DOI: 10.1007/s00129-022-05039-9] [Reference Citation Analysis]
|
| 66 |
Sabio JM, Garcia-de Los Ríos C, Medina-Casado M, Del Mar Del Águila-García M, Cáliz-Cáliz R, Díaz-Chamorro A. High-sensitivity cardiac troponin I is a biomarker for increased arterial stiffness in systemic lupus erythematous women with normal kidney function. Rheumatol Int 2023;43:253-63. [PMID: 36094601 DOI: 10.1007/s00296-022-05204-2] [Reference Citation Analysis]
|
| 67 |
Chalvon NB, Costedoat-Chalumeau N, Pennaforte JL, Servettaz A, Boulagnon Rombi C, Gavand PE, Lekieffre M, Le Guern V, Morel N, Cohen Aubart F, Haroche J, Mathian A, Collet JP, Piette JC, Amoura Z, Orquevaux P. Severe Libman-Sacks endocarditis complicating antiphospholipid syndrome: a retrospective analysis of 23 operated cases. Rheumatology (Oxford) 2023;62:707-15. [PMID: 35686908 DOI: 10.1093/rheumatology/keac315] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 68 |
Arora R, Sachdeva M, Rathee A, Agarwal U. Should Endometrium be Sampled in Cases of Recurrent Pregnancy Loss? Journal of South Asian Federation of Obstetrics and Gynaecology 2023;14:714-718. [DOI: 10.5005/jp-journals-10006-2164] [Reference Citation Analysis]
|
| 69 |
Lim Y, Afkhamnejad ER, Kavoussi S. Unilateral CRAO as the presenting clinical sign of systemic lupus erythematosus. Am J Ophthalmol Case Rep 2023;29:101810. [PMID: 36793793 DOI: 10.1016/j.ajoc.2023.101810] [Reference Citation Analysis]
|
| 70 |
Kahn SA, Leonard MM, Westra SJ, Hausmann JS, Mueller SB. Case 3-2023: A 16-Year-Old Girl with Abdominal Pain and Bloody Diarrhea. N Engl J Med 2023;388:358-68. [PMID: 36720137 DOI: 10.1056/NEJMcpc2211367] [Reference Citation Analysis]
|
| 71 |
Yang HT, Hong XP, Guo JW, Zhong XL, Liao R, Liu CL, Liu LX, Li K, Chen YL, Liu DZ. Clinical Significance of Different Profiles of anti-Ro Antibodies in Connective Tissue Diseases. J Immunol Res 2023;2023:9195157. [PMID: 36741231 DOI: 10.1155/2023/9195157] [Reference Citation Analysis]
|
| 72 |
Capozzi A, Manganelli V, Riitano G, Caissutti D, Longo A, Garofalo T, Sorice M, Misasi R. Advances in the Pathophysiology of Thrombosis in Antiphospholipid Syndrome: Molecular Mechanisms and Signaling through Lipid Rafts. J Clin Med 2023;12. [PMID: 36769539 DOI: 10.3390/jcm12030891] [Reference Citation Analysis]
|
| 73 |
Kansuttiviwat C, Niprapan P, Tantiworawit A, Norasetthada L, Rattarittamrong E, Rattanathammethee T, Hantrakool S, Piriyakhuntorn P, Punnachet T, Hantrakun N, Chai-Adisaksopha C. Impact of antiphospholipid antibodies on thrombotic events in ambulatory cancer patients. PLoS One 2023;18:e0279450. [PMID: 36662720 DOI: 10.1371/journal.pone.0279450] [Reference Citation Analysis]
|
| 74 |
Spiliopoulou P, Janse van Rensburg HJ, Avery L, Kulasingam V, Razak A, Bedard P, Hansen A, Chruscinski A, Wang B, Kulikova M, Chen R, Speers V, Nguyen A, Lee J, Coburn B, Spreafico A, Siu LL. Longitudinal efficacy and toxicity of SARS-CoV-2 vaccination in cancer patients treated with immunotherapy. Cell Death Dis 2023;14:49. [PMID: 36670100 DOI: 10.1038/s41419-022-05548-4] [Reference Citation Analysis]
|
| 75 |
Justinussen T, Gram JB, Bor MV. Antiphospholipid antibodies in pulmonary embolism treated with direct oral anticoagulants: Prevalence data from unselected consecutive patients. Res Pract Thromb Haemost 2023;7:100050. [PMID: 36798898 DOI: 10.1016/j.rpth.2023.100050] [Reference Citation Analysis]
|
| 76 |
Zhu R, Cheng GY, Denas G, Pengo V. Antiphospholipid antibodies in chronic thromboembolic pulmonary hypertension. Eur J Intern Med 2023:S0953-6205(23)00017-1. [PMID: 36642578 DOI: 10.1016/j.ejim.2023.01.012] [Reference Citation Analysis]
|
| 77 |
Rodríguez-Almaraz E, Gutiérrez-Solís E, Rabadán E, Rodríguez P, Alonso M, Carmona L, de Yébenes MJG, Morales E, Galindo-Izquierdo M. Searching for a prognostic index in lupus nephritis. Eur J Med Res 2023;28:19. [PMID: 36631838 DOI: 10.1186/s40001-022-00946-y] [Reference Citation Analysis]
|
| 78 |
Arachchillage DJ, Laffan M, Pericleous C. Hydroxychloroquine as an Immunomodulatory and Antithrombotic Treatment in Antiphospholipid Syndrome. Int J Mol Sci 2023;24. [PMID: 36674847 DOI: 10.3390/ijms24021331] [Reference Citation Analysis]
|
| 79 |
Mazharian A, Maître B, Bornert A, Hennequin D, Lourenco-Rodrigues M, Geer MJ, Smith CW, Heising S, Walter M, Montel F, Walker LSK, de la Salle H, Watson SP, Gachet C, Senis YA. Treatment of congenital thrombocytopenia and decreased collagen reactivity in G6b-B-deficient mice. Blood Adv 2023;7:46-59. [PMID: 36269841 DOI: 10.1182/bloodadvances.2022008873] [Reference Citation Analysis]
|
| 80 |
Hayashi Y, Kaneko R, Ogino H, Uekusa T, Kitajima M, Ikehara T, Nagai H, Matsuda T. A case of multiple hepatocellular carcinoma experiencing complete responses to sorafenib and atezolizumab-bevacizumab and developing severe, refractory venous congestive cutaneous ulcers on either regimen. Clin J Gastroenterol 2023. [PMID: 36624210 DOI: 10.1007/s12328-023-01756-3] [Reference Citation Analysis]
|
| 81 |
Lee D, Jeon H, Ahn Y, Kim HJ, Shin HE, Koh JH. Case 6: A 27-Year-Old Woman With Dysarthria. J Korean Med Sci 2023;38:e5. [PMID: 36625170 DOI: 10.3346/jkms.2023.38.e5] [Reference Citation Analysis]
|
| 82 |
Bolla E, Tentolouris N, Sfikakis PP, Tektonidou MG. Metabolic syndrome in antiphospholipid syndrome versus rheumatoid arthritis and diabetes mellitus: Association with arterial thrombosis, cardiovascular risk biomarkers, physical activity, and coronary atherosclerotic plaques. Front Immunol 2022;13:1077166. [PMID: 36700208 DOI: 10.3389/fimmu.2022.1077166] [Reference Citation Analysis]
|
| 83 |
Płazak W, Drabik L. SARS-CoV-2 infection and SLE: endothelial dysfunction, atherosclerosis, and thrombosis. Clin Rheumatol 2023;:1-12. [PMID: 36622519 DOI: 10.1007/s10067-022-06497-1] [Reference Citation Analysis]
|
| 84 |
Talon L, Fourneyron V, Tardieu M, Trapani A, Sinegre T, Lebreton A. Evaluation of newly developed dilute Russell's viper venom reagents for lupus anticoagulant detection. Int J Lab Hematol 2023. [PMID: 36623547 DOI: 10.1111/ijlh.14018] [Reference Citation Analysis]
|
| 85 |
Zotova N, Zhuravleva Y, Chereshnev V, Gusev E. Acute and Chronic Systemic Inflammation: Features and Differences in the Pathogenesis, and Integral Criteria for Verification and Differentiation. Int J Mol Sci 2023;24. [PMID: 36674657 DOI: 10.3390/ijms24021144] [Reference Citation Analysis]
|
| 86 |
He Y, Li M, Yu H, Yin F, Zhang X, Yang Q, Xie X, Wei G, Chen H, He C, He Y, Chen J. Bibliometric and altmetric analysis of research relating to antiphospholipid syndrome based on VOS viewer (2011-2021). Clin Rheumatol 2023. [PMID: 36604357 DOI: 10.1007/s10067-022-06485-5] [Reference Citation Analysis]
|
| 87 |
Pérez-nieto OR, Herrera-venegas CA, Pozos-cortés KP, Flores-ramírez R, Ugalde-real JS, Argüello-bolaños J, Phinder-puente ME, Zamarrón-lópez ÉI, Deloya-tomas E. A Case report of atypical preeclampsia with severity criteria for hydatidiform complete mole.. [DOI: 10.21203/rs.3.rs-2440071/v1] [Reference Citation Analysis]
|
| 88 |
Fayard D, Lobbes H, Pereira B, Ruivard M. Risk of thrombosis associated with antiphospholipid antibodies in immune thrombocytopenic Purpura: A single center retrospective study of 152 patients. Thromb Res 2023;221:7-9. [PMID: 36435049 DOI: 10.1016/j.thromres.2022.11.008] [Reference Citation Analysis]
|
| 89 |
Verrou KM, Sfikakis PP, Tektonidou MG. Whole blood transcriptome identifies interferon-regulated genes as key drivers in thrombotic primary antiphospholipid syndrome. J Autoimmun 2023;134:102978. [PMID: 36587511 DOI: 10.1016/j.jaut.2022.102978] [Reference Citation Analysis]
|
| 90 |
Mendel A, Fritzler MJ, St-Pierre Y, Rauch J, Bernatsky S, Vinet É. Outcomes associated with antiphospholipid antibodies in COVID-19: A prospective cohort study. Res Pract Thromb Haemost 2023;7:100041. [PMID: 36644653 DOI: 10.1016/j.rpth.2023.100041] [Reference Citation Analysis]
|
| 91 |
Abdelrahman W, Sakr SA, Gohar N. Impact of antiphospholipid syndrome on disease characteristics and outcome in patients with systemic lupus erythematosus. The Egyptian Rheumatologist 2023;45:67-72. [DOI: 10.1016/j.ejr.2022.11.002] [Reference Citation Analysis]
|
| 92 |
Foret T, Dufrost V, Heymonet M, Risse J, Faure GC, Louis H, Lagrange J, Lacolley P, Devreese K, Gibot S, Regnault V, Zuily S, Wahl D. Circulating Endothelial Cells are Associated with Thromboembolic Events in Patients with Antiphospholipid Antibodies. Thromb Haemost 2023;123:76-84. [PMID: 35977699 DOI: 10.1055/a-1926-0453] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 93 |
Hernández JL, Napal JJ, Icardo M, Bores PG, Pérez-Montes R, Cerveró A, Salmón Z, Olmos JM, Martínez-Taboada VM. Adjusted global antiphospholipid syndrome score (aGAPSS) is useful to predict relapses in patients with retinal vein occlusion. Thromb Res 2023;221:113-9. [PMID: 36525919 DOI: 10.1016/j.thromres.2022.11.009] [Reference Citation Analysis]
|
| 94 |
Carosso AR, Ruffa A, Evangelisti B, Mercaldo NL, Garolla A, Foresta C, Benedetto C, Revelli A. Preparing the couple for ART: necessary and unnecessary diagnostic tests. Management of Infertility 2023. [DOI: 10.1016/b978-0-323-89907-9.00021-1] [Reference Citation Analysis]
|
| 95 |
Wang J, Lim HY, Brook R, Lai J, Nandurkar H, Ho P. Overall haemostatic potential (OHP) assay can risk stratify for venous thromboembolism recurrence in anticoagulated patients. J Thromb Thrombolysis 2023;55:32-41. [PMID: 35908244 DOI: 10.1007/s11239-022-02686-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 96 |
von Steinburg SP, Schleußner E, Kuon R, Vomstein K, Toth B. Disorders of Early Pregnancy and Pregnancy Loss. The Placenta 2023. [DOI: 10.1007/978-3-662-66256-4_10] [Reference Citation Analysis]
|
| 97 |
Noordermeer T, Urbanus RT, Wong CY, Jansma JJ, Wiersma NM, Zivkovic M, Huisman A, Limper M. Interference in point-of-care international normalized ratio monitoring in patients with lupus anticoagulant is correlated with anti-β2-glycoprotein I antibody titers. Res Pract Thromb Haemost 2023;7:100011. [PMID: 36891523 DOI: 10.1016/j.rpth.2022.100011] [Reference Citation Analysis]
|
| 98 |
Cecchi I, Radin M, Foddai SG, Arbrile M, Barinotti A, Rubini E, Morotti A, Pengo V, Roccatello D, Sciascia S. "How we treat" clinical dilemmas in antiphospholipid syndrome: A case-based approach. Eur J Intern Med 2023;107:1-6. [PMID: 36272871 DOI: 10.1016/j.ejim.2022.10.010] [Reference Citation Analysis]
|
| 99 |
Harsini S, Rezaei N. Autoimmune diseases. Clinical Immunology 2023. [DOI: 10.1016/b978-0-12-818006-8.00001-3] [Reference Citation Analysis]
|
| 100 |
Galea SA, Wilton E. Hypercoagulable states associated with chronic venous insufficiency. Venous Ulcers 2023. [DOI: 10.1016/b978-0-323-90610-4.00018-5] [Reference Citation Analysis]
|
| 101 |
N. Stram M, Gill JR, Ely SF. Recent and ongoing technological advancements in forensic pathology practice. Principles of Forensic Pathology 2023. [DOI: 10.1016/b978-0-323-91796-4.00007-6] [Reference Citation Analysis]
|
| 102 |
Guzmán-Martín CA, Juárez-Vicuña Y, Domínguez-López A, González-Ramírez J, Amezcua-Guerra LM, Martínez-Martínez LA, Sánchez-Muñoz F. lncRNAs dysregulation in monocytes from primary antiphospholipid syndrome patients: a bioinformatic and an experimental proof-of-concept approach. Mol Biol Rep 2023;50:937-41. [PMID: 36367661 DOI: 10.1007/s11033-022-08080-y] [Reference Citation Analysis]
|
| 103 |
Lim MY, Abou-Ismail MY, Branch DW. Differentiating and Managing Rare Thrombotic Microangiopathies During Pregnancy and Postpartum. Obstet Gynecol 2023;141:85-108. [PMID: 36455925 DOI: 10.1097/AOG.0000000000005024] [Reference Citation Analysis]
|
| 104 |
Capozzi A, Riitano G, Recalchi S, Manganelli V, Longo A, Falcou A, De Michele M, Garofalo T, Pulcinelli FM, Sorice M, Misasi R. Antiphospholipid antibodies in patients with stroke during COVID-19: A role in the signaling pathway leading to platelet activation. Front Immunol 2023;14:1129201. [PMID: 36936925 DOI: 10.3389/fimmu.2023.1129201] [Reference Citation Analysis]
|
| 105 |
Sciascia S, Yazdany J, Moroni G, Becker JU, Seshan SV, Andrade D, Emmi G, Cuadrado MJ, Radin M, Cecchi I, De Simone E, Barreca A, Caroti L, Innocenti S, Fenoglio R, Roccatello D. Clinical-pathological characteristics of renal injuries identify different clusters in patients with antiphospholipid antibodies. Kidney International Reports 2023. [DOI: 10.1016/j.ekir.2023.01.018] [Reference Citation Analysis]
|
| 106 |
Tsukamoto Y, Sugimoto T, Umeda M, Kato T, Hiura Y, Morita K, Ariyoshi K. A Patient with Severe Fever with Thrombocytopenia Syndrome, Activated Partial Thromboplastin Time Prolongation, and Transient Antiphospholipid Antibodies. Intern Med 2023. [DOI: 10.2169/internalmedicine.0782-22] [Reference Citation Analysis]
|
| 107 |
Talotta R. The diagnostic laboratory tests in rheumatic diseases. Translational Autoimmunity 2023. [DOI: 10.1016/b978-0-323-85831-1.00007-3] [Reference Citation Analysis]
|
| 108 |
Kojok D, Ghazeeri G, Kutteh W. Recurrent miscarriage. Management of Infertility 2023. [DOI: 10.1016/b978-0-323-89907-9.00026-0] [Reference Citation Analysis]
|
| 109 |
Legros J, Besnard N, Bobbia X. Découverte d’un syndrome catastrophique des antiphospholipides au cours de douleurs intenses des membres. Ann Fr Med Urgence 2023. [DOI: 10.3166/afmu-2022-0471] [Reference Citation Analysis]
|
| 110 |
Li S, Xiao Y, Wang C, Zhao J, Zhang N, Yin Y, Qin L, Jia M, Cui L. Risk factors for adverse pregnancy outcomes in obstetric antiphospholipid syndrome.. [DOI: 10.21203/rs.3.rs-2361740/v1] [Reference Citation Analysis]
|
| 111 |
Christopher N, Periaswamy G, Arunachalam VK, Mangalakumar V, Mehta P, Cherian M. Catastrophic Antiphospholipid Syndrome: A Case Series. Indian J Radiol Imaging 2022. [DOI: 10.1055/s-0042-1759857] [Reference Citation Analysis]
|
| 112 |
Tang Z, Shi H, Liu H, Cheng X, Su Y, Ye J, Sun Y, Hu Q, Chi H, Zhou Z, Jia J, Meng J, Wang M, Wang F, Teng J, Yang C, Liu T. Methylenetetrahydrofolate Reductase 677T Allele Is a Risk Factor for Arterial Thrombosis in Chinese Han Patients with Antiphospholipid Syndrome. Biomedicines 2022;11. [PMID: 36672563 DOI: 10.3390/biomedicines11010055] [Reference Citation Analysis]
|
| 113 |
Durao-Carvalho G, Fernández-González R, Goulden B, Farinha F, Isenberg D. Major determinants of prolonged remission in systemic lupus erythematosus: retrospective study over a 41+ year period. Rheumatology (Oxford) 2022;62:209-16. [PMID: 35451471 DOI: 10.1093/rheumatology/keac242] [Reference Citation Analysis]
|
| 114 |
Ogrič M, Žigon P, Sodin-Semrl S, Zlatković-Švenda M, Zdravković M, Ovuka M, Švec T, Lakota K, Radšel P, Rotar Ž, Čučnik S. Longitudinal Analysis of Antiphospholipid Antibody Dynamics after Infection with SARS-CoV-2 or Vaccination with BNT162b2. Int J Mol Sci 2022;24. [PMID: 36613655 DOI: 10.3390/ijms24010211] [Reference Citation Analysis]
|
| 115 |
Salet DM, Bekkering S, Middeldorp S, van den Hoogen LL. Targeting thromboinflammation in antiphospholipid syndrome. J Thromb Haemost 2022:S1538-7836(22)12803-5. [PMID: 36696191 DOI: 10.1016/j.jtha.2022.12.002] [Reference Citation Analysis]
|
| 116 |
Grabarczyk M, Gorczyca M, Cieślik P, Hrycek A, Holecki M. Addison's Disease in the Course of Recurrent Microangiopathic Antiphospholipid Syndrome-A Clinical Presentation and Review of the Literature. Medicina (Kaunas) 2022;59. [PMID: 36676628 DOI: 10.3390/medicina59010004] [Reference Citation Analysis]
|
| 117 |
van den Hoogen LL, Bisoendial RJ. B-Cells and BAFF in Primary Antiphospholipid Syndrome, Targets for Therapy? J Clin Med 2022;12. [PMID: 36614819 DOI: 10.3390/jcm12010018] [Reference Citation Analysis]
|
| 118 |
Shaikhomar OA, Ali ST. A Comparative Analysis of Anticardiolipin, Anti-Β2-Glycoprotein-1, and Lupus Anticoagulants in Saudi Women with Recurrent Spontaneous Abortions. J Pers Med 2022;13. [PMID: 36675663 DOI: 10.3390/jpm13010002] [Reference Citation Analysis]
|
| 119 |
Park JK, Yi J. Lupus Anticoagulant and Anticardiolipin Antibody IgG are Associated with Increased Atherosclerosis at the Suprainguinal Elastic and Infrainguinal Muscular Arteries in the Abdomen and Lower Extremities. Artery Res 2022. [DOI: 10.1007/s44200-022-00026-w] [Reference Citation Analysis]
|
| 120 |
Shengeliia MO, Bespalova ON, Zhernakova TS, Zagaynova VA, Agnayeva AO, Pachuliia OV, Chepanov SV, Domanskaya MA, Selkov SA, Kogan IY. Immune interface of patients with reproductive loss in the North-West region of the Russian Federation. Journal of obstetrics and women's diseases 2022;71:51-63. [DOI: 10.17816/jowd110886] [Reference Citation Analysis]
|
| 121 |
Coss SL, Zhou D, Chua GT, Aziz RA, Hoffman RP, Wu YL, Ardoin SP, Atkinson JP, Yu CY. The complement system and human autoimmune diseases. J Autoimmun 2022;:102979. [PMID: 36535812 DOI: 10.1016/j.jaut.2022.102979] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 122 |
Kim H, Kim HR, Kang MG, Kim K, Koh JS, Park JR, Hwang SJ, Hwang JY. Native Aortic Valve Thrombus Complicating Intermittent Occlusion of a Left Main Coronary Artery. Intern Med 2022;61:3687-91. [PMID: 35569992 DOI: 10.2169/internalmedicine.9652-22] [Reference Citation Analysis]
|
| 123 |
McLeod B, Lim HY, Nandurkar H, Ho P, Wang J. Overall Hemostatic Potential Assay Detects Risk of Progression to Post-Thrombotic Syndrome in Anticoagulated Patients following Deep Vein Thrombosis. Diagnostics (Basel) 2022;12. [PMID: 36553172 DOI: 10.3390/diagnostics12123165] [Reference Citation Analysis]
|
| 124 |
Melayah S, Ghozzi M, Ghedira I, Mankaï A. Anticardiolipin and anti-beta 2-glycoprotein I antibodies in patients with unexplained articular manifestations. J Clin Lab Anal 2023;37:e24812. [PMID: 36514859 DOI: 10.1002/jcla.24812] [Reference Citation Analysis]
|
| 125 |
Buschulte K, Kreuter M, Schneider U, Casteleyn V. „Enthusiast meets the Experienced“: Pneumo meets … Rheumatologie. Z Pneumologie 2022. [DOI: 10.1007/s10405-022-00483-9] [Reference Citation Analysis]
|
| 126 |
Seguí M, Llamas-Velasco M. A comprehensive review on pathogenesis, associations, clinical findings, and treatment of livedoid vasculopathy. Front Med (Lausanne) 2022;9:993515. [PMID: 36569162 DOI: 10.3389/fmed.2022.993515] [Reference Citation Analysis]
|
| 127 |
Buliková A, Penka M. Venous thromboembolism in antiphosholipid syndrome. Vnitr Lek 2022;68:493-7. [PMID: 36575066 DOI: 10.36290/vnl.2022.106] [Reference Citation Analysis]
|
| 128 |
Weiner JK, Smith T, Hoy CK, Sarosh C, Madison JA, Ambati A, Tambralli A, Peters N, Packel C, Gockman K, Zuo Y, Briceño EM, Nagaraja V, Knight JS. Predictors and Interrelationship of Patient-Reported Outcomes in Antiphospholipid Syndrome: A Cross-Sectional Study. ACR Open Rheumatol 2023;5:28-37. [PMID: 36461647 DOI: 10.1002/acr2.11512] [Reference Citation Analysis]
|
| 129 |
Rangel-Patiño J, Barrera-Vargas A, Govea-Pelaéz S, Merayo-Chalico J, Pérez-Sámano D, Vargas-Serafín O, Demichelis-Gómez R. Splenectomy outcomes in patients with autoimmune cytopenias and persistent antiphospholipid antibodies. Transfusion 2022;62:2639-47. [PMID: 36208143 DOI: 10.1111/trf.17141] [Reference Citation Analysis]
|
| 130 |
Murarasu A, Guettrot-imbert G, Le Guern V, Yelnik C, Queyrel V, Schleinitz N, Ferreira-maldent N, Diot E, Urbanski G, Pannier E, Lazaro E, Souchaud-debouverie O, Orquevaux P, Belhomme N, Morel N, Chauvet E, Maurier F, Le Besnerais M, Abisror N, Goulenok T, Sarrot-reynauld F, Deroux A, Pasquier E, de Moreuil C, Bezanahary H, Pérard L, Limal N, Langlois V, Calas A, Godeau B, Lavigne C, Hachulla E, Cohen F, Benhamou Y, Raffray L, de Menthon M, Tieulié N, Poindron V, Mouthon L, Larosa M, Eléfant E, Sentilhes L, Molto A, Deneux-tharaux C, Costedoat-chalumeau N, Azzi E, Banneville B, Baudet A, Beaudouin-bazire C, Belizna C, Belkhir R, Berezne A, Berthoux E, Berthier S, Biale L, Bienvenu B, Blanchard-delaunay C, Cathebras P, Cazalets C, Chaigne B, Chandesris O, Chatelais J, Chatelus E, Coquerelle P, Couderc M, Delforge J, Denis A, Desouches S, Dieudé P, Direz G, Driessen M, Du Thanh A, Dunogeant L, Durant C, Durieu I, Fabre M, Fain O, Flipo R, Frazier A, Froissart A, Georgin-lavialle S, Gervais E, Gompel A, Gossec L, Goupille P, Grange C, Guillaud-danis C, Hummel A, Jallouli M, Jego P, Jobard S, Josselin-mahr L, Jourde-chiche N, Korganow A, Lambert M, Lariviere D, Larroche C, Lartigau-roussin C, Latourte A, Le Gallou T, Leroux G, Levesque H, Lioté F, London J, Loustau V, Maheu E, Mahevas M, Maillard H, Mariette X, Marotte H, Martin-silva N, Martis N, Masseau A, Mekinian A, Melboucy-belkhir S, Michaud M, Michel M, Morati-hafsaoui C, Nizard J, Ora J, Pennaforte J, Perlat A, Petit Bauer H, Pillebout E, Piot J, Portier A, Pugnet G, Redondin M, Regent A, Richez C, Roriz M, Sailler L, Sauvêtre G, Savey L, Sobanski V, Sordet C, Soubrier M, Stankovic Stojanovic K, Thomas T, Timsit M, Tsatsaris V. Characterisation of a high-risk profile for maternal thrombotic and severe haemorrhagic complications in pregnant women with antiphospholipid syndrome in France (GR2): a multicentre, prospective, observational study. The Lancet Rheumatology 2022;4:e842-e852. [DOI: 10.1016/s2665-9913(22)00308-3] [Reference Citation Analysis]
|
| 131 |
Scarrone M, Canti V, Vanni VS, Bordoli S, Pasi F, Quaranta L, Erra R, De Lorenzo R, Rosa S, Castiglioni MT, Candiani M, Rovere-Querini P. Treating unexplained recurrent pregnancy loss based on lessons learned from obstetric antiphospholipid syndrome and inherited thrombophilia: A propensity-score adjusted retrospective study. J Reprod Immunol 2022;154:103760. [PMID: 36395545 DOI: 10.1016/j.jri.2022.103760] [Reference Citation Analysis]
|
| 132 |
Li H, Zheng Y, Chen L, Lin S. Antinuclear antibody-negative systemic lupus erythematosus: How many patients and how to identify? Arch Rheumatol 2022;37:626-34. [PMID: 36879579 DOI: 10.46497/ArchRheumatol.2022.9366] [Reference Citation Analysis]
|
| 133 |
Álvarez D, Rúa C, Velásquez Berrío M, Cataño JU, Escudero C, Cadavid J ÁP. Extracellular vesicles released upon stimulation with antiphospholipid antibodies: An actual direct procoagulant mechanism or a new factor in the lupus anticoagulant paradox? J Autoimmun 2022;133:102905. [PMID: 36115210 DOI: 10.1016/j.jaut.2022.102905] [Reference Citation Analysis]
|
| 134 |
Radin M, Schreiber K, Cecchi I, Signorelli F, de Jesús G, Aso K, Kono M, Urban ML, Bacco B, Gallo Cassarino S, Lo Sardo L, Foddai SG, Barinotti A, Gómez-garcía I, Quaglia MI, Tissera Y, Gervasoni F, Aguirre-zamorano MÁ, Alba P, Benedetto C, Atsumi T, Amengual O, Emmi G, Andrade D, Marozio L, Roccatello D, Sciascia S. Disease activity at conception predicts lupus flare up to two years after birth: A multicentre long term follow-up study. Seminars in Arthritis and Rheumatism 2022;57:152113. [DOI: 10.1016/j.semarthrit.2022.152113] [Reference Citation Analysis]
|
| 135 |
Serrano M, Espinosa G, Serrano A, Cervera R. COVID-19 and the antiphospholipid syndrome. Autoimmun Rev 2022;21:103206. [PMID: 36195247 DOI: 10.1016/j.autrev.2022.103206] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 136 |
Stoian M, Scarlat G, Șeitan S, Procopiescu B. A Clinical Approach of Lupus Nephritis Associated with Catastrophic Antiphospholipid - Antibody Syndrome - Review and Case Report. Internal Medicine 2022;19:77-87. [DOI: 10.2478/inmed-2022-0231] [Reference Citation Analysis]
|
| 137 |
Schreiber K, Ní Áinle F. Maternal thrombotic and haemorrhagic complications in pregnant women with antiphospholipid syndrome. The Lancet Rheumatology 2022;4:e808-e810. [DOI: 10.1016/s2665-9913(22)00337-x] [Reference Citation Analysis]
|
| 138 |
El Miedany Y, Kamel NS, Abu-zaid MH, El Hadidi K, Mahmoud GA, El Gaafary M, Sarhan E, Abdel-nasser A, Abualfadl EM, Azim AA, Fathi NA, Mokbel A, Hassan W, Eissa M, Tabra SAA, Mortada M, Fouad NA, Elnemr R, Mansour AE, Elaraby I, Medhat BM, Mohamed SS, Abdelradi ER, Ibrahim RA, Saber S. Egyptian recommendations for treating to target of lupus nephritis: an evidence-based consensus on clinical practice recommendations for the management of lupus nephritis and pregnancy. Egypt Rheumatol Rehabil 2022;49:47. [DOI: 10.1186/s43166-022-00142-0] [Reference Citation Analysis]
|
| 139 |
Barilaro G, Coloma-Bazan E, Chacur A, Della Rocca C, Perez-Isidro A, Ruiz-Ortiz E, Viñas O, Tàssies Penella D, Reverter JC, Molina Andujar A, Cervera R, Espinosa G. Persistence of antiphospholipid antibodies over time and its association with recurrence of clinical manifestations: A longitudinal study from a single centre. Autoimmun Rev 2022;21:103208. [PMID: 36202304 DOI: 10.1016/j.autrev.2022.103208] [Reference Citation Analysis]
|
| 140 |
Azoulay LD, Pineton de Chambrun M, Larcher R, Pène F, Argaud L, Mayaux J, Jamme M, Coudroy R, Mathian A, Gibelin A, Azoulay E, Tandjaoui-Lambiotte Y, Dargent A, Beloncle F, Raphalen JH, Troger A, de Prost N, Devaquet J, Contou D, Gaugain S, Trouiller P, Grangé S, Ledochowski S, Lemarie J, Faguer S, Degos V, Moyon Q, Luyt CE, Kerneis M, Combes A, Amoura Z. Prevalence, characteristics and outcome of cardiac manifestations in critically-ill antiphospholipid syndrome patients. J Autoimmun 2022;133:102908. [PMID: 36126365 DOI: 10.1016/j.jaut.2022.102908] [Reference Citation Analysis]
|
| 141 |
Stamm B, Barbhaiya M, Siegel C, Lieber S, Lockshin M, Sammaritano L. Infertility in systemic lupus erythematosus: what rheumatologists need to know in a new age of assisted reproductive technology. Lupus Sci Med 2022;9. [PMID: 36600642 DOI: 10.1136/lupus-2022-000840] [Reference Citation Analysis]
|
| 142 |
Kits A, Pantalone MR, Illies C, Antovic A, Landtblom AM, Iacobaeus E. Fatal Acute Hemorrhagic Encephalomyelitis and Antiphospholipid Antibodies following SARS-CoV-2 Vaccination: A Case Report. Vaccines (Basel) 2022;10. [PMID: 36560456 DOI: 10.3390/vaccines10122046] [Reference Citation Analysis]
|
| 143 |
Capecchi M, Abbattista M, Ciavarella A, Uhr M, Novembrino C, Martinelli I. Anticoagulant Therapy in Patients with Antiphospholipid Syndrome. J Clin Med 2022;11. [PMID: 36498557 DOI: 10.3390/jcm11236984] [Reference Citation Analysis]
|
| 144 |
Favaloro EJ, Pasalic L, Lippi G. Autoimmune Diseases Affecting Hemostasis: A Narrative Review. Int J Mol Sci 2022;23. [PMID: 36499042 DOI: 10.3390/ijms232314715] [Reference Citation Analysis]
|
| 145 |
Toth B, Bohlmann M, Hancke K, Kuon R, Nawroth F, von Otte S, Rogenhofer N, Rudnik-schöneborn S, Schleußner E, Tempfer C, Vomstein K, Wischmann T, von Wolff M, Würfel W, Zschocke J. Recurrent Miscarriage: Diagnostic and Therapeutic Procedures. Guideline of the DGGG, OEGGG and SGGG (S2k-Level, AWMF Registry No. 015/050, May 2022). Geburtshilfe Frauenheilkd 2022. [DOI: 10.1055/a-1895-9940] [Reference Citation Analysis]
|
| 146 |
Fernández-Buhigas I. Obstetric management of the most common autoimmune diseases: A narrative review. Front Glob Womens Health 2022;3:1031190. [PMID: 36505012 DOI: 10.3389/fgwh.2022.1031190] [Reference Citation Analysis]
|
| 147 |
Solow EB, Mineo C. Editorial: Cardiovascular diseases in autoimmune diseases: Dyslipidemia and vascular inflammation. Front Cardiovasc Med 2022;9. [DOI: 10.3389/fcvm.2022.1043669] [Reference Citation Analysis]
|
| 148 |
Ganapati A, Mathew J, Yadav B, Kabeerdoss J, Gowri M, Dave RG, Thankachen R, Nair SC. Comparison of Point-of-Care PT-INR by Hand-Held Device with Conventional PT-INR Testing in Anti-phospholipid Antibody Syndrome Patients on Oral Anticoagulation. Indian J Hematol Blood Transfus 2022. [DOI: 10.1007/s12288-022-01611-4] [Reference Citation Analysis]
|
| 149 |
Baños N, Castellanos AS, Barilaro G, Figueras F, Lledó GM, Santana M, Espinosa G. Early Prediction of Adverse Pregnancy Outcome in Women with Systemic Lupus Erythematosus, Antiphospholipid Syndrome, or Non-Criteria Obstetric Antiphospholipid Syndrome. J Clin Med 2022;11. [PMID: 36431299 DOI: 10.3390/jcm11226822] [Reference Citation Analysis]
|
| 150 |
Martínez-Taboada VM, Blanco-Olavarri P, Del Barrio-Longarela S, Riancho-Zarrabeitia L, Merino A, Comins-Boo A, López-Hoyos M, Hernández JL. Non-Criteria Obstetric Antiphospholipid Syndrome: How Different Is from Sidney Criteria? A Single-Center Study. Biomedicines 2022;10. [PMID: 36428506 DOI: 10.3390/biomedicines10112938] [Reference Citation Analysis]
|
| 151 |
Saini A, Wilkie G, Dumont T. Catastrophic Antiphospholipid syndrome after pregnancy complicated by hemolysis, elevated liver enzymes and low platelets syndrome. Obstet Med 2022. [DOI: 10.1177/1753495x221137941] [Reference Citation Analysis]
|
| 152 |
Gamal SM, Mokbel A, Niazy MH, Elgengehy FT, Elsaid NY, Fouad NA, Sobhy N, Tantawy M, Mohamed SS, Ghaleb RM, Abdelaleem EA, El-Zorkany B. Comorbidities among Egyptian systemic lupus erythematosus: The COMOSLE-EGYPT study. Chronic Illn 2022;:17423953221138921. [PMID: 36373605 DOI: 10.1177/17423953221138921] [Reference Citation Analysis]
|
| 153 |
Cheldieva FA, Reshetnyak TM, Shumilova AA, Nurbaeva KS, Cherkasova MV, Lila AM, Nasonov EL. Global antiphospholipid syndrome score (GAPSS) in patients with systemic lupus erythematosus. Naučno-praktičeskaâ revmatologiâ 2022;60:546-553. [DOI: 10.47360/1995-4484-2022-546-553] [Reference Citation Analysis]
|
| 154 |
Spiliopoulou P, Rensburg HJV, Avery L, Kulasingam V, Razak A, Bedard P, Hansen A, Chruscinski A, Wang B, Kulikova M, Chen R, Speers V, Nguyen A, Lee J, Coburn B, Spreafico A, Siu L. Longitudinal efficacy and toxicity of SARS-CoV-2 vaccination in cancer patients treated with immunotherapy.. [DOI: 10.21203/rs.3.rs-2214679/v1] [Reference Citation Analysis]
|
| 155 |
Valke LLFG, Rijpma S, Meijer D, Schols SEM, van Heerde WL. Thrombin generation assays to personalize treatment in bleeding and thrombotic diseases. Front Cardiovasc Med 2022;9. [DOI: 10.3389/fcvm.2022.1033416] [Reference Citation Analysis]
|
| 156 |
Moraes-fontes MF, Pedro F, Campos MM, Fernandes M, Yavuz S, Oliveira F, Panarra A. Primary Anti-Phospholipid Antibody Syndrome: Real-World Defining Features of Rethrombosis in the Course of Disease. International Journal of Rheumatology 2022;2022:1-7. [DOI: 10.1155/2022/7331586] [Reference Citation Analysis]
|
| 157 |
Yafoshkina TY, Fedorova DV, Poletaev AV, Seregina EA, Zharkov PA. Thrombophilia in children with venous thrombosis. Ross ž det gematol onkol 2022;9:75-82. [DOI: 10.21682/2311-1267-2022-9-3-75-82] [Reference Citation Analysis]
|
| 158 |
Specker C. Therapeutische Aspekte beim Antiphospholipidsyndrom. Aktuelle Rheumatologie 2022. [DOI: 10.1055/a-1927-0834] [Reference Citation Analysis]
|
| 159 |
Meisinger C, Kirchberger I, Warm TD, Hyhlik-Dürr A, Goßlau Y, Linseisen J. Elevated Plasma D-Dimer Concentrations in Adults after an Outpatient-Treated COVID-19 Infection. Viruses 2022;14. [PMID: 36366539 DOI: 10.3390/v14112441] [Reference Citation Analysis]
|
| 160 |
Gan Y, Zhong X, Zhao Y, Li G, Ye H, Li C. Low dose versus standard dose rituximab for the treatment of antiphospholipid syndrome: A pilot study from a tertiary medical center. Front Immunol 2022;13. [DOI: 10.3389/fimmu.2022.971366] [Reference Citation Analysis]
|
| 161 |
Mahdy SH, Abd Elkader NM, Kassim NA, Elhady MM. Genetic variation in toll-like receptor 4 gene with primary antiphospholipid syndrome susceptibility: a cohort of Egyptian patients. Egypt J Med Hum Genet 2022;23:148. [DOI: 10.1186/s43042-022-00363-0] [Reference Citation Analysis]
|
| 162 |
Noble H, Crossette-Thambiah C, Odho Z, Karawitage N, Logan K, Pericleous C, Laffan M, Arachchillage DJ. Frequency and Clinical Significance Anti-PS/PT Antibodies in Patients with Antiphospholipid Syndrome - Single Centre Observational Study in the United Kingdom. Semin Thromb Hemost 2022. [PMID: 36318961 DOI: 10.1055/s-0042-1757633] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 163 |
Bhoelan S, Borjas Howard J, Tichelaar V, van Daele P, Hak L, Voskuyl A, Limper M, Goekoop R, Teng O, Vosters J, Bijl M, Zirkzee E, Schilder A, Bernelot Moens H, de Leeuw K, Meijer K. Recurrence risk of venous thromboembolism associated with systemic lupus erythematosus: A retrospective cohort study. Res Pract Thromb Haemost 2022;6. [DOI: 10.1002/rth2.12839] [Reference Citation Analysis]
|
| 164 |
Reiter T, Demirbas S, Schmalzing M, Voelker W, Bauer WR, Güder G. CMR detects extensive intracavitary thrombi as solitary clinical presentation of Antiphospholipid Syndrome: A case report. Clinical Case Reports 2022;10. [DOI: 10.1002/ccr3.6568] [Reference Citation Analysis]
|
| 165 |
Teng Wu, Wei Huang, Jiaping Qi, Yixuan Li, Yuan Zhang, Huan Jiang, Jing Wang, Ju Zhang, Zhaoyu Jiang, Lin Chen, Zhenhua Ying. Research trends and frontiers on antiphospholipid syndrome: A 10-year bibliometric analysis (2012–2021). Front Pharmacol 2022;13:1035229. [PMID: 36386238 DOI: 10.3389/fphar.2022.1035229] [Reference Citation Analysis]
|
| 166 |
Baiazid L, Hraib M. Effects of low-dose aspirin and heparin on the pregnancy outcome in women with antiphospholipid syndrome. Annals of Medicine and Surgery 2022;83:104807. [DOI: 10.1016/j.amsu.2022.104807] [Reference Citation Analysis]
|
| 167 |
Lin T, Tsai M, Lee J, Yang Y, Lin Y, Yu H, Chiang B, Wang L. The Outcome of Kidney Transplantation in Lupus Patients.. [DOI: 10.21203/rs.3.rs-2183628/v1] [Reference Citation Analysis]
|
| 168 |
Liu X, Zhu L, Liu H, Cai Q, Yun Z, Sun F, Jia Y, Guo J, Li C. Non-criteria antiphospholipid antibodies in antiphospholipid syndrome: Diagnostic value added. Front Immunol 2022;13. [DOI: 10.3389/fimmu.2022.972012] [Reference Citation Analysis]
|
| 169 |
Moghbel M, Roth A, Baptista D, Miteva K, Burger F, Montecucco F, Vuilleumier N, Mach F, Brandt KJ. Epitope of antiphospholipid antibodies retrieved from peptide microarray based on R39-R43 of β2-glycoprotein I. Res Pract Thromb Haemost 2022;6:e12828. [PMID: 36304483 DOI: 10.1002/rth2.12828] [Reference Citation Analysis]
|
| 170 |
Aseeva EA, Lila AM, Soloviev SK, Nasonov EL, Glukhova SI. Clinical and immunological phenotypes of systemic lupus erythematosus, identified based on cluster analysis of data from 400 patients from V.A. Nasonova Research Institute of Rheumatology. Sovremennaâ revmatologiâ 2022;16:13-21. [DOI: 10.14412/1996-7012-2022-5-13-21] [Reference Citation Analysis]
|
| 171 |
Neto TS, Neto ED, Balbi GG, Signorelli F, Higashi AH, Monteiro MLR, Bonfá E, Zacharias LC, Andrade DC. Ocular findings in asymptomatic patients with primary antiphospholipid syndrome. Lupus 2022;:9612033221133687. [PMID: 36239237 DOI: 10.1177/09612033221133687] [Reference Citation Analysis]
|
| 172 |
Stanisavljevic N, Stojanovich L, Djokovic A, Todic B, Dopsaj V, Saponjski J, Saponjski D, Markovic O, Belizna C, Zdravkovic M, Marisavljevic D. Asymmetric Dimethylarginine Is a Marker of Endothelial Dysfunction in Thrombotic Antiphospholipid Syndrome Patients. Int J Mol Sci 2022;23. [PMID: 36293156 DOI: 10.3390/ijms232012309] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 173 |
Peuranpää PL, Gissler M, Peltopuro P, Tiitinen A, Hautamäki H. The effect of paternal and maternal factors on the prognosis of live birth in couples with recurrent pregnancy loss. Acta Obstet Gynecol Scand 2022;101:1374-85. [PMID: 36210542 DOI: 10.1111/aogs.14469] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 174 |
Erton ZB, K Leaf R, de Andrade D, Clarke AE, Tektonidou MG, Pengo V, Sciascia S, Ugarte A, Belmont HM, Gerosa M, Fortin PR, Lopez-Pedrera C, Atsumi T, Zhang Z, Cohen H, Ramires de Jesús G, Branch DW, Wahl D, Andreoli L, Rodriguez-Almaraz E, Petri M, Barilaro G, Zuo Y, Artim-Esen B, Willis R, Quintana R, Vendramini MB, Barber MW, Bertolaccini ML, Roubey R, Erkan D. Immunosuppression use in primary antiphospholipid antibody-positive patients: Descriptive analysis of the AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) Clinical Database and Repository ("Registry"). Lupus 2022;:9612033221128742. [PMID: 36206383 DOI: 10.1177/09612033221128742] [Reference Citation Analysis]
|
| 175 |
Migliorini S, Santoro C, Scatteia A, Dellegrottaglie S, Tufano A, Cuomo V, Pilato E, Comentale G, D’armiento M, Guida M, Sarno L. A Rare Case of Tricuspid Valve Libman–Sacks Endocarditis in a Pregnant Woman with Primary Antiphospholipid Syndrome. JCM 2022;11:5875. [DOI: 10.3390/jcm11195875] [Reference Citation Analysis]
|
| 176 |
Silva CA, Medeiros-Ribeiro AC, Kupa LVK, Yuki EFN, Pasoto SG, Saad CGS, Fusco SRG, Pereira RMR, Shinjo SK, Halpern ASR, Borba EF, Souza FHC, Guedes LKN, Miossi R, Bonfiglioli KR, Domiciano DS, Shimabuco AY, Andrade DCO, Seguro LPC, Fuller R, Sampaio-Barros PD, Assad APL, Moraes JCB, Goldenstein-Schainberg C, Giardini HAM, Silva HC, Martins VAO, Villamarin LEB, Novellino RS, Sales LP, Araújo CSR, Silva MSR, Filho DMN, Lopes MH, Duarte AJS, Kallas EG, Aikawa NE, Bonfa E. Immunogenicity decay and case incidence six months post Sinovac-CoronaVac vaccine in autoimmune rheumatic diseases patients. Nat Commun 2022;13:5801. [PMID: 36192386 DOI: 10.1038/s41467-022-33042-0] [Reference Citation Analysis]
|
| 177 |
Kayser C, Dutra LA, Dos Reis-Neto ET, Castro CHM, Fritzler MJ, Andrade LEC. The Role of Autoantibody Testing in Modern Personalized Medicine. Clin Rev Allergy Immunol 2022;63:251-88. [PMID: 35244870 DOI: 10.1007/s12016-021-08918-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 178 |
Redondo Villatoro A, Carmona Domínguez E, Barroso Castro J. Actualización sobre trombofilias y gestación. Clínica e Investigación en Ginecología y Obstetricia 2022;49:100794. [DOI: 10.1016/j.gine.2022.100794] [Reference Citation Analysis]
|
| 179 |
Mustafa R. Neurologic Manifestations of Catastrophic Antiphospholipid Syndrome. Curr Neurol Neurosci Rep 2022;22:589-600. [PMID: 36040563 DOI: 10.1007/s11910-022-01228-0] [Reference Citation Analysis]
|
| 180 |
Morad CS, Fayez D, Mahmoud M, Aboud FM. Primary and secondary antiphospholipid syndrome characteristics in an Egyptian cohort. The Egyptian Rheumatologist 2022;44:373-376. [DOI: 10.1016/j.ejr.2022.07.006] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 181 |
Hubben A, McCrae KR. Emerging Therapies in Antiphospholipid Syndrome. Transfus Med Rev 2022;36:195-203. [PMID: 36272841 DOI: 10.1016/j.tmrv.2022.09.002] [Reference Citation Analysis]
|
| 182 |
Djokovic A, Stojanovich L, Stanisavljevic N, Matic P, Colic D, Skrijelj D, Djokic S, Filipovic B. Analysis of Serbian Primary Antiphospholipid Syndrome Patients Confirmed a Strong Association Between Livedo Reticularis and Arterial Thrombosis: A National Cross-Sectional Cohort Study. J Clin Rheumatol 2022;28:362-6. [PMID: 35697016 DOI: 10.1097/RHU.0000000000001879] [Reference Citation Analysis]
|
| 183 |
Urrego-callejas T, Hernández A, Ruiz Giraldo S, Frade-sosa B, Vanegas-garcía AL, Muñoz CH, Rua C, Duque Botero J, González LA, Vásquez G, Gómez-puerta JA. Importancia de los títulos de anticuerpos antifosfolípidos no criterio entre pacientes con síndrome antifosfolípido primario y pacientes con lupus eritematoso sistémico. Reumatología Clínica 2022. [DOI: 10.1016/j.reuma.2022.07.003] [Reference Citation Analysis]
|
| 184 |
Masson C, An Nguyen TT, Dufrost V, Audrain M, Hémont C, Agard C, Artifoni M, Connault J, Fouassier M, Hamidou M, Guedon AF, Wahl D, Zuily S, Espitia O. Antiphospholipid syndrome in patients over 65 years: A comparative study of clinical and biological features and thrombotic relapses. Lupus 2022;:9612033221130975. [PMID: 36177950 DOI: 10.1177/09612033221130975] [Reference Citation Analysis]
|
| 185 |
Saulescu IC, Opris-belinski D, Balanescu AR, Pavel B, Gica N, Panaitescu AM. Preparing for Pregnancy in Women with Systemic Lupus Erythematosus—A Multidisciplinary Approach. Medicina 2022;58:1371. [DOI: 10.3390/medicina58101371] [Reference Citation Analysis]
|
| 186 |
Becker YLC, Duvvuri B, Fortin PR, Lood C, Boilard E. The role of mitochondria in rheumatic diseases. Nat Rev Rheumatol 2022. [PMID: 36175664 DOI: 10.1038/s41584-022-00834-z] [Reference Citation Analysis]
|
| 187 |
Li S, Zhao Y, Sun Z, Guo Y, Deng X, Liu Y, Zhang T, Shu Q. Outcomes and Influencing Factors of 126 Pregnancy Patients with Undifferentiated Connective Tissue Disease: A Real-world Prospective Study.. [DOI: 10.21203/rs.3.rs-2070032/v1] [Reference Citation Analysis]
|
| 188 |
Štok U, Štucin N, Blokar E, Ambrožič A, Sodin-šemrl S, Čučnik S, Žigon P. Antiphospholipid Antibody Syndrome-Associated Increased Surface Expression of VLA4 Integrin on Human Monocytes. Biomedicines 2022;10:2341. [DOI: 10.3390/biomedicines10102341] [Reference Citation Analysis]
|
| 189 |
Fischer K, Przepiera-będzak H, Brzosko I, Sawicki M, Walecka A, Brzosko M. Anti-Phosphatidylethanolamine and Anti-Phosphatidylserine Antibodies—Association with Renal Involvement, Atherosclerosis, Cardiovascular Manifestations, Raynaud Phenomenon and Disease Activity in Polish Patients with Systemic Lupus Erythematosus. Biomolecules 2022;12:1328. [DOI: 10.3390/biom12101328] [Reference Citation Analysis]
|
| 190 |
Erazo-martínez V, Ruiz-ordoñez I, Álvarez C, Serrano L, Aragón CC, Tobón GJ, Concha S, Lasso R, Ramírez L. Characterization of Pediatric Patients with Rheumatological Diseases Admitted to a Single Tertiary Health Hospital's Pediatric Intensive Care Unit in Latin America. J Pediatr Intensive Care 2022. [DOI: 10.1055/s-0042-1755444] [Reference Citation Analysis]
|
| 191 |
Gris JC, Bourguignon C, Bouvier S, Nouvellon É, Laurent J, Perez-Martin A, Mousty È, Nikolaeva MG, Khizroeva J, Bitsadze V, Makatsariya A. Combined oral contraceptive-associated venous thromboembolism revealing an antiphospholipid syndrome: International retrospective study of outcomes. Thromb Res 2022;219:102-8. [PMID: 36152459 DOI: 10.1016/j.thromres.2022.09.013] [Reference Citation Analysis]
|
| 192 |
Lee NA, Jeong ES, Jang HS, Park YC, Kang JH, Kim JC, Jo YG. Antiphospholipid syndrome with renal and splenic infarction after blunt trauma: A case report. World J Clin Cases 2022; 10(26): 9404-9410 [DOI: 10.12998/wjcc.v10.i26.9404] [Reference Citation Analysis]
|
| 193 |
Kitagata Y, Tsuneyoshi H, Katayama H, Wada T, Yamada K. Successful Heparin Management Using HMS PLUS for a Patient with Endocarditis and Antiphospholipid Syndrome Undergoing Valve Replacement. J J C V S 2022;51:280-284. [DOI: 10.4326/jjcvs.51.280] [Reference Citation Analysis]
|
| 194 |
Loiseau P, Foret T, Defilippis EM, Risse J, Etienne AD, Dufrost V, Moulinet T, Erkan D, Devilliers H, Wahl D, Zuily S. Risk of livedo with antiphospholipid antibodies in patients with systemic lupus erythematosus: A systematic review and meta-analysis. Lupus. [DOI: 10.1177/09612033221126852] [Reference Citation Analysis]
|
| 195 |
Gris J, Guillotin F, Chéa M, Bourguignon C, Nouvellon É, Bouvier S. Antiphospholipid Antibodies in Pregnancy: Maternal and Neonatal Implications. Semin Thromb Hemost. [DOI: 10.1055/s-0042-1756193] [Reference Citation Analysis]
|
| 196 |
Radin M, Barinotti A, Cecchi I, Foddai SG, Rubini E, Roccatello D, Menegatti E, Sciascia S. Thrombin generation assay and lupus anticoagulant synergically distinguish populations of patients with antiphospholipid antibodies. J Clin Pathol 2022:jclinpath-2022-208199. [PMID: 36100400 DOI: 10.1136/jcp-2022-208199] [Reference Citation Analysis]
|
| 197 |
Naranjo L, Stojanovich L, Djokovic A, Andreoli L, Tincani A, Maślińska M, Sciascia S, Infantino M, Garcinuño S, Kostyra-grabczak K, Manfredi M, Regola F, Stanisavljevic N, Milanovic M, Saponjski J, Roccatello D, Cecchi I, Radin M, Benucci M, Pleguezuelo D, Serrano M, Shoenfeld Y, Serrano A. Circulating immune-complexes of IgG/IgM bound to B2-glycoprotein-I associated with complement consumption and thrombocytopenia in antiphospholipid syndrome. Front Immunol 2022;13:957201. [DOI: 10.3389/fimmu.2022.957201] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 198 |
Sayar Z, Burke S, Mittal P, Cohen H. The use of fondaparinux and rituximab for recurrent thrombotic events in antiphospholipid syndrome. Lupus 2022;:9612033221122147. [PMID: 36074077 DOI: 10.1177/09612033221122147] [Reference Citation Analysis]
|
| 199 |
Butt A, Erkan D, Lee AI. COVID-19 and antiphospholipid antibodies. Best Pract Res Clin Haematol 2022;35:101402. [PMID: 36494152 DOI: 10.1016/j.beha.2022.101402] [Reference Citation Analysis]
|
| 200 |
Ong J, Bennett A. A review of laboratory considerations in thrombophilia testing. Pathology 2022. [DOI: 10.1016/j.pathol.2022.09.001] [Reference Citation Analysis]
|
| 201 |
Yao WC, Leong KH, Chiu LT, Chou PY, Wu LC, Chou CY, Kuo CF, Tsai SY. The trends in the incidence and thrombosis-related comorbidities of antiphospholipid syndrome: a 14-year nationwide population-based study. Thromb J 2022;20:50. [PMID: 36050731 DOI: 10.1186/s12959-022-00409-8] [Reference Citation Analysis]
|
| 202 |
Bilici Salman R, Haznedaroğlu S. Relationship between antibodies and clinical manifestations in systemic lupus erythematosus. raed 2022;14:66-73. [DOI: 10.4274/raed.galenos.2022.57966] [Reference Citation Analysis]
|
| 203 |
Skoura R, Andronikidi P, Anestakis D, Petanidis S, Orovou E, Tzitiridou M, Eskitzis P. Antiphospholipid Syndrome and Preeclampsia in Pregnancy: A Case Report. Cureus 2022. [DOI: 10.7759/cureus.28458] [Reference Citation Analysis]
|
| 204 |
Moroni G, Calatroni M, Ponticelli C. Severe lupus nephritis in the present days. Front Nephrol 2022;2. [DOI: 10.3389/fneph.2022.984613] [Reference Citation Analysis]
|
| 205 |
Reshetnyak T, Cheldieva F, Cherkasova M, Lila A, Nasonov E. IgA Antiphospholipid Antibodies in Antiphospholipid Syndrome and Systemic Lupus Erythematosus. Int J Mol Sci 2022;23. [PMID: 36012697 DOI: 10.3390/ijms23169432] [Cited by in Crossref: 4] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 206 |
Mahmud SA, Bullock DR, Correll CK, Hobday PM, Riskalla MM, Vehe RK, Binstadt BA. Non-criteria antiphospholipid antibodies and pediatric rheumatic disease: a case series. Pediatr Rheumatol Online J 2022;20:70. [PMID: 35987646 DOI: 10.1186/s12969-022-00732-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 207 |
Meroni PL, Grossi C, Tedesco F. Pathogenesis of the obstetric antiphospholipid syndrome: the key role of beta 2 glycoprotein I. Explor Immunol 2022. [DOI: 10.37349/ei.2022.00064] [Reference Citation Analysis]
|
| 208 |
Vandevelde A, Devreese KMJ. Role of anti-phosphatidylserine/prothrombin antibodies in antiphospholipid syndrome: Still matter of debate. Comment on: "Prevalence of aPhosphatidylserine/prothrombin antibodies and association with antiphospholipid antibody profiles in patients with antiphospholipid syndrome: A systematic review and meta-analysis". Thromb Res 2022;218:169-70. [PMID: 36057166 DOI: 10.1016/j.thromres.2022.08.012] [Reference Citation Analysis]
|
| 209 |
Pires da Rosa G, Ferreira E, Sousa-pinto B, Rodríguez-pintó I, Brito I, Mota A, Cervera R, Espinosa G. Comparison of non-criteria antiphospholipid syndrome with definite antiphospholipid syndrome: A systematic review. Front Immunol 2022;13:967178. [DOI: 10.3389/fimmu.2022.967178] [Reference Citation Analysis]
|
| 210 |
Schulz A, Herrmann E, Ott O, Lindhoff-Last E. Thromboembolic Antiphospholipid Syndrome (APS): Efficacy and Safety of Different Anticoagulants-Results of the APSantiCO Registry. J Clin Med 2022;11. [PMID: 36013082 DOI: 10.3390/jcm11164845] [Reference Citation Analysis]
|
| 211 |
Rousselin C, Amoura Z, Faguer S, Bataille P, Boffa JJ, Canaud G, Guerrot D, Jourde-Chiche For The Gclr N, Karras A, Auxenfants E, Chapelet A, Lambert M, Behal H, Nochy D, Jean-Paul DVH, Brocheriou For The Cfpr I, Gnemmi V, Quemeneur T. Renal and vascular outcomes in patients with isolated antiphospholipid syndrome nephropathy. J Autoimmun 2022;132:102889. [PMID: 35987174 DOI: 10.1016/j.jaut.2022.102889] [Reference Citation Analysis]
|
| 212 |
Liang H, Ma C, Chen X. Case report: Mitral valve replacement for Libman-Sacks endocarditis and cerebral embolism of primary antiphospholipid syndrome. Front Cardiovasc Med 2022;9. [DOI: 10.3389/fcvm.2022.985111] [Reference Citation Analysis]
|
| 213 |
Jin J, Xu X, Hou L, Hou Y, Li J, Liang M, Li C. Thrombocytopenia in the first trimester predicts adverse pregnancy outcomes in obstetric antiphospholipid syndrome. Front Immunol 2022;13:971005. [DOI: 10.3389/fimmu.2022.971005] [Reference Citation Analysis]
|
| 214 |
Bobircă A, Dumitrache A, Alexandru C, Florescu A, Ciobotaru G, Bobircă F, Sima R, Poalelungi C, Bojincă M, Ancuța I. Pathophysiology of Placenta in Antiphospholipid Syndrome. Physiologia 2022;2:66-79. [DOI: 10.3390/physiologia2030007] [Reference Citation Analysis]
|
| 215 |
Lee YH, Song GG. Direct oral anticoagulants versus warfarin in patients with antiphospholipid syndrome: A meta-analysis of randomized controlled trials. Lupus. [DOI: 10.1177/09612033221118463] [Reference Citation Analysis]
|
| 216 |
Cheng C, Bison E, Pontara E, Cattini MG, Tonello M, Denas G, Pengo V. Platelet- and endothelial-derived microparticles in the context of different antiphospholipid antibody profiles. Lupus. [DOI: 10.1177/09612033221118465] [Reference Citation Analysis]
|
| 217 |
Karathanasis DK, Rapti A, Nezos A, Skarlis C, Kilidireas C, Mavragani CP, Evangelopoulos ME. Differentiating central nervous system demyelinating disorders: The role of clinical, laboratory, imaging characteristics and peripheral blood type I interferon activity. Front Pharmacol 2022;13:898049. [DOI: 10.3389/fphar.2022.898049] [Reference Citation Analysis]
|
| 218 |
Bradáčová P, Slavík L, Skoumalová A, Úlehlová J, Kriegová E, Manukyan G, Friedecký D, Piskláková B, Ullrychová J, Procházková J, Hluší A. Determination of Thrombogenicity Levels of Various Antiphospholipid Antibodies by a Modified Thrombin Generation Assay in Patients with Suspected Antiphospholipid Syndrome. Int J Mol Sci 2022;23. [PMID: 36012233 DOI: 10.3390/ijms23168973] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 219 |
Pontara E, Cattini MG, Bison E, Cheng C, Denas G, Pengo V. Antiphospholipid syndrome: Reversal of antiphosphatidylserine/prothrombin-induced activated protein C resistance. Thromb Res 2022;218:17-23. [PMID: 35973396 DOI: 10.1016/j.thromres.2022.08.004] [Reference Citation Analysis]
|
| 220 |
Sciascia S, Bloch R, O’malley T, Kammesheidt A, Alexander RV. Antiphospholipid antibodies are persistently positive at high titers. Additive value of platelet-bound C4d. Front Immunol 2022;13:949919. [DOI: 10.3389/fimmu.2022.949919] [Reference Citation Analysis]
|
| 221 |
Ceccarelli F, Natalucci F, Olivieri G, Pirone C, Picciariello L, Orefice V, Truglia S, Spinelli FR, Alessandri C, Chistolini A, Conti F. Development of Systemic Autoimmune Diseases in Healthy Subjects Persistently Positive for Antiphospholipid Antibodies: Long-Term Follow-Up Study. Biomolecules 2022;12:1088. [PMID: 36008983 DOI: 10.3390/biom12081088] [Reference Citation Analysis]
|
| 222 |
Mahroum N, Elsalti A, Alwani A, Seida I, Alrais M, Seida R, Esirgun SN, Abali T, Kiyak Z, Zoubi M, Shoenfeld Y. The mosaic of autoimmunity - Finally discussing in person. The 13th international congress on autoimmunity 2022 (AUTO13) Athens. Autoimmun Rev 2022;:103166. [PMID: 35932955 DOI: 10.1016/j.autrev.2022.103166] [Reference Citation Analysis]
|
| 223 |
Sanlés González I, Napal Lecumberri J, Pérez-montes R, Cerveró Varona A, Casado Rojo A, Hernández Hernández J. Retinal vein occlusion in patients under 50 years. Analysis of vascular risk factors, thrombophilia, carotid ultrasound findings and uncommon aetiologies. Archivos de la Sociedad Española de Oftalmología (English Edition) 2022;97:443-449. [DOI: 10.1016/j.oftale.2021.12.002] [Reference Citation Analysis]
|
| 224 |
Sloan EE, McCurdy D. The Antiphospholipid Syndrome in the Pediatric Population. Adv Pediatr 2022;69:107-21. [PMID: 35985703 DOI: 10.1016/j.yapd.2022.03.013] [Reference Citation Analysis]
|
| 225 |
Masucci M, Li Kam Wa A, Shingleton E, Martin J, Mahir Z, Breen K. Point of care testing to monitor INR control in patients with antiphospholipid syndrome. eJHaem 2022;3:899-902. [DOI: 10.1002/jha2.522] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 226 |
Studt J, Trinchero A. Gerinnungshemmung in Schwangerschaft und Wochenbett. Gynäkologie 2022;55:567-574. [DOI: 10.1007/s00129-022-04965-y] [Reference Citation Analysis]
|
| 227 |
Sanlés González I, Napal Lecumberri J, Pérez-montes R, Cerveró Varona A, Casado Rojo A, Hernández Hernández J. Oclusión venosa retiniana en pacientes menores de 50 años. Análisis de factores de riesgo vascular, trombofilia, hallazgos ecográficos carotídeos y etiologías poco frecuentes. Archivos de la Sociedad Española de Oftalmología 2022;97:443-449. [DOI: 10.1016/j.oftal.2021.12.003] [Reference Citation Analysis]
|
| 228 |
McDonnell T, Amarnani R, Spicer C, Jbari H, Pericleous C, Spiteri VA, Wincup C, Artim-Esen B, Mackie I, Botto M, Rahman A, Giles I. Antibodies to FXa and thrombin in patients with SLE differentially regulate C3 and C5 cleavage. Lupus Sci Med 2022;9. [PMID: 36007979 DOI: 10.1136/lupus-2022-000738] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 229 |
Ireifej B, Freijat M, Song D, Shah N, Mukherjee D, Jaiswal V. Aortitis presenting as acute myeloid leukemia - A case report. Annals of Medicine and Surgery 2022;80:104255. [DOI: 10.1016/j.amsu.2022.104255] [Reference Citation Analysis]
|
| 230 |
Yamada H, Deguchi M, Saito S, Takeshita T, Mitsui M, Saito T, Nagamatsu T, Takakuwa K, Nakatsuka M, Yoneda S, Egashira K, Tachibana M, Matsubara K, Honda R, Fukui A, Tanaka K, Sengoku K, Endo T, Yata H. Intravenous immunoglobulin treatment in women with four or more recurrent pregnancy losses: A double-blind, randomised, placebo-controlled trial. EClinicalMedicine 2022;50:101527. [PMID: 35795714 DOI: 10.1016/j.eclinm.2022.101527] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 231 |
Song X, Fan Y, Jia Y, Li G, Liu M, Xu Y, Zhang J, Li C. A novel aGAPSS-based nomogram for the prediction of ischemic stroke in patients with antiphospholipid syndrome. Front Immunol 2022;13:930087. [DOI: 10.3389/fimmu.2022.930087] [Reference Citation Analysis]
|
| 232 |
Papadimitriou E, Boutzios G, Mathioudakis AG, Vlahos NF, Vlachoyiannopoulos P, Mastorakos G. Presence of antiphospholipid antibodies is associated with increased implantation failure following in vitro fertilization technique and embryo transfer: A systematic review and meta-analysis. PLoS ONE 2022;17:e0260759. [DOI: 10.1371/journal.pone.0260759] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
|
| 233 |
Chock EY, Domingues V, Dufrost V, Risse J, Seshan SV, Barbhaiya M, Sartelet H, Erkan D, Wahl D, Zuily S. Increased risk of acute and chronic microvascular renal lesions associated with antiphospholipid antibodies in patients with systemic lupus erythematosus: A systematic review and meta-analysis. Autoimmun Rev 2022;:103158. [PMID: 35907609 DOI: 10.1016/j.autrev.2022.103158] [Reference Citation Analysis]
|
| 234 |
Dziedzic-Oleksy H, Mazurek A, Bugała K, Perricone C, Drabik L, Płazak W. Arterial stiffness and atherosclerosis in systemic lupus erythematosus patients. Reumatologia 2022;60:165-72. [PMID: 35875719 DOI: 10.5114/reum.2022.117836] [Reference Citation Analysis]
|
| 235 |
Seeley EA, Zimmer M, Berghea R. Suspected COVID-19 Immunization-Induced Probable Catastrophic Antiphospholipid Syndrome. Cureus 2022. [DOI: 10.7759/cureus.27313] [Reference Citation Analysis]
|
| 236 |
Rup AR, Dash AK, Behera JR, Sahu SK, Gudu RK, Gyandeep G, Puramjai M, Padhan P, Jain MK. Antiphospholipid Antibody Syndrome in Childhood Systemic Lupus Erythematous With a Unique Presentation: A Case Report. Cureus 2022. [DOI: 10.7759/cureus.27205] [Reference Citation Analysis]
|
| 237 |
Vrotniakaite-Bajerciene K, Tritschler T, Jalowiec KA, Broughton H, Brodard J, Porret NA, Haynes A, Rovo A, Kremer Hovinga JA, Aujesky D, Angelillo-Scherrer A. Thrombophilia Impact on Treatment Decisions, Subsequent Venous or Arterial Thrombosis and Pregnancy-Related Morbidity: A Retrospective Single-Center Cohort Study. J Clin Med 2022;11. [PMID: 35887951 DOI: 10.3390/jcm11144188] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 238 |
Lee Y, Gu JY, Kim HK. Real-world evidence of lupus anticoagulant testing: simultaneous positivity of diluted Russell's viper venom time and silica clotting time increases thrombotic risk prediction. J Thromb Thrombolysis 2022. [PMID: 35841477 DOI: 10.1007/s11239-022-02675-9] [Reference Citation Analysis]
|
| 239 |
Lenti MV, Rossi CM, Melazzini F, Gastaldi M, Bugatti S, Rotondi M, Bianchi PI, Gentile A, Chiovato L, Montecucco C, Corazza GR, Di Sabatino A. Seronegative autoimmune diseases: A challenging diagnosis. Autoimmun Rev 2022;21:103143. [PMID: 35840037 DOI: 10.1016/j.autrev.2022.103143] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 240 |
Roubertou Y, Mainbourg S, Hot A, Fouque D, Confavreux C, Chapurlat R, Debarbieux S, Jullien D, Sève P, Juillard L, Kolopp-Sarda MN, Lega JC. Cryoglobulinemia in systemic lupus erythematosus: a retrospective study of 213 patients. Arthritis Res Ther 2022;24:167. [PMID: 35836280 DOI: 10.1186/s13075-022-02857-z] [Reference Citation Analysis]
|
| 241 |
Yelnik CM, Martin C, Ledoult E, Sanges S, Sobanski V, Farhat M, Morell-Dubois S, Maillard H, Drumez E, Launay D, Hachulla E, Lambert M. Dyslipidemia is insufficiently treated in antiphospholipid syndrome patients. Lupus 2022;:9612033221114275. [PMID: 35822929 DOI: 10.1177/09612033221114275] [Reference Citation Analysis]
|
| 242 |
Shehata H, Ali A, Silva-Edge M, Haroon S, Elfituri A, Viswanatha R, Jan H, Akolekar R. Thrombophilia screening in women with recurrent first trimester miscarriage: is it time to stop testing? - a cohort study and systematic review of the literature. BMJ Open 2022;12:e059519. [PMID: 35831047 DOI: 10.1136/bmjopen-2021-059519] [Reference Citation Analysis]
|
| 243 |
Shi M, Gao W, Jin Y, Zhu J, Liu Y, Wang T, Li C. Antiphospholipid Syndrome-Related Pulmonary Embolism: Clinical Characteristics and Early Recognition. Front Cardiovasc Med 2022;9. [DOI: 10.3389/fcvm.2022.872523] [Reference Citation Analysis]
|
| 244 |
Cheldieva FA, Reshetnyak TM, Cherkasova MV, Glukhova SI, Lila AM, Nasonov EL. Antibodies to domain I β2 -glycoprotein 1 in patients with antiphospholipid syndrome and systemic lupus erythematosus. Naučno-praktičeskaâ revmatologiâ 2022;60:353-359. [DOI: 10.47360/1995-4484-2022-353-359] [Reference Citation Analysis]
|
| 245 |
Yang W, Kang DW, Kim JM, Jung KH, Lee SH. Neuroimaging features of antiphospholipid antibody-related stroke compared with atrial fibrillation-related stroke. Sci Rep 2022;12:11686. [PMID: 35804027 DOI: 10.1038/s41598-022-16019-3] [Reference Citation Analysis]
|
| 246 |
Gan Y, Zhao Y, Li G, Ye H, Zhou Y, Hou C, Wang L, Guo J, Li C. Risk Factors and Outcomes of Acute Myocardial Infarction in a Cohort of Antiphospholipid Syndrome. Front Cardiovasc Med 2022;9. [DOI: 10.3389/fcvm.2022.871011] [Reference Citation Analysis]
|
| 247 |
Truglia S, Capozzi A, Mancuso S, Manganelli V, Rapino L, Riitano G, Recalchi S, Colafrancesco S, Ceccarelli F, Garofalo T, Alessandri C, Longo A, Misasi R, Conti F, Sorice M. Relationship Between Gender Differences and Clinical Outcome in Patients With the Antiphospholipid Syndrome. Front Immunol 2022;13:932181. [DOI: 10.3389/fimmu.2022.932181] [Reference Citation Analysis]
|
| 248 |
Huang Y, Liu H, Qi W, Du L, Li M, Zeng X, Guo X, Zhao J, Zhang S. Sex Differences in Clinical Characteristics and Prognosis in Primary Thrombotic Antiphospholipid Syndrome. Front Cardiovasc Med 2022;9. [DOI: 10.3389/fcvm.2022.895098] [Reference Citation Analysis]
|
| 249 |
Johnsen SJA, Skadberg Ø, Svendsen KN, Åsberg A. Letter to the editors-in-chief: Gender differences in the dilute Russell's viper venom time lupus anticoagulant test. Thrombosis Research 2022;215:52-4. [DOI: 10.1016/j.thromres.2022.05.011] [Reference Citation Analysis]
|
| 250 |
Bader B, Schäfer-graf U. Nierenerkrankungen und Schwangerschaft. Nephrologie 2022;17:271-285. [DOI: 10.1007/s11560-022-00588-5] [Reference Citation Analysis]
|
| 251 |
Avila ML, Amiri N, Zavareh ZT, Al-Saoud SA, Sabapathy C, Vincelli J, Moharir M, Silverman E, Williams S, Brandão LR, Levy D. Characterization of recurrent thrombosis in pediatric antiphospholipid syndrome. Am J Hematol 2022;97:E268-70. [PMID: 35389524 DOI: 10.1002/ajh.26565] [Reference Citation Analysis]
|
| 252 |
Signorelli F, Balbi GGM, Aikawa NE, Silva CA, Kupa LVK, Medeiros-Ribeiro AC, Yuki EF, Pasoto SG, Saad CG, Borba EF, Seguro LPC, Pedrosa T, Oliveira VAA, Costa ALCS, Ribeiro CT, Santos REB, Andrade DCO, Bonfá E. Immunogenicity, safety, and antiphospholipid antibodies after SARS-CoV-2 vaccine in patients with primary antiphospholipid syndrome. Lupus 2022;31:974-84. [PMID: 35593174 DOI: 10.1177/09612033221102073] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 253 |
Liu A, Rupani KV, Naymagon L. Direct oral anticoagulants versus warfarin in patients with single antibody-positive anti-phospholipid syndrome. Eur J Haematol 2022;109:69-74. [PMID: 35305281 DOI: 10.1111/ejh.13770] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 254 |
Liu J, Zhang L, Tian Y, Wan S, Hu M, Song S, Zhang M, Zhou Q, Xia Y, Wang X. Protection by hydroxychloroquine prevents placental injury in obstetric antiphospholipid syndrome. J Cell Mol Med 2022. [PMID: 35770338 DOI: 10.1111/jcmm.17459] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 255 |
Hamzah R, Yusof N, Tumian NR, Abdul Aziz S, Mohammad Basri NS, Leong TS, Ho KW, Selvaratnam V, Tan SM, Muhamad Jamil SA. Clinical Epidemiology, Treatment Outcome and Mortality Rate of Newly Diagnosed Immune Thrombocytopenia in Adult Multicentre Study in Malaysia. J Blood Med 2022;13:337-49. [PMID: 35761846 DOI: 10.2147/JBM.S358993] [Reference Citation Analysis]
|
| 256 |
Guan H. Cerebral venous sinuses thrombosis and pulmonary embolism due to antiphospholipid syndrome. Radiopaedia.org 2022. [DOI: 10.53347/rid-147761] [Reference Citation Analysis]
|
| 257 |
Statache G, Brown S. Vitamin D in Lupus Patients of Childbearing Age: Are We Doing Enough? Front Reprod Health 2022;4. [DOI: 10.3389/frph.2022.936810] [Reference Citation Analysis]
|
| 258 |
Bitsadze V, Khizroeva J, Alexander M, Elalamy I. Venous thrombosis risk factors in pregnant women. J Perinat Med 2022;50:505-18. [PMID: 35044114 DOI: 10.1515/jpm-2022-0008] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 259 |
Assunção H, Rodrigues M, Prata AR, Luís M, da Silva JAP, Inês L. Predictors of hospitalization in patients with systemic lupus erythematosus: a 10-year cohort study. Clin Rheumatol 2022. [PMID: 35732984 DOI: 10.1007/s10067-022-06251-7] [Reference Citation Analysis]
|
| 260 |
Bhasker N. Interrelation between Recurrent Pregnancy Loss and Antiphospholipid: A Clinico-Diagnostic Perspective. Protein Detection 2022. [DOI: 10.5772/intechopen.100125] [Reference Citation Analysis]
|
| 261 |
Demir S, Keskin A, Sağ E, Kaya Akca Ü, Atalay E, Cüceoğlu MK, Batu Akal ED, Özen S, Bilginer Y. The challenges in diagnosing pediatric primary antiphospholipid syndrome. Lupus 2022;:9612033221108853. [PMID: 35746827 DOI: 10.1177/09612033221108853] [Reference Citation Analysis]
|
| 262 |
Delarue A, Dragon-Durey MA, Darnige L. [Contribution of antiphosphatidylserine/prothrombin (anti-PS/PT) antibody detection in the diagnosis and management of antiphospholipid syndrome (APS)]. Rev Med Interne 2022:S0248-8663(22)00454-4. [PMID: 35752484 DOI: 10.1016/j.revmed.2022.04.031] [Reference Citation Analysis]
|
| 263 |
Wang TKM, Zmaili M, Xu B. Cardiovascular Manifestations in Systemic Lupus Erythematosus-Focus on Valvular Heart Disease and Non-Bacterial Thrombotic Endocarditis. Angiology 2022;:33197221110718. [PMID: 35729855 DOI: 10.1177/00033197221110718] [Reference Citation Analysis]
|
| 264 |
Pengo V, Denas G. Antiphospholipid Syndrome in Patients with Venous Thromboembolism. Semin Thromb Hemost 2022. [PMID: 35728601 DOI: 10.1055/s-0042-1749590] [Reference Citation Analysis]
|
| 265 |
Yeo J, Hwang I, Sohn C, Lee EE, Lee S, Lee EB, Park JK. Proliferative Vasculopathy Associated With Antiphospholipid Antibodies in Patients With Neurological Symptoms. Front Med 2022;9:913203. [DOI: 10.3389/fmed.2022.913203] [Reference Citation Analysis]
|
| 266 |
Reshetnyak TM, Cheldieva FA, Cherkasova MV, Lila AM, Nasonov EL. Antibodies to the phosphatidylserine/prothrombin complex in the diagnosis of antiphospholipid syndrome. Terapevticheskii arkhiv 2022;94:628-634. [DOI: 10.26442/00403660.2022.05.201488] [Reference Citation Analysis]
|
| 267 |
Aringer M, Costenbader K, Dörner T, Johnson SR. Advances in SLE classification criteria. J Autoimmun 2022;:102845. [PMID: 35725680 DOI: 10.1016/j.jaut.2022.102845] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 268 |
Asif S, Bali A, Dang AK, Gonzalez DA, Kumar R. Neurological and Neuropsychiatric Manifestations of Antiphospholipid-Antibody Syndrome (APS). Cureus 2022. [DOI: 10.7759/cureus.26022] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 269 |
Boggio F, Ciavarella A, Arcudi S, Gualtierotti R, Rossio R, Tafuri F, Artoni A, Peyvandi F. Plasma Exchange in a Patient with Immune Thrombocytopenia Associated with Antiphospholipid Syndrome Hospitalized for COVID-19. Rheumatol Ther 2022. [PMID: 35704176 DOI: 10.1007/s40744-022-00469-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 270 |
AliceMSc B, MassimoMD R, IreneMD C, GraziettaMD FS, MartaMD A, ElenaMD R, Elisa M, DarioMD R, Savino S. Assessing the cardiovascular risk in patients with systemic lupus erythematosus: QRISK and GAPSS scores head-to-head. Int J Cardiol 2022:S0167-5273(22)00939-1. [PMID: 35714714 DOI: 10.1016/j.ijcard.2022.06.040] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 271 |
Qi W, Zhao J, Huang C, Jiang N, Li J, Wu C, Zhang S, Hu C, Xu D, Wang Q, Li M, Tian X, Zhao Y, Zeng X. Clinical characteristics and prognosis of patients with antiphospholipid antibodies based on cluster analysis: an 8-year cohort study. Arthritis Res Ther 2022;24:140. [PMID: 35690831 DOI: 10.1186/s13075-022-02814-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 272 |
Devreese KMJ. Solid Phase Assays for Antiphospholipid Antibodies. Semin Thromb Hemost 2022. [PMID: 35675831 DOI: 10.1055/s-0042-1744364] [Reference Citation Analysis]
|
| 273 |
Gohr M, Jakobsen IM, Helmig RB, Stengaard-Pedersen K, Laurberg TB, Troldborg A. Improved pregnancy outcomes in systemic lupus erythematosus: A retrospective study of pregnancies from a single centre in Denmark from 2010-2020 compared with the period 1990-2010. Lupus 2022;:9612033221107538. [PMID: 35676102 DOI: 10.1177/09612033221107538] [Reference Citation Analysis]
|
| 274 |
Melayah S, Ghozzi M, Mankaï A, Mechi F, Ghedira I. Frequency of serological markers of rheumatoid arthritis in patients with IgA anti-β2 glycoprotein I antibodies. J Clin Lab Anal 2022;:e24537. [PMID: 35666694 DOI: 10.1002/jcla.24537] [Reference Citation Analysis]
|
| 275 |
Medina G, Cimé-Aké E, Bonilla-Vázquez R, Vera-Lastra O, Saavedra MÁ, Cruz-Domínguez MP, Jara LJ. Disability and cognitive impairment are interdependent in primary antiphospholipid syndrome. Lupus 2022;:9612033221106647. [PMID: 35657275 DOI: 10.1177/09612033221106647] [Reference Citation Analysis]
|
| 276 |
Makarm WK, Zaghlol RS, Kotb LI. Risk assessment score for adverse pregnancy outcome in systemic lupus erythematosus patients. Egypt Rheumatol Rehabil 2022;49. [DOI: 10.1186/s43166-022-00131-3] [Reference Citation Analysis]
|
| 277 |
Erton ZB, Sevim E, de Jesús GR, Cervera R, Ji L, Pengo V, Ugarte A, Andrade D, Andreoli L, Atsumi T, Fortin PR, Gerosa M, Zuo Y, Petri M, Sciascia S, Tektonidou MG, Aguirre-Zamorano MA, Branch DW, Erkan D; APS ACTION. Pregnancy outcomes in antiphospholipid antibody positive patients: prospective results from the AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) Clinical Database and Repository ('Registry'). Lupus Sci Med 2022;9:e000633. [PMID: 35701043 DOI: 10.1136/lupus-2021-000633] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 278 |
Serrano M, Espinosa G, Cervera R, Serrano A. COVID-19 coagulopathy and antiphospholipid syndrome. Revista Colombiana de Reumatología 2022;29:S25-S34. [DOI: 10.1016/j.rcreu.2021.02.013] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 279 |
Abouda A, Hajjej Z, Mansart A, Kaabechi W, Mahmoud DE, Lamine O, Ghazouani E, Ferjani M, Labbene I, Jiao P. Anticardiolipin Autoantibodies as Useful Biomarkers for the Prediction of Mortality in Septic Patients. Journal of Immunology Research 2022;2022:1-8. [DOI: 10.1155/2022/9775111] [Reference Citation Analysis]
|
| 280 |
Arachchillage DJ, Mackillop L, Chandratheva A, Motawani J, Maccallum P, Laffan M. Guidelines for thrombophilia testing: A British Society for Haematology guideline. Br J Haematol. [DOI: 10.1111/bjh.18239] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 281 |
Rosa Dos Santos AP, de Oliveira Vaz C, Hounkpe BW, Jacintho BC, Oliveira JD, Tripiquia Vechiatto Mesquita GL, Pereira Dos Santos I, Annichino-Bizzacchi J, Appenzeller S, de Moraes Mazetto Fonseca B, Orsi FA. Association between interferon-I producing plasmacytoid dendritic cells and thrombotic antiphospholipid syndrome. Lupus 2022;:9612033221101731. [PMID: 35612283 DOI: 10.1177/09612033221101731] [Reference Citation Analysis]
|
| 282 |
Hoxha A, Tormene D, Campello E, Simioni P. Treatment of Refractory/High-Risk Pregnancies With Antiphospholipid Syndrome: A Systematic Review of the Literature. Front Pharmacol 2022;13:849692. [DOI: 10.3389/fphar.2022.849692] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 283 |
Shen J, Tao Z, Chen W, Sun J, Li Y, Fu F. Malignant Isolated Cortical Vein Thrombosis as the Initial Manifestation of Primary Antiphospholipid Syndrome: Lessons on Diagnosis and Management From a Case Report. Front Immunol 2022;13:882032. [PMID: 35547735 DOI: 10.3389/fimmu.2022.882032] [Reference Citation Analysis]
|
| 284 |
Zmira O, Gofrit SG, Aharoni SA, Weiss R, Shavit-Stein E, Chapman J. Teriflunomide normalizes anti-anxiety effect in anti-ANXA2 APS mice model teriflunomide in anti-ANXA2 mice model. Lupus 2022;31:855-63. [PMID: 35575144 DOI: 10.1177/09612033221095150] [Reference Citation Analysis]
|
| 285 |
Kwok TSH, Basso Dias A, Cino M, Khalili K. Antiphospholipid syndrome presenting with inferior mesenteric vein thrombosis and associated rectal edema in a patient with systemic lupus erythematosus. Clin Rheumatol 2022. [PMID: 35556188 DOI: 10.1007/s10067-022-06207-x] [Reference Citation Analysis]
|
| 286 |
Niznik S, Rapoport MJ, Avnery O, Lubetsky A, Haj Yahia S, Ellis MH, Agmon-Levin N. Patterns of Recurrent Thrombosis in Primary Antiphospholipid Syndrome-Multicenter, Real-Life Long-Term Follow-Up. Front Immunol 2022;13:843718. [PMID: 35514968 DOI: 10.3389/fimmu.2022.843718] [Reference Citation Analysis]
|
| 287 |
Reshetnyak TM, Cheldieva FA, Cherkasova MV, Lila AM. Clinical significance of antibodies to the phosphatidylserine/prothrombin complex. Sovremennaâ revmatologiâ 2022;16:81-86. [DOI: 10.14412/1996-7012-2022-2-81-86] [Reference Citation Analysis]
|
| 288 |
Yan H, Li B, Su R, Gao C, Li X, Wang C. Preliminary Study on the Imbalance Between Th17 and Regulatory T Cells in Antiphospholipid Syndrome. Front Immunol 2022;13:873644. [DOI: 10.3389/fimmu.2022.873644] [Reference Citation Analysis]
|
| 289 |
Okeke R, Lok J, Wells R, Wycoff M, Engelhardt A, Bettag J, O’leary C, Hallcox T, Nazzal M, Grenda R. Catastrophic Antiphospholipid Syndrome after Orthotopic Liver Transplant. Case Reports in Transplantation 2022;2022:1-8. [DOI: 10.1155/2022/6209300] [Reference Citation Analysis]
|
| 290 |
Hoxha A, Simioni P. Obstetric Antiphospholipid Syndrome. Antiphospholipid Syndrome - Recent Advances in Clinical and Basic Aspects 2022. [DOI: 10.5772/intechopen.101804] [Reference Citation Analysis]
|
| 291 |
Grimes K, P. Klein A, Lalla R, Morawo A, Somani S, J. Woodward M, W. Cole J. Antiphospholipid Syndrome and Stroke. Antiphospholipid Syndrome - Recent Advances in Clinical and Basic Aspects 2022. [DOI: 10.5772/intechopen.101777] [Reference Citation Analysis]
|
| 292 |
Tanimura K, Sasagawa Y, Deguchi M, Arase N, Arase H, Yamada H. A Novel Autoantibody against β2-Glycoprotein I/HLA Class II Complexes in Antiphospholipid Syndrome. Antiphospholipid Syndrome - Recent Advances in Clinical and Basic Aspects 2022. [DOI: 10.5772/intechopen.97511] [Reference Citation Analysis]
|
| 293 |
Štok U, Čučnik S, Sodin-šemrl S, Žigon P. Extracellular Vesicles: Intercellular Communication Mediators in Antiphospholipid Syndrome. Antiphospholipid Syndrome - Recent Advances in Clinical and Basic Aspects 2022. [DOI: 10.5772/intechopen.97412] [Reference Citation Analysis]
|
| 294 |
Žigon P. Introductory Chapter: Antiphospholipid Antibodies - A Laboratory Criterion for the Antiphospholipid Syndrome, but Also Bystanders in Infections, Cancer, and Other Conditions. Antiphospholipid Syndrome - Recent Advances in Clinical and Basic Aspects 2022. [DOI: 10.5772/intechopen.103846] [Reference Citation Analysis]
|
| 295 |
Bucci T, Ames PR, Cammisotto V, Bartimoccia S, Triggiani M, Parente R, Ciampa A, Pignatelli P, Carnevale R, Pastori D; ATHERO-APS Study Group. Proprotein convertase subtilisin/kexin type 9 (PCSK9) levels in primary antiphospholipid syndrome. The multicenter ATHERO-APS study. J Autoimmun 2022;129:102832. [PMID: 35512480 DOI: 10.1016/j.jaut.2022.102832] [Reference Citation Analysis]
|
| 296 |
Pérez ML, Laso RV, Velasco-rodríguez D, Martín-herrero S, Alfonzo IM, García-raso A, Llamas-sillero P. Lupus anticoagulant-hypoprothrombinemia syndrome: A cerebral bleeding case report as systemic lupus erythematosus debut. Reumatología Clínica 2022. [DOI: 10.1016/j.reuma.2022.02.007] [Reference Citation Analysis]
|
| 297 |
Kwak-kim J, Alsubki L, Luu T, Ganieva U, Thees A, Dambaeva S, Gilman-sachs A. The role of immunologic tests for subfertility in the clinical environment. Fertility and Sterility 2022. [DOI: 10.1016/j.fertnstert.2022.04.009] [Reference Citation Analysis]
|
| 298 |
Castilla Agudelo GA, Rodríguez Padilla LM, Jaramillo Velásquez S, Hernández Zapata LJ, Mesa Navas MA, Álvarez Barreneche MF, Velásquez Franco CJ. Determinación del percentil 99 de los anticuerpos anticardiolipina y anti-β2 glicoproteína I en una institución en la ciudad de Medellín, Colombia. Revista Colombiana de Reumatología 2022. [DOI: 10.1016/j.rcreu.2022.01.003] [Reference Citation Analysis]
|
| 299 |
Zhu R, Cheng C, Yang Y, Denas G, Pengo V. Prevalence of aPhosphatidylserine/prothrombin antibodies and association with antiphospholipid antibody profiles in patients with antiphospholipid syndrome: A systematic review and meta-analysis. Thrombosis Research 2022. [DOI: 10.1016/j.thromres.2022.04.021] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 300 |
de Moraes Mazetto B, Hounkpe BW, da Silva Saraiva S, Vieira-damiani G, dos Santos APR, Jacinto BC, de Oliveira Vaz C, Mesquita GTV, Annichino-bizzacchi JM, De Paula EV, Orsi FA. Association between neutrophil extracellular traps (NETs) and thrombosis in antiphospholipid syndrome. Thrombosis Research 2022. [DOI: 10.1016/j.thromres.2022.05.001] [Reference Citation Analysis]
|
| 301 |
Matsuzaki Y, Fujimoto H, Adachi S, Matsumoto K, Oyama S, Saito H, Saijo Y, Azuhata K, Ito N, Igarashi T, Arakura N, Usuda S, Kiyosawa K. A male case of acute onset antimitochondrial-M2 antibody-positive autoimmune hepatitis after pulmonary thromboembolism: A case report. Acta hepatologica Japonica 2022;63:246-254. [DOI: 10.2957/kanzo.63.246] [Reference Citation Analysis]
|
| 302 |
Yelnik C, Puigrenier S, Lambert M. Négativation des anticorps antiphospholipides et arrêt du traitement anticoagulant au cours du syndrome des antiphospholipides : qu’en penser ? La Revue de Médecine Interne 2022. [DOI: 10.1016/j.revmed.2022.04.033] [Reference Citation Analysis]
|
| 303 |
Djokovic A, Stojanovich L, Stanisavljevic N, Djokic S, Filipovic B, Matic P, Milanovic M, Apostolovic S, Saponjski J. Cardiac manifestations in primary antiphospholipid syndrome and their association to antiphospholipid antibodies' types and titers-cross-sectional study of Serbian cohort. Clin Rheumatol 2022;41:1447-55. [PMID: 35018582 DOI: 10.1007/s10067-022-06056-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 304 |
Park YH. Diagnosis and management of thrombocytopenia in pregnancy. Blood Res 2022;57:79-85. [PMID: 35483931 DOI: 10.5045/br.2022.2022068] [Reference Citation Analysis]
|
| 305 |
Serrano M, Espinosa G, Serrano A, Cervera R. Antigens and Antibodies of the Antiphospholipid Syndrome as New Allies in the Pathogenesis of COVID-19 Coagulopathy. Int J Mol Sci 2022;23:4946. [PMID: 35563337 DOI: 10.3390/ijms23094946] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 306 |
Moreno-Torres V, Castejón R, Martínez-Urbistondo M, Gutiérrez-Rojas Á, Vázquez-Comendador J, Tutor P, Durán-Del Campo P, Mellor-Pita S, Rosado S, Vargas-Núñez JA. Serum cytokines to predict systemic lupus erythematosus clinical and serological activity. Clin Transl Sci 2022. [PMID: 35478259 DOI: 10.1111/cts.13283] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 307 |
Monahan RC, Middelkoop HAM, Beaart-van de Voorde LJJ, Fronczek R, Groenwold RHH, Kloppenburg M, Huizinga TWJ, Steup-Beekman GM. High Prevalence but Low Impact of Cognitive Dysfunction on Quality of Life in Patients With Lupus and Neuropsychiatric Symptoms. Arthritis Care Res (Hoboken) 2022. [PMID: 35470979 DOI: 10.1002/acr.24904] [Reference Citation Analysis]
|
| 308 |
Imazeki A, Miyachi H, Nakamura Y, Sugiura T, Matsue H. Development of venous thromboembolism in an elderly man with plaque psoriasis and antiphospholipid syndrome: A case report. J Cutaneous Imm & Allergy. [DOI: 10.1002/cia2.12246] [Reference Citation Analysis]
|
| 309 |
Cornish EF, McDonnell T, Williams DJ. Chronic Inflammatory Placental Disorders Associated With Recurrent Adverse Pregnancy Outcome. Front Immunol 2022;13:825075. [PMID: 35529853 DOI: 10.3389/fimmu.2022.825075] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 310 |
Tkachenko OY, Lapin SV, Masing AV, Blinova TV, Moshnikova AN, Kuznetsova DA, Kholopova IV. Diagnostic value of autoantibodies and novel automated methods of their detection. Medicinskij alfavit 2022;1:40-46. [DOI: 10.33667/2078-5631-2022-6-40-46] [Reference Citation Analysis]
|
| 311 |
Niznik S, Rapoport MJ, Avnery O, Lubetsky A, Shavit R, Ellis MH, Agmon-levin N. Long Term Follow up of Patients With Primary Obstetric Antiphospholipid Syndrome. Front Pharmacol 2022;13:824775. [DOI: 10.3389/fphar.2022.824775] [Reference Citation Analysis]
|
| 312 |
Matza MA, Rincon SP, Yucel E, Jorge AM, Singhal AB, Coleman CA, Uljon SN. Case 12-2022: A 41-Year-Old Woman with Transient Ischemic Attack and Mitral Valve Masses. N Engl J Med 2022;386:1560-70. [PMID: 35443111 DOI: 10.1056/NEJMcpc2115855] [Reference Citation Analysis]
|
| 313 |
Jarne-Borràs M, Miró-Mur F, Anunciación-Llunell A, Alijotas-Reig J. Antiphospholipid antibodies in women with recurrent embryo implantation failure: A systematic review and meta-analysis. Autoimmun Rev 2022;:103101. [PMID: 35452853 DOI: 10.1016/j.autrev.2022.103101] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 314 |
Xie W, Ji L, Zhang Z. Sirolimus Monotherapy for Thrombocytopenia in Primary Antiphospholipid Syndrome: A Pilot Study From a Tertiary Referral Center. Front Immunol 2022;13:857424. [PMID: 35401500 DOI: 10.3389/fimmu.2022.857424] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 315 |
Vandevelde A, Devreese KMJ. Laboratory Diagnosis of Antiphospholipid Syndrome: Insights and Hindrances. J Clin Med 2022;11:2164. [PMID: 35456258 DOI: 10.3390/jcm11082164] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 316 |
Castro-Gutierrez A, Young K, Bermas BL. Pregnancy and Management in Women with Rheumatoid Arthritis, Systemic Lupus Erythematosus, and Obstetric Antiphospholipid Syndrome. Rheum Dis Clin North Am 2022;48:523-35. [PMID: 35400376 DOI: 10.1016/j.rdc.2022.02.009] [Reference Citation Analysis]
|
| 317 |
Zisa D, Goodman SM. Perioperative Management of Rheumatic Disease and Therapies. Rheum Dis Clin North Am 2022;48:455-66. [PMID: 35400371 DOI: 10.1016/j.rdc.2022.02.005] [Reference Citation Analysis]
|
| 318 |
Riancho-Zarrabeitia L, Lopez-Marin L, Cacho PM, López-Hoyos M, Barrio RD, Haya A, Martínez-Taboada VM. Treatment with low-dose prednisone in refractory obstetric antiphospholipid syndrome: A retrospective cohort study and meta-analysis. Lupus 2022;:9612033221091401. [PMID: 35410552 DOI: 10.1177/09612033221091401] [Reference Citation Analysis]
|
| 319 |
Riitano G, Capozzi A, Recalchi S, Caissutti D, Longo A, Mattei V, Conti F, Misasi R, Garofalo T, Sorice M, Manganelli V. Anti-β2-GPI Antibodies Induce Endothelial Cell Expression of Tissue Factor by LRP6 Signal Transduction Pathway Involving Lipid Rafts. Cells 2022;11:1288. [PMID: 35455968 DOI: 10.3390/cells11081288] [Reference Citation Analysis]
|
| 320 |
Willis R, Mcdonnell TCR, Pericleous C, Gonzalez EB, Schleh A, Romay-penabad Z, Giles IP, Rahman A. PEGylated Domain I of Beta-2-Glycoprotein I Inhibits Thrombosis in a Chronic Mouse Model of the Antiphospholipid Syndrome. Front Immunol 2022;13:842923. [DOI: 10.3389/fimmu.2022.842923] [Reference Citation Analysis]
|
| 321 |
Leonardi GR, Lescano CH, Costa JL, Mazetto B, Orsi FA, Monica FZ. Adenosine diphosphate-induced aggregation is enhanced in platelets obtained from patients with thrombotic primary antiphospholipid syndrome (t-PAPS): Role of P2Y12 -cAMP signaling pathway. J Thromb Haemost 2022. [PMID: 35395698 DOI: 10.1111/jth.15724] [Reference Citation Analysis]
|
| 322 |
Christiansen TK, Nilsson AC, Madsen GI, Voss A. Small intestine necrosis in catastrophic antiphospholipid syndrome: A rare and severe case. Lupus 2022;:9612033221093496. [PMID: 35393873 DOI: 10.1177/09612033221093496] [Reference Citation Analysis]
|
| 323 |
Ho YC, Brake SJ, Ahuja K, Acott N, Tiao J, Baker R, Adams MJ. IgG fractions from patients with antiphospholipid syndrome and systemic lupus erythematosus bind to platelets, but do not affect collagen-induced platelet activation. Biotech Histochem 2022;:1-12. [PMID: 35394397 DOI: 10.1080/10520295.2022.2049878] [Reference Citation Analysis]
|
| 324 |
Doskas T, Dardiotis E, Vavougios GD, Ntoskas KT, Sionidou P, Vadikolias K. Stroke risk in multiple sclerosis: a critical appraisal of the literature. International Journal of Neuroscience. [DOI: 10.1080/00207454.2022.2056459] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 325 |
Yeo J, Shin N, Ahn KJ, Seo M, Jang AY, Kim M, Chung WJ. Pulmonary arterial hypertension due to antiphospholipid syndrome initially mimicking chronic thromboembolic pulmonary hypertension. Clin Hypertens 2022;28:10. [PMID: 35361265 DOI: 10.1186/s40885-021-00191-1] [Reference Citation Analysis]
|
| 326 |
Hocine I. Similarities of antiphospholipid antibodies in HIT and APS patients with heparin-platelet factor 4 antibodies. Thrombosis Update 2022. [DOI: 10.1016/j.tru.2022.100106] [Reference Citation Analysis]
|
| 327 |
Blain S, Kondyli M, De Bruycker JJ, Winikoff R. Two cases of refractory pediatric antiphospholipid syndrome. Pediatr Blood Cancer 2022;69:e29506. [PMID: 34889517 DOI: 10.1002/pbc.29506] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 328 |
Wei M, Xu Y, Xia D, Li J, Dong S. Care and Treatment for an Antiphospholipid Syndrome-Related Lower Limb Skin Ulcer Unhealed for 7 Years: A Case Report. Int J Low Extrem Wounds 2022;:15347346221090079. [PMID: 35360964 DOI: 10.1177/15347346221090079] [Reference Citation Analysis]
|
| 329 |
Oliveira CB, Kaplan MJ. Cardiovascular disease risk and pathogenesis in systemic lupus erythematosus. Semin Immunopathol 2022. [PMID: 35355124 DOI: 10.1007/s00281-022-00922-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 330 |
Tan XF, Xu L, Li TT, Wu YT, Ma WW, Ding JY, Dong HL. Serum antiphospholipid antibody status may not be associated with the pregnancy outcomes of patients undergoing in vitro fertilization. Medicine (Baltimore) 2022;101:e29146. [PMID: 35357357 DOI: 10.1097/MD.0000000000029146] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 331 |
Kaneshige R, Motoki Y, Yoshida M, Oku K, Morishita E, Ieko M, Ichihara K, Nojima J. Determination of diagnostic threshold in harmonization and comparison of clinical utility for five major antiphospholipid antibody assays used in Japan. Clinical Laboratory Analysis. [DOI: 10.1002/jcla.24340] [Reference Citation Analysis]
|
| 332 |
Ashworth KJ, Thomas KA, Shea SM. Von Willebrand Factor and Platelet Aggregation: from Bench to Clinical Practice. Curr Anesthesiol Rep. [DOI: 10.1007/s40140-022-00521-5] [Reference Citation Analysis]
|
| 333 |
Killian M, van Mens TE. Risk of Thrombosis, Pregnancy Morbidity or Death in Antiphospholipid Syndrome. Front Cardiovasc Med 2022;9:852777. [PMID: 35299976 DOI: 10.3389/fcvm.2022.852777] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 334 |
Nappi F, Giacinto O, Ellouze O, Nenna A, Avtaar Singh SS, Chello M, Bouzguenda A, Copie X. Association between COVID-19 Diagnosis and Coronary Artery Thrombosis: A Narrative Review. Biomedicines 2022;10:702. [DOI: 10.3390/biomedicines10030702] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 335 |
Tarhan EF, Keser G, İlhan Çelik Ö, Kilinç RM, Kirli İ, Akar S. Coexistence of Axial Spondyloarthritis, Systemic Lupus Erythematosus, Sjögren’s Syndrome and Secondary Antiphospholipid Syndrome: Case Report. Muğla Sıtkı Koçman Üniversitesi Tıp Dergisi 2022. [DOI: 10.47572/muskutd.890480] [Reference Citation Analysis]
|
| 336 |
Wang CR, Lee CH. Pelvic deep venous thrombosis mimicking lower limb cellulitis in systemic lupus erythematosus-associated antiphospholipid syndrome. Lupus 2022;:9612033221084230. [PMID: 35293251 DOI: 10.1177/09612033221084230] [Reference Citation Analysis]
|
| 337 |
Ling LQ, Liu CN, Huang XB, Liao J, Jia J, Zhou J. Interpretation of clot-based lupus anticoagulant assays-Normalizing clotting time against different denominators. Int J Lab Hematol 2022. [PMID: 35297205 DOI: 10.1111/ijlh.13830] [Reference Citation Analysis]
|
| 338 |
Favaloro EJ, Pasalic L. Lupus anticoagulant testing during anticoagulation, including direct oral anticoagulants. Res Pract Thromb Haemost 2022;6. [DOI: 10.1002/rth2.12676] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 339 |
Hegde A, Dorji T, Asturkar V, Yangzom S, Bhanu KU. Cases of catastrophic anti-phospholipid syndrome in systemic lupus erythematosus: An experience. SAGE Open Medical Case Reports 2022;10:2050313X2210850. [DOI: 10.1177/2050313x221085099] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 340 |
Meloni C, Schreiber C, Studt J, Kamm S, Di Chiara M, Herren T. Liver infarctions as the first manifestation of antiphospholipid antibody syndrome in pregnancy: a case report. J Med Case Reports 2022;16. [DOI: 10.1186/s13256-022-03324-8] [Reference Citation Analysis]
|
| 341 |
Aikawa NE, Kupa LDVK, Medeiros-ribeiro AC, Saad CGS, Yuki EFN, Pasoto SG, Rojo PT, Pereira RMR, Shinjo SK, Sampaio-barros PD, Andrade DCO, Halpern ASR, Fuller R, Souza FHC, Guedes LKN, Assad APL, Moraes JCBD, Lopes MRU, Martins VADO, Betancourt L, Ribeiro CT, Sales LP, Bertoglio IM, Bonoldi VLN, Mello RLP, Balbi GGM, Sartori AMC, Antonangelo L, Silva CA, Bonfa E. Increment of immunogenicity after third dose of a homologous inactivated SARS-CoV-2 vaccine in a large population of patients with autoimmune rheumatic diseases. Ann Rheum Dis. [DOI: 10.1136/annrheumdis-2021-222096] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 11.0] [Reference Citation Analysis]
|
| 342 |
Fonseca MES, Balbi GGM, Signorelli F, Gouvea CP, de Andrade DCO. CoaguChek® XS versus standard laboratory prothrombin time for anticoagulant monitoring in patients with antiphospholipid syndrome. Lupus 2022;:9612033221086134. [PMID: 35266798 DOI: 10.1177/09612033221086134] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 343 |
Kim HS, Lee ES, Shin B, Kang HG. Recurrent Cerebral Artery Dissection Associated with Seronegative Antiphospholipid Antibody Syndrome. Tomography 2022;8:754-9. [DOI: 10.3390/tomography8020062] [Reference Citation Analysis]
|
| 344 |
Eide JG, Wu J, Stevens WW, Bai J, Hou S, Huang JH, Rosenberg J, Utz P, Shintani-Smith S, Conley DB, Welch KC, Kern RC, Hulse KE, Peters AT, Grammer LC, Zhao M, Lindholm P, Schleimer RP, Tan BK. Anti-phospholipid antibodies are elevated and functionally active in chronic rhinosinusitis with nasal polyps. Clin Exp Allergy 2022. [PMID: 35253284 DOI: 10.1111/cea.14120] [Reference Citation Analysis]
|
| 345 |
Choudhary RA, Siddiqui MAR, Moiz B, Ishaq S. Combined central retinal artery and vein occlusion associated with antiphospholipid syndrome. BMJ Case Rep 2022;15:e248425. [PMID: 35246439 DOI: 10.1136/bcr-2021-248425] [Reference Citation Analysis]
|
| 346 |
Nowak KM, Carpinteiro A, Szalai C, Saner FH. Acquired Hemophilia A: A Permanent Challenge for All Physicians. Medicines (Basel) 2022;9:21. [PMID: 35323720 DOI: 10.3390/medicines9030021] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 347 |
Tektonidou MG. Cardiovascular disease risk in antiphospholipid syndrome: Thrombo-inflammation and atherothrombosis. J Autoimmun 2022;128:102813. [PMID: 35247655 DOI: 10.1016/j.jaut.2022.102813] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 348 |
Svenungsson E, Spaak J, Strandberg K, Wallén HN, Agewall S, Brolin EB, Collste O, Daniel M, Ekenbäck C, Frick M, Henareh L, Malmqvist K, Elvin K, Sörensson P, Y-Hassan S, Hofman-Bang C, Tornvall P. Antiphospholipid antibodies in patients with myocardial infarction with and without obstructive coronary arteries. J Intern Med 2022;291:327-37. [PMID: 34820922 DOI: 10.1111/joim.13409] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 349 |
Hasse S, Julien AS, Duchez AC, Zhao C, Boilard E, Fortin PR, Bourgoin SG. Red blood cell-derived phosphatidylserine positive extracellular vesicles are associated with past thrombotic events in patients with systemic erythematous lupus. Lupus Sci Med 2022;9:e000605. [PMID: 35260475 DOI: 10.1136/lupus-2021-000605] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 350 |
Hoang TT, Ichinose K, Morimoto S, Furukawa K, Le LH, Kawakami A. Measurement of anti-suprabasin antibodies, multiple cytokines and chemokines as potential predictive biomarkers for neuropsychiatric systemic lupus erythematosus. Clinical Immunology 2022. [DOI: 10.1016/j.clim.2022.108980] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 351 |
Carmona-Rivera C, O'Neil LJ, Patino-Martinez E, Shipman WD, Zhu C, Li QZ, Kerns ML, Barnes LA, Caffrey JA, Kang S, Kaplan MJ, Okoye GA, Byrd AS. Autoantibodies Present in Hidradenitis Suppurativa Correlate with Disease Severity and Promote the Release of Proinflammatory Cytokines in Macrophages. J Invest Dermatol 2022;142:924-35. [PMID: 34606886 DOI: 10.1016/j.jid.2021.07.187] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 11.0] [Reference Citation Analysis]
|
| 352 |
Favaloro EJ, Mohammed S, Vong R, Chapman K, Swanepoel P, Kershaw G, Cai N, Just S, Connelly L, Brighton T, Pasalic L. A multi-laboratory assessment of lupus anticoagulant assays performed on the ACL TOP 50 family for harmonized testing in a large laboratory network. Int J Lab Hematol 2022. [PMID: 35234361 DOI: 10.1111/ijlh.13818] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 353 |
Pécourt M, Yelnik C, Ghesquière L, Drumez É, Cailliau É, Hachulla É, Debarge V, Morel N, Le Guern V, Garabedian C, Costedoat-chalumeau N, Lambert M. Anticorps antiphospholipides, un facteur pronostique négatif pour le HELLP syndrome ? JMV-Journal de Médecine Vasculaire 2022;47:S34. [DOI: 10.1016/j.jdmv.2022.01.029] [Reference Citation Analysis]
|
| 354 |
Dao KH, Bermas BL. Systemic Lupus Erythematosus Management in Pregnancy. Int J Womens Health 2022;14:199-211. [PMID: 35210867 DOI: 10.2147/IJWH.S282604] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 355 |
Middeldorp S, Naue C, Köhler C. Thrombophilia, Thrombosis and Thromboprophylaxis in Pregnancy: For What and in Whom? Hamostaseologie 2022;42:54-64. [PMID: 35196731 DOI: 10.1055/a-1717-7663] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 356 |
Madison JA, Gockman K, Hoy C, Tambralli A, Zuo Y, Knight JS. Pediatric antiphospholipid syndrome: clinical features and therapeutic interventions in a single center retrospective case series. Pediatr Rheumatol Online J 2022;20:17. [PMID: 35197077 DOI: 10.1186/s12969-022-00677-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 357 |
Scheen M, Adedjouma A, Esteve E, Buob D, Abisror N, Planche V, Fain O, Boffa JJ, De Seigneux S, Mekinian A, Haidar F. Kidney disease in antiphospholipid antibody syndrome: Risk factors, pathophysiology and management. Autoimmun Rev 2022;:103072. [PMID: 35217200 DOI: 10.1016/j.autrev.2022.103072] [Reference Citation Analysis]
|
| 358 |
Uludağ Ö, Çene E, Gurel E, Çetin Ç, Bektaş M, Yalçınkaya Y, Diz-Küçükkaya R, Gül A, Inanç M, Artim-Esen B. Description of damage in different clusters of patients with antiphospholipid syndrome. Lupus 2022;:9612033221079781. [PMID: 35166607 DOI: 10.1177/09612033221079781] [Reference Citation Analysis]
|
| 359 |
Udry S, Peréz SM, Belizna C, Aranda F, Esteve-Valverde E, Wingeyer SP, Fernández-Romero DS, Latino JO, de Larrañaga G, Alijotas-Reig J. Clinical and therapeutic value of the adjusted Global Antiphospholipid Syndrome Score in primary obstetric antiphospholipid syndrome. Lupus 2022;:9612033221078223. [PMID: 35157809 DOI: 10.1177/09612033221078223] [Reference Citation Analysis]
|
| 360 |
Torres-Jimenez AR, Ramirez-Nova V, Cespedes-Cruz AI, Sanchez-Jara B, Velazquez-Cruz A, Bekker-Méndez VC, Guerra-Castillo FX. Primary antiphospholipid syndrome in pediatrics: beyond thrombosis. Report of 32 cases and review of the evidence. Pediatr Rheumatol Online J 2022;20:13. [PMID: 35164787 DOI: 10.1186/s12969-022-00673-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 361 |
Lonati PA, Bodio C, Scavone M, Martini G, Pesce E, Bandera A, Lombardi A, Gerosa M, Franceschini F, Tincani A, Podda G, Abrignani S, Grifantini R, Cattaneo M, Borghi MO, Meroni PL. Production of anti-PF4 antibodies in antiphospholipid antibody-positive patients is not affected by COVID-19 vaccination. RMD Open 2022;8:e001902. [PMID: 35131751 DOI: 10.1136/rmdopen-2021-001902] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 362 |
Mac Grory B, Ohman EM, Feng W, Xian Y, Yaghi S, Kamel H, Reznik ME. Advances in the management of cardioembolic stroke associated with patent foramen ovale. BMJ 2022;376:e063161. [PMID: 35140114 DOI: 10.1136/bmj-2020-063161] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 363 |
Schapkaitz E, Libhaber E, Jacobson BF, Gerber A, Rhemtula H, Büller HR. Profile of antiphospholipid antibodies in HIV-infected and HIV-uninfected women with a history of thrombosis. Int J Lab Hematol 2022. [PMID: 35132770 DOI: 10.1111/ijlh.13805] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 364 |
B Rathna R, Dhali A, Varghese AK, H Balakrishnan C. Rare association of haemophagocytic lymphohistiocytosis (HLH) and antiphospholipid syndrome (APS) in postpartum period: a considerable overlap? BMJ Case Rep 2022;15:e247376. [PMID: 35110287 DOI: 10.1136/bcr-2021-247376] [Reference Citation Analysis]
|
| 365 |
Sacks HS, Smirnoff M, Carson D, Cooney ML, Shapiro MZ, Hahn CJ, Dasaro CR, Crowson C, Tassiulas I, Hirten RP, Cohen BL, Haber RS, Davies TF, Simpson DM, Crane MA, Harrison DJ, Luft BJ, Moline JM, Udasin IG, Todd AC, Sloan NL, Teitelbaum SL. Autoimmune conditions in the World Trade Center general responder cohort: A nested case-control and standardized incidence ratio analysis. Am J Ind Med 2022;65:117-31. [PMID: 34825393 DOI: 10.1002/ajim.23313] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 366 |
Jepsen SY, Larsen JB, Christensen TD, Grove EL, Maegaard M, Hvas A. Warfarin monitoring and interference by lupus anticoagulant in patients with antiphospholipid syndrome. Thrombosis Research 2022. [DOI: 10.1016/j.thromres.2022.01.021] [Reference Citation Analysis]
|
| 367 |
Morales Torres J, Aceves FJ, Amigo Castañeda MC, Hernández Cuevas CB. Could Frida Kahlo have had antiphospholipid syndrome? Reumatología Clínica (English Edition) 2022;18:65-68. [DOI: 10.1016/j.reumae.2020.07.013] [Reference Citation Analysis]
|
| 368 |
Melayah S, Kallala O, Ben Ahmed M, Fodha I, Yacoub Jemni S, Ghedira I, Mankaï A. IgA anti-beta-2 glycoprotein I antibodies in chronic hepatitis C. Arab Journal of Gastroenterology 2022. [DOI: 10.1016/j.ajg.2021.12.003] [Reference Citation Analysis]
|
| 369 |
Morales Torres J, Aceves FJ, Amigo Castañeda MC, Hernández Cuevas CB. Could Frida Kahlo have had antiphospholipid syndrome? Reumatología Clínica 2022;18:65-68. [DOI: 10.1016/j.reuma.2020.07.012] [Reference Citation Analysis]
|
| 370 |
Kapsala N, Nikolopoulos D, Flouda S, Chavatza A, Tseronis D, Aggelakos M, Katsimbri P, Bertsias G, Fanouriakis A, Boumpas DT. First Diagnosis of Systemic Lupus Erythematosus in Hospitalized Patients: Clinical Phenotypes and Pitfalls for the Non-Specialist. Am J Med 2022;135:244-253.e3. [PMID: 34411524 DOI: 10.1016/j.amjmed.2021.07.015] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 371 |
Bai M, Liu S, Song Y, Chen H, Wang M, Liu K, Zhu M. WITHDRAWN: Cerebral Venous Thrombosis is a Rare Complication of Sjögren's Syndrome: A Case Report. Neuroimmunology Reports 2022. [DOI: 10.1016/j.nerep.2022.100081] [Reference Citation Analysis]
|
| 372 |
Xu J, Chen D, Tian Y, Wang X, Peng B, Athalye-jape GK. Antiphospholipid Antibodies Increase the Risk of Fetal Growth Restriction: A Systematic Meta-Analysis. International Journal of Clinical Practice 2022;2022:1-10. [DOI: 10.1155/2022/4308470] [Reference Citation Analysis]
|
| 373 |
Tumian NR, Hunt BJ. Clinical Management of Thrombotic Antiphospholipid Syndrome. JCM 2022;11:735. [DOI: 10.3390/jcm11030735] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 374 |
Alijotas-Reig J, Esteve-Valverde E, Anunciación-Llunell A, Marques-Soares J, Pardos-Gea J, Miró-Mur F. Pathogenesis, Diagnosis and Management of Obstetric Antiphospholipid Syndrome: A Comprehensive Review. J Clin Med 2022;11:675. [PMID: 35160128 DOI: 10.3390/jcm11030675] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 11.0] [Reference Citation Analysis]
|
| 375 |
Tsikouras P, Tsiggalou C, Bothou A, Gerede A, Apostolou I, Gaitatzi F, Chalkidou A, Anthoulaki X, Michalopoulos S, Dragoutsos G, Tsirkas I, Babageorgaka I, Nalbanti T, Sachnova N, Alexiou A, Nikolettos K, Tsalikidis C, Zervoudis S, Peitsidis P, Nikolettos N. Antiphospholipid Syndrome and Pregnancy-Diagnosis, Complications and Management: An Overview. Inflammation in the 21st Century 2022. [DOI: 10.5772/intechopen.99283] [Reference Citation Analysis]
|
| 376 |
Del Porto F, Ferrero S, Cifani N, Sesti G, Proietta M. Antiphospholipid antibodies and idiopathic infertility. Lupus 2022;:9612033221076735. [PMID: 35073215 DOI: 10.1177/09612033221076735] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 377 |
Shavit-Stein E, Berkowitz S, Gofrit SG, Altman K, Weinberg N, Maggio N. Neurocoagulation from a Mechanistic Point of View in the Central Nervous System. Semin Thromb Hemost 2022. [PMID: 35052009 DOI: 10.1055/s-0041-1741569] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 378 |
Dai Y, Lin L, Lin N, He D, Guo D, Xue H, Li Y, Xie X, Xu L, He S. APA scoring system: a novel predictive model based on risk factors of pregnancy loss for recurrent spontaneous abortion patients. Journal of Obstetrics and Gynaecology. [DOI: 10.1080/01443615.2021.2021507] [Reference Citation Analysis]
|
| 379 |
Xie Z, Li H, Qi W, Li J, Wu C, Hu C, Jiang N, Wang Q, Tian X, Li M, Zhao J, Sui R, Zeng X. Characteristics and risk factors of retinal vasculopathy in antiphospholipid syndrome. Lupus 2022;:9612033211069762. [PMID: 35042380 DOI: 10.1177/09612033211069762] [Reference Citation Analysis]
|
| 380 |
Watanabe Y, Kaneda T. Anesthetic Management Using Epidural Analgesia for Emergency Laparoscopic Cholecystectomy in a Patient with Lupus Anticoagulant Positivity and Prolonged Activated Partial Thromboplastin Time. Case Rep Anesthesiol 2022;2022:6310630. [PMID: 35087690 DOI: 10.1155/2022/6310630] [Reference Citation Analysis]
|
| 381 |
Lazzaroni MG, Crisafulli F, Moschetti L, Semeraro P, Cunha AR, Neto A, Lojacono A, Ramazzotto F, Zanardini C, Zatti S, Airò P, Tincani A, Franceschini F, Andreoli L. Reproductive Issues and Pregnancy Implications in Systemic Sclerosis. Clin Rev Allergy Immunol 2022. [PMID: 35040084 DOI: 10.1007/s12016-021-08910-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 382 |
Khefacha L, Rassas R, Bergaoui H, Mustapha H, Faleh R, Sakly N, Sassi M. Antiphospholipid antibodies in the obstetric antiphospholipid syndrome: Detection and antibodies profile at the Maternity and Neonatal Medicine Center of Monastir, Tunisia. J Obstet Gynaecol Res 2022. [PMID: 35042279 DOI: 10.1111/jog.15143] [Reference Citation Analysis]
|
| 383 |
Holers VM, La Rosa FG, Banda NK. A Potential New Mouse Model of Axial Spondyloarthritis Involving the Complement System. Immune Netw 2021;21:e45. [PMID: 35036032 DOI: 10.4110/in.2021.21.e45] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 384 |
Isabel Sieiro Santos C. Antiphospholipid Antibodies in Patients with COVID-19. Current Perspectives on Viral Disease Outbreaks - Epidemiology, Detection and Control 2022. [DOI: 10.5772/intechopen.95261] [Reference Citation Analysis]
|
| 385 |
Tekgöl Uzuner G, Özdemir AÖ, Korkmaz C, Uzuner N. Anti-Phosholipid Syndrome Misdiagnosed As Multiple Sclerosis: A Case Report. OSMANGAZİ JOURNAL OF MEDICINE 2022. [DOI: 10.20515/otd.978880] [Reference Citation Analysis]
|
| 386 |
Man YL, Sanna G. Neuropsychiatric Manifestations of Antiphospholipid Syndrome—A Narrative Review. Brain Sciences 2022;12:91. [DOI: 10.3390/brainsci12010091] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 387 |
Kwak S, Green M. Rare yet catastrophic presentation of undiagnosed antiphospholipid syndrome. BMJ Case Rep 2022;15:e245838. [PMID: 35012938 DOI: 10.1136/bcr-2021-245838] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 388 |
Martin J, Petryayeva E, Khan WI. Autoantibodies in Common Connective Tissue Diseases: A Primer for Laboratory Professionals. The Journal of Applied Laboratory Medicine 2022;7:114-136. [DOI: 10.1093/jalm/jfab131] [Reference Citation Analysis]
|
| 389 |
Xourgia E, Tektonidou MG. An Update on Antiphospholipid Syndrome. Curr Rheumatol Rep 2022;23:84. [PMID: 34985625 DOI: 10.1007/s11926-021-01051-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 390 |
Dabit JY, Valenzuela-Almada MO, Vallejo-Ramos S, Duarte-García A. Epidemiology of Antiphospholipid Syndrome in the General Population. Curr Rheumatol Rep 2022;23:85. [PMID: 34985614 DOI: 10.1007/s11926-021-01038-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 391 |
Selby R, Abdulrehman J. Antiphospholipid Antibodies and the Antiphospholipid Syndrome: From Coagulation to the Clinic. J Appl Lab Med 2022;7:373-8. [PMID: 34996086 DOI: 10.1093/jalm/jfab134] [Reference Citation Analysis]
|
| 392 |
Hirmerová J. Antithrombotic therapy in antiphospholipid syndrome, the role of direct oral anticoagulants. Klin Farmakol Farm 2022;35:101-105. [DOI: 10.36290/far.2021.024] [Reference Citation Analysis]
|
| 393 |
da Rosa GP, Sousa-Pinto B, Ferreira E, Araújo O, Barilaro G, Bettencourt P, Cervera R, Espinosa G. The presence of non-criteria manifestations negatively affects the prognosis of seronegative antiphospholipid syndrome patients: a multicenter study. Arthritis Res Ther 2022;24:9. [PMID: 34980238 DOI: 10.1186/s13075-021-02702-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 394 |
Gurajala S. Autoimmune disorders with special reference to Coronavirus Disease-2019. J Datta Meghe Inst Med Sci Univ 2022;17:792. [DOI: 10.4103/jdmimsu.jdmimsu_475_20] [Reference Citation Analysis]
|
| 395 |
Lisle B, Bushnell C. Hematologic Disorders and Stroke. Stroke 2022. [DOI: 10.1016/b978-0-323-69424-7.00042-9] [Reference Citation Analysis]
|
| 396 |
Malavasi AL, Moreira DA. Acquired Thrombophilia in Pregnancy. Perinatology 2022. [DOI: 10.1007/978-3-030-83434-0_23] [Reference Citation Analysis]
|
| 397 |
伏 林. Myocardial Infarction with Non-Obstructive Coronary Artery Disease Caused by Antiphospholipid Syndrome: A Case Report. ACM 2022;12:10003-10007. [DOI: 10.12677/acm.2022.12111442] [Reference Citation Analysis]
|
| 398 |
Borisova A, Veltishchev D, Lisitsyna T, Reshetnyak T, Seravina O, Kovalevskaya O, Cheldieva F, Abramkin A. Anxiety-depressive disorders and stress factors in patients with systemic lupus erythematosus and antiphospholipid syndrome. Z nevrol psikhiatr im S S Korsakova 2022;122:65. [DOI: 10.17116/jnevro202212203165] [Reference Citation Analysis]
|
| 399 |
Wagner N, Haffner D, Tenbrock K, Dannecker G. Systemischer Lupus erythematodes bei Kindern und Jugendlichen. Pädiatrische Rheumatologie 2022. [DOI: 10.1007/978-3-662-60410-6_38] [Reference Citation Analysis]
|
| 400 |
Sano E, Arawaka S. White Matter Hyperintensities as a Risk Factor for Ischemic Stroke in Patients With Systemic Lupus Erythematosus. Front Neurol 2021;12:738173. [PMID: 34970201 DOI: 10.3389/fneur.2021.738173] [Reference Citation Analysis]
|
| 401 |
Cavalcante MB, Barini R. Thrombophilia, antiphospholipid antibodies, and anticoagulation in recurrent implantation failure. Immunology of Recurrent Pregnancy Loss and Implantation Failure 2022. [DOI: 10.1016/b978-0-323-90805-4.00020-1] [Reference Citation Analysis]
|
| 402 |
de la Hera Madrazo M, Muñoz Cacho P, Riancho Zarrabeitia L, Álvarez Rodríguez L, Haya A, López-hoyos M, Martínez-taboada VM. Pregnancy and systemic lupus erythematosus in Spain: Has anything changed in the 21st century? Reumatología Clínica (English Edition) 2022;18:42-48. [DOI: 10.1016/j.reumae.2020.07.008] [Reference Citation Analysis]
|
| 403 |
Oo Z, Manvar K, Wang JC. Eltrombopag-Induced Thrombocytosis and Thrombosis in Patients With Antiphospholipid Syndrome and Immune Thrombocytopenic Purpura. J Investig Med High Impact Case Rep 2022;10:23247096211060581. [PMID: 35277086 DOI: 10.1177/23247096211060581] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 404 |
Rezaei N, Yazdanpanah N. Introduction on translational autoimmunity: From bench to bedside. Translational Autoimmunity 2022. [DOI: 10.1016/b978-0-12-822564-6.00013-6] [Reference Citation Analysis]
|
| 405 |
Mills B, Bermas BL. Rheumatic diseases and reproductive outcomes. Immunology of Recurrent Pregnancy Loss and Implantation Failure 2022. [DOI: 10.1016/b978-0-323-90805-4.00006-7] [Reference Citation Analysis]
|
| 406 |
Arreola-Diaz R, Majluf-Cruz A, Sanchez-Torres LE, Hernandez-Juarez J. The Pathophysiology of The Antiphospholipid Syndrome: A Perspective From The Blood Coagulation System. Clin Appl Thromb Hemost 2022;28:10760296221088576. [PMID: 35317658 DOI: 10.1177/10760296221088576] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 407 |
Su Z, Huang Z, Zhao J, Li M, Hu J, Zeng X, Hu C, Yang B. Detection of IgA Antiphospholipid Antibodies Does not Improve Thrombotic Antiphospholipid Syndrome Classification: A two-Center Study. Clin Appl Thromb Hemost 2022;28:10760296221081129. [PMID: 35379020 DOI: 10.1177/10760296221081129] [Reference Citation Analysis]
|
| 408 |
Islabão AG, Trindade VC, da Mota LMH, Andrade DCO, Silva CA. Managing Antiphospholipid Syndrome in Children and Adolescents: Current and Future Prospects. Paediatr Drugs 2022;24:13-27. [PMID: 34904182 DOI: 10.1007/s40272-021-00484-w] [Reference Citation Analysis]
|
| 409 |
Turocy J, Williams Z. Early and recurrent pregnancy loss. Comprehensive Gynecology 2022. [DOI: 10.1016/b978-0-323-65399-2.00025-5] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 410 |
Chong KY, Mol BW. Recurrent Early Pregnancy Loss. Clinical Reproductive Medicine and Surgery 2022. [DOI: 10.1007/978-3-030-99596-6_15] [Reference Citation Analysis]
|
| 411 |
Roberta E, Laura T, Wally O, Luigi MP. Antiphospholipid syndrome and recurrent pregnancy losses. Immunology of Recurrent Pregnancy Loss and Implantation Failure 2022. [DOI: 10.1016/b978-0-323-90805-4.00008-0] [Reference Citation Analysis]
|
| 412 |
Mendoza-pinto C, García-carrasco M, Cervera R. Microorganisms in the Pathogenesis and Management of Anti-phospholipid Syndrome (Hughes Syndrome). Role of Microorganisms in Pathogenesis and Management of Autoimmune Diseases 2022. [DOI: 10.1007/978-981-19-4800-8_17] [Reference Citation Analysis]
|
| 413 |
Schreck R, Govindavari JP, Williams J. Fetal Loss. Emery and Rimoin's Principles and Practice of Medical Genetics and Genomics 2022. [DOI: 10.1016/b978-0-12-815236-2.00012-6] [Reference Citation Analysis]
|
| 414 |
Otsuka R, Saito S, Yamamoto T, Ohno T, Koyama A, Morimae H, Matsushita M, Yokota K, Miyahara K, Matsuura A. Recurrent Mural Thrombosis of the Ascending Aorta in a Patient with Antiphospholipid Syndrome. Annals of Vascular Diseases. [DOI: 10.3400/avd.cr.21-00138] [Reference Citation Analysis]
|
| 415 |
Miller-hodges E, Bellamy COC, Kluth DC, Dhaun N. Systemic Lupus Erythematosus, Antiphospholipid Syndrome and the Kidney. Primer on Nephrology 2022. [DOI: 10.1007/978-3-030-76419-7_28] [Reference Citation Analysis]
|
| 416 |
Murgu A, Onofrei A, Dobre I, Rusu D, Cernescu I, Cater P. Diagnostic pitfalls in child thrombosis. Pediatru ro 2022;3:20. [DOI: 10.26416/pedi.67.3.2022.7233] [Reference Citation Analysis]
|
| 417 |
Förger F, Mayer-pickel K. Rheumatologische Krankheiten und Schwangerschaft: Systemischer Lupus erythematodes, Antiphospholipidsyndrom, rheumatoide Arthritis, Spondyloarthritis, systemische Sklerose, entzündliche Myopathien und Vaskulitis. Die Geburtshilfe 2022. [DOI: 10.1007/978-3-662-44369-9_72-1] [Reference Citation Analysis]
|
| 418 |
Stankić D, Miljić P. Investigation of the relation between the type and titer of antiphospholipid antibodies and the clinical manifestations of antiphospholipid syndrome. Srpski medicinski časopis Lekarske komore 2022;3:35-44. [DOI: 10.5937/smclk3-32463] [Reference Citation Analysis]
|
| 419 |
Zhang T, Chen X, Li TC, Wang CC, Chung JPW. Autoimmunity and infertility. Translational Autoimmunity 2022. [DOI: 10.1016/b978-0-323-85415-3.00008-8] [Reference Citation Analysis]
|
| 420 |
Reich A, Antiga E, Bowszyc-dmochowska M, Dańczak-pazdrowska A, Polańska A, Samotij D, Sokolik R, Szczęch J, Szmyrka M, Woźniak Z. The “Connective Tissue Diseases”. Atlas of Dermatology, Dermatopathology and Venereology 2022. [DOI: 10.1007/978-3-319-53808-2_43] [Reference Citation Analysis]
|
| 421 |
Shendi AM. Laboratory Tests in Nephrology. Primer on Nephrology 2022. [DOI: 10.1007/978-3-030-76419-7_3] [Reference Citation Analysis]
|
| 422 |
Hedrich CM, Kallinich T. Antiphospholipid-Syndrom bei Kindern und Jugendlichen. Pädiatrische Rheumatologie 2022. [DOI: 10.1007/978-3-662-60410-6_39] [Reference Citation Analysis]
|
| 423 |
Couto E, Junior RP. Prophylaxis for Deep Venous Thrombosis During Pregnancy, Delivery, and Postpartum. Perinatology 2022. [DOI: 10.1007/978-3-030-83434-0_29] [Reference Citation Analysis]
|
| 424 |
Santacruz JC, Mantilla MJ, Rueda I, Pulido S, Rodríguez G, Londono J. Obstetric Antiphospholipid Syndrome From the Perspective of a Rheumatologist. Cureus 2022;14:e21090. [PMID: 35165550 DOI: 10.7759/cureus.21090] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 425 |
George JS, Mortimer R, Anchan RM. The role of reproductive immunology in recurrent pregnancy loss and repeated implantation failure. Immunology of Recurrent Pregnancy Loss and Implantation Failure 2022. [DOI: 10.1016/b978-0-323-90805-4.00005-5] [Reference Citation Analysis]
|
| 426 |
Märker-hermann E. Kardiale Beteiligung bei rheumatischen Erkrankungen. Klinische Kardiologie 2022. [DOI: 10.1007/978-3-662-62939-0_31-1] [Reference Citation Analysis]
|
| 427 |
Bezerra AS, Moya FG, Filho ISF, Fioretti AC. Bilateral Carotid Aneurysms Secondary to Catastrophic Antiphospholipid Syndrome in a Patient with Differential Diagnosis of Polyarteritis Nodosa. WJCD 2022;12:30-37. [DOI: 10.4236/wjcd.2022.121004] [Reference Citation Analysis]
|
| 428 |
de la Hera Madrazo M, Muñoz Cacho P, Riancho Zarrabeitia L, Álvarez Rodríguez L, Haya A, López-hoyos M, Martínez-taboada VM. Embarazo y lupus eritematoso sistémico en España: ¿ha cambiado algo en el siglo xxi? Reumatología Clínica 2022;18:42-48. [DOI: 10.1016/j.reuma.2020.07.009] [Reference Citation Analysis]
|
| 429 |
Del Barrio-Longarela S, Martínez-Taboada VM, Blanco-Olavarri P, Merino A, Riancho-Zarrabeitia L, Comins-Boo A, López-Hoyos M, Hernández JL. Does Adjusted Global Antiphospholipid Syndrome Score (aGAPSS) Predict the Obstetric Outcome in Antiphospholipid Antibody Carriers? A Single-Center Study. Clin Rev Allergy Immunol 2022;63:297-310. [PMID: 34910282 DOI: 10.1007/s12016-021-08915-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 430 |
Zúñiga-garza E, Franco-lópez F. Isquemia mesentérica como presentación de síndrome antifosfolípidos primario en paciente masculino. Cirujano General 2022;44:93-96. [DOI: 10.35366/109719] [Reference Citation Analysis]
|
| 431 |
Zhao K, Zhou P, Xu L, Li R, Yang J, Zhang Q, Yang M, Wei X. Was Antiphospholipid Syndrome a Risk Factor of Stroke? A Systemic Review and Meta-Analysis of Cohort Studies. Dis Markers 2021;2021:4431907. [PMID: 34956419 DOI: 10.1155/2021/4431907] [Reference Citation Analysis]
|
| 432 |
Pirtea P, de Ziegler D, Ayoubi JM. Recurrent Implantation Failure-Is It the Egg or the Chicken? Life (Basel) 2021;12:39. [PMID: 35054432 DOI: 10.3390/life12010039] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 433 |
Chen JL, Yu X, Luo R, Liu M. Severe digital ischemia coexists with thrombocytopenia in malignancy-associated antiphospholipid syndrome: A case report and review of literature. World J Clin Cases 2021; 9(36): 11457-11466 [DOI: 10.12998/wjcc.v9.i36.11457] [Reference Citation Analysis]
|
| 434 |
Efthymiou M, Lane PJ, Isenberg D, Cohen H, Mackie IJ. Comparison of Acquired Activated Protein C Resistance, Using the CAT and ST-Genesia® Analysers and Three Thrombin Generation Methods, in APS and SLE Patients. JCM 2021;11:69. [DOI: 10.3390/jcm11010069] [Reference Citation Analysis]
|
| 435 |
Al-dohayan ND, Al-batniji F, Alotaibi HA, Elbaage AT. Hepatitis-A Infection-Induced Secondary Antiphospholipid Syndrome With Neuro-ophthalmological Manifestations. Cureus 2021. [DOI: 10.7759/cureus.20603] [Reference Citation Analysis]
|
| 436 |
Carré J, Jourdi G, Gendron N, Helley D, Gaussem P, Darnige L. Recent Advances in Anticoagulant Treatment of Immune Thrombosis: A Focus on Direct Oral Anticoagulants in Heparin-Induced Thrombocytopenia and Anti-Phospholipid Syndrome. Int J Mol Sci 2021;23:93. [PMID: 35008518 DOI: 10.3390/ijms23010093] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 437 |
Velásquez M, Peláez LF, Rojas M, Narváez-Sánchez R, Velásquez JA, Escudero C, San Martín S, Cadavid ÁP. Differences in Endothelial Activation and Dysfunction Induced by Antiphospholipid Antibodies Among Groups of Patients With Thrombotic, Refractory, and Non-refractory Antiphospholipid Syndrome. Front Physiol 2021;12:764702. [PMID: 34925061 DOI: 10.3389/fphys.2021.764702] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
|
| 438 |
Voigtlaender M, Langer F. Management of Vascular Thrombosis in Patients with Thrombocytopenia. Hamostaseologie 2021. [PMID: 34933376 DOI: 10.1055/a-1675-7824] [Reference Citation Analysis]
|
| 439 |
Rogenhofer N, Mahner S, von Hasselbach YL, Thaler CJ. Effects of intralipid infusions on anti-trophoblast antibody (ATAb)-activities in patients with recurrent pregnancy loss: An observational report. Am J Reprod Immunol 2021;:e13506. [PMID: 34935238 DOI: 10.1111/aji.13506] [Reference Citation Analysis]
|
| 440 |
Gracia-Ramos AE, Martin-Nares E, Hernández-Molina G. New Onset of Autoimmune Diseases Following COVID-19 Diagnosis. Cells 2021;10:3592. [PMID: 34944099 DOI: 10.3390/cells10123592] [Cited by in Crossref: 28] [Cited by in F6Publishing: 35] [Article Influence: 14.0] [Reference Citation Analysis]
|
| 441 |
Pinto V, Ministro A, Carreira NR, Cardoso A, Gonçalves CS, Henriques M, Rato J, Silva E, Pedro LM. A catastrophic seronegative anti-phospholipid syndrome: case and literature review. Thromb J 2021;19:103. [PMID: 34930339 DOI: 10.1186/s12959-021-00356-w] [Reference Citation Analysis]
|
| 442 |
Bolla E, Tentolouris N, Sfikakis PP, Tektonidou MG. Cardiovascular risk management in antiphospholipid syndrome: trends over time and comparison with rheumatoid arthritis and diabetes mellitus. Lupus Sci Med 2021;8:e000579. [PMID: 34921093 DOI: 10.1136/lupus-2021-000579] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 443 |
Kempers EK, Dalm VASH, van Rijn MJE, Mulders AGMGJ, Leebeek FWG, de Maat MPM, Jansen AJG. Indication and outcome of lupus anticoagulant and antiphospholipid antibodies testing in routine clinical practice. Rheumatol Adv Pract 2021;5:rkab093. [PMID: 34917873 DOI: 10.1093/rap/rkab093] [Reference Citation Analysis]
|
| 444 |
Rodríguez CM, Velásquez-Berrío M, Rúa C, Viana M, Abrahams VM, Cadavid AP, Alvarez AM. Antiphospholipid Antibodies From Women With Pregnancy Morbidity and Vascular Thrombosis Induce Endothelial Mitochondrial Dysfunction, mTOR Activation, and Autophagy. Front Physiol 2021;12:706743. [PMID: 34912234 DOI: 10.3389/fphys.2021.706743] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 445 |
Wang X, Gkrouzman E, Andrade DCO, Andreoli L, Barbhaiya M, Belmont HM, Branch DW, de Jesús GR, Efthymiou M, Ríos-Garcés R, Gerosa M, El Hasbani G, Knight J, Meroni PL, Pazzola G, Petri M, Rand J, Salmon J, Tektonidou M, Tincani A, Uthman IW, Zuily S, Zuo Y, Lockshin M, Cohen H, Erkan D; APS ACTION. COVID-19 and antiphospholipid antibodies: A position statement and management guidance from AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION). Lupus 2021;:9612033211062523. [PMID: 34915764 DOI: 10.1177/09612033211062523] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 446 |
DeSpenza RA, Jones DM, Chamley LW, Abrahams VM. Antiphospholipid antibody-induced trophoblast responses are differentially modulated by viral dsRNA and viral ssRNA. Am J Reprod Immunol 2021;:e13516. [PMID: 34904767 DOI: 10.1111/aji.13516] [Reference Citation Analysis]
|
| 447 |
Jerez-Lienas A, Mathian A, Aboab J, Crassard I, Hie M, Cohen-Aubart F, Haroche J, Wahl D, Cervera R, Amoura Z. Cerebral Vein Thrombosis in the Antiphospholipid Syndrome: Analysis of a Series of 27 Patients and Review of the Literature. Brain Sci 2021;11:1641. [PMID: 34942943 DOI: 10.3390/brainsci11121641] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 448 |
Liu H, Li P, Li K, Zhou Z, Zhou Y, Leng X, Zhao L, Zhang X. Monoclonal gammopathy in autoimmune diseases: Analysis and follow-up of 160 cases in a tertiary center in China. Clin Immunol 2021;234:108909. [PMID: 34915197 DOI: 10.1016/j.clim.2021.108909] [Reference Citation Analysis]
|
| 449 |
Meter M, Meter D, Ceprnja T, Perkovic D. Left Atrial Myxoma and Antiphospholipid Syndrome—A Case Report. Int J Angiol. [DOI: 10.1055/s-0041-1740103] [Reference Citation Analysis]
|
| 450 |
Bucci T, Ames PRJ, Triggiani M, Parente R, Ciampa A, Pignatelli P, Pastori D; Multicenter ATHERO-APS Study group. Cardiac and vascular features of arterial and venous primary antiphospholipid syndrome. The multicenter ATHERO-APS study. Thromb Res 2022;209:69-74. [PMID: 34891057 DOI: 10.1016/j.thromres.2021.12.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 451 |
May JE, Moll S. Unexplained arterial thrombosis: approach to diagnosis and treatment. Hematology 2021;2021:76-84. [DOI: 10.1182/hematology.2021000235] [Reference Citation Analysis]
|
| 452 |
Noureldine HA, El Hasbani G, Nour Eldine M, Nour-Eldine W, Taher A, Uthman I. Postural tachycardia syndrome (POTS) and antiphospholipid syndrome (APS): What do we know so far? Rev Neurol (Paris) 2021:S0035-3787(21)00772-4. [PMID: 34895744 DOI: 10.1016/j.neurol.2021.10.006] [Reference Citation Analysis]
|
| 453 |
Thakur N. Antiphospholipid Syndrome – Early Pregnancy Loss. AJNER 2021. [DOI: 10.52711/2349-2996.2021.00136] [Reference Citation Analysis]
|
| 454 |
Park DJ, Yoon CS, Choi SE, Xu H, Kang JH, Lee SS. Risk factors for thrombotic events in Korean patients with systemic lupus erythematosus. Sci Rep 2021;11:23529. [PMID: 34876633 DOI: 10.1038/s41598-021-03074-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 455 |
du Fossé NA, van der Hoorn MP, de Koning R, Mulders AGMGJ, van Lith JMM, le Cessie S, Lashley EELO. Toward more accurate prediction of future pregnancy outcome in couples with unexplained recurrent pregnancy loss: taking both partners into account. Fertil Steril 2022;117:144-52. [PMID: 34863518 DOI: 10.1016/j.fertnstert.2021.08.037] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 456 |
Muñoz Muñoz C, Ahmed K, Thomas M, Cohen H, Alijotas-Reig J, Giles I. Comparing pregnancy outcomes in patients with criteria and non-criteria autoimmune disease: A systematic review. Lupus 2021;:9612033211061850. [PMID: 34866492 DOI: 10.1177/09612033211061850] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 457 |
Emmenegger M, Kumar SS, Emmenegger V, Malinauskas T, Buettner T, Rose L, Schierack P, Sprinzl MF, Sommer CJ, Lackner KJ, Aguzzi A, Roggenbuck D, Frauenknecht KBM. Anti-prothrombin autoantibodies enriched after infection with SARS-CoV-2 and influenced by strength of antibody response against SARS-CoV-2 proteins. PLoS Pathog 2021;17:e1010118. [PMID: 34860860 DOI: 10.1371/journal.ppat.1010118] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 5.5] [Reference Citation Analysis]
|
| 458 |
Haertel F, Kretzschmar D, Schulze PC, Neumann T. Immunomodulation in antiphospholipid-antibody-associated endocarditis: a case report and review of the literature. European Heart Journal - Case Reports 2021;5. [DOI: 10.1093/ehjcr/ytab445] [Reference Citation Analysis]
|
| 459 |
Sun S, Urbanus RT, ten Cate H, de Groot PG, de Laat B, Heemskerk JWM, Roest M. Platelet Activation Mechanisms and Consequences of Immune Thrombocytopenia. Cells 2021;10:3386. [DOI: 10.3390/cells10123386] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 460 |
Guedon A, Catano J, Ricard L, Laurent C, De Moreuil C, Urbansky G, Deriaz S, Gerotziafas G, Elalamy I, Alexandra A, Chasset F, Alamowitch S, Sellam J, Maillot F, Boffa J, Cohen A, Abisror N, Fain O, Mekinian A. Manifestations non-criteria dans le syndrome des antiphospholipides: une étude cas-témoin multicentrique rétrospective française. La Revue de Médecine Interne 2021;42:A304. [DOI: 10.1016/j.revmed.2021.10.258] [Reference Citation Analysis]
|
| 461 |
Perez Botero J, Reese JA, George JN, McIntosh JJ. Severe thrombocytopenia and microangiopathic hemolytic anemia in pregnancy: A guide for the consulting hematologist. Am J Hematol 2021;96:1655-65. [PMID: 34424560 DOI: 10.1002/ajh.26328] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 462 |
Zhang J, Li C, Han X, Chen Z, Adhikari BK, Wang Y, Wang Y, Sun J. The digestive system involvement of antiphospholipid syndrome: pathophysiology, clinical characteristics, and treatment strategies. Ann Med 2021;53:1328-39. [PMID: 34409894 DOI: 10.1080/07853890.2021.1962964] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 463 |
Li S, Shen Y, Zhu Y, Li H, Jiang W, Yan J, Chen Z. The interaction effect between advanced paternal age and paternal obesity is associated with the low implantation rate in couples with unexplained recurrent pregnancy loss. Gynecology and Obstetrics Clinical Medicine 2021;1:197-204. [DOI: 10.1016/j.gocm.2021.10.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 464 |
Li Y, Wang E, Huang S, Zhu C, Zhang K, Zhang J, Xu H, Shu J. Autoantibodies in association with subchorionic haematoma in early pregnancy. Ann Med 2021;53:841-7. [PMID: 34085897 DOI: 10.1080/07853890.2021.1936150] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 465 |
Cai S, Singla A, Dinh K, Puttaswamy V. Mimics of vascular ischaemia: Rare variant of drug-induced vasculitis and associated autoimmune pathogenicity – A report of two cases. Annals of Vascular Surgery - Brief Reports and Innovations 2021;1:100013. [DOI: 10.1016/j.avsurg.2021.100013] [Reference Citation Analysis]
|
| 466 |
Evangelatos G, Kravvariti E, Konstantonis G, Tentolouris N, Sfikakis PP, Tektonidou MG. Atherosclerosis progression in antiphospholipid syndrome is comparable to diabetes mellitus: a 3-year prospective study. Rheumatology (Oxford) 2021:keab882. [PMID: 34850863 DOI: 10.1093/rheumatology/keab882] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 467 |
Arora S, Nair S, Prabhu R, Avanthika C, Jhaveri S, Samayam S, Katta MR, Agarwal P. Role of Direct Oral Anticoagulation Agents as Thromboprophylaxis in Antiphospholipid Syndrome. Cureus 2021;13:e19009. [PMID: 34824926 DOI: 10.7759/cureus.19009] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 468 |
Devreese KMJ, Zuily S, Meroni PL. Role of antiphospholipid antibodies in the diagnosis of antiphospholipid syndrome. J Transl Autoimmun 2021;4:100134. [PMID: 34816113 DOI: 10.1016/j.jtauto.2021.100134] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 469 |
Williams B, Saseen JJ, Trujillo T, Palkimas S. Direct oral anticoagulants versus warfarin in patients with single or double antibody-positive antiphospholipid syndrome. J Thromb Thrombolysis 2021. [PMID: 34817786 DOI: 10.1007/s11239-021-02587-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 470 |
Chen C, Fang M, Zheng H, Xie S, Wang Y, Tong Y, Ma X, Guo L, Lu R. The characteristics of clinical laboratory indicators in anticardiolipin antibody positive cerebral infarction patients. Int Immunopharmacol 2022;102:108276. [PMID: 34810127 DOI: 10.1016/j.intimp.2021.108276] [Reference Citation Analysis]
|
| 471 |
Groarke EM, Dulau-Florea AE, Kanthi Y. Thrombotic manifestations of VEXAS syndrome. Semin Hematol 2021;58:230-8. [PMID: 34802545 DOI: 10.1053/j.seminhematol.2021.10.006] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 472 |
Yang W, Kang MK, Ha SY, Kang DW, Bae J, Lee EJ, Jeong HY, Kim JM, Jung KH, Lee SH. Current status and role of antiphospholipid antibody testing in cryptogenic stroke. Eur J Neurol 2021. [PMID: 34800314 DOI: 10.1111/ene.15191] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 473 |
Svensson C, Eriksson P, Bjarnegård N, Jonasson H, Strömberg T, Sjöwall C, Zachrisson H. Impaired Microcirculation and Vascular Hemodynamics in Relation to Macrocirculation in Patients With Systemic Lupus Erythematosus. Front Med (Lausanne) 2021;8:722758. [PMID: 34790671 DOI: 10.3389/fmed.2021.722758] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 474 |
Egri N, Bentow C, Rubio L, Norman GL, López-Sañudo S, Mahler M, Pérez-Isidro A, Cervera R, Viñas O, Espinosa G, Ruiz-Ortiz E. Anti-Phosphatidylserine/Prothrombin Antibodies at Two Points: Correlation With Lupus Anticoagulant and Thrombotic Risk. Front Immunol 2021;12:754469. [PMID: 34790198 DOI: 10.3389/fimmu.2021.754469] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 475 |
Fodina V, Dudorova A, Erenpreiss J. Reasons and Mechanisms of Recurrent Failed Implantation in IVF. Infertility and Assisted Reproduction 2021. [DOI: 10.5772/intechopen.98301] [Reference Citation Analysis]
|
| 476 |
Foret T, Dufrost V, Salomon du Mont L, Costa P, Lakomy C, Lagrange J, Lacolley P, Regnault V, Zuily S, Wahl D. A new pro-thrombotic mechanism of neutrophil extracellular traps in antiphospholipid syndrome: impact on activated protein C resistance. Rheumatology (Oxford) 2021:keab853. [PMID: 34791113 DOI: 10.1093/rheumatology/keab853] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 477 |
Dziadkowiak E, Moreira H, Buska-Mach K, Szmyrka M, Budrewicz S, Barg E, Janik M, Pokryszko-Dragan A. Occult Autoimmune Background for Epilepsy-The Preliminary Study on Antibodies Against Neuronal Surface Antigens. Front Neurol 2021;12:660126. [PMID: 34744955 DOI: 10.3389/fneur.2021.660126] [Reference Citation Analysis]
|
| 478 |
Constans M, Santiago R, Jimenez L, Motllo C, Lopez R, Trapé J, Reverter JC, Altes A. Lupus anticoagulant is an independent risk factor for non-thrombotic in-hospital mortality in COVID-19 patients. Thromb Res 2021;208:99-105. [PMID: 34743034 DOI: 10.1016/j.thromres.2021.10.017] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 479 |
Biscetti L, De Vanna G, Cresta E, Corbelli I, Gaetani L, Cupini L, Calabresi P, Sarchielli P. Headache and immunological/autoimmune disorders: a comprehensive review of available epidemiological evidence with insights on potential underlying mechanisms. J Neuroinflammation 2021;18:259. [PMID: 34749743 DOI: 10.1186/s12974-021-02229-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 480 |
Turgut E, Turan G, Koohnavard S, Küçük H, Tufan A, Karçaaltincaba D. EVALUATION OF MATERNAL AND FETAL OUTCOMES OF PREGNANT WOMEN WITH SYSTEMIC LUPUS ERYTHEMATOSUS. Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi 2021. [DOI: 10.38136/jgon.981014] [Reference Citation Analysis]
|
| 481 |
Fierro JJ, Velásquez M, Cadavid AP, de Leeuw K. Effects of anti-beta 2-glycoprotein 1 antibodies and its association with pregnancy-related morbidity in antiphospholipid syndrome. Am J Reprod Immunol 2021;:e13509. [PMID: 34738282 DOI: 10.1111/aji.13509] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 482 |
Assan F, Bottin L, Francès C, Moguelet P, Tavolaro S, Barbaud A, de Zuttere D, Alamowitch S, Chasset F. Antiphospholipid-negative Sneddon's syndrome: A comprehensive overview of a rare entity. Ann Dermatol Venereol 2021:S0151-9638(21)00096-X. [PMID: 34740467 DOI: 10.1016/j.annder.2021.08.007] [Reference Citation Analysis]
|
| 483 |
Coletto LA, Gerosa M, Valentini M, Cimaz R, Caporali R, Meroni PL, Chighizola CB. Myocardial involvement in anti-phospholipid syndrome: Beyond acute myocardial infarction. Autoimmun Rev 2021;:102990. [PMID: 34740852 DOI: 10.1016/j.autrev.2021.102990] [Reference Citation Analysis]
|
| 484 |
Vdovychenko S, Zhuk S, Salnikov S. Obstetric and perinatal aspects of retrochorial hematomas. RHW 2021. [DOI: 10.30841/2708-8731.7-8.2021.250834] [Reference Citation Analysis]
|
| 485 |
Thurm C, Reinhold A, Borucki K, Kahlfuss S, Feist E, Schreiber J, Reinhold D, Schraven B. Anti-SARS-CoV-2 vaccination does not induce the formation of autoantibodies but provides humoral immunity following heterologous and homologous vaccination regimens: Results from a clinical and prospective study within professionals of a German University Hospital.. [DOI: 10.1101/2021.11.01.21265737] [Reference Citation Analysis]
|
| 486 |
Eesa NN, Abdel Nabi H, Owaidy RE, Khalifa I, Radwan AR, NourEl-Din AM, Amer MA, ElShereef RR, Hassan E, Ismail F, El-Gazzar II, Khalil NM, Moshrif AH, Abualfadl E, Tharwat S, Fathi HM, Abd Elazeem MI, El-Shebini E, Samy N, Noshy N, El-Bahnasawy AS, Abdalla AM, Abousehly OS, Mohamed EF, Nasef SI, Elsaman AM, ElKhalifa M, Salem MN, Abaza NM, Fathy HM, Abdel Salam N, El-Saadany HM, El-Najjar AR, El-Hammady DH, Hammam N, Mohammed RH, Gheita TA; Egyptian College of Rheumatology (ECR) SLE Study Group. Systemic lupus erythematosus children in Egypt: Homeland spectrum amid the global situation. Lupus 2021;30:2135-43. [PMID: 34528835 DOI: 10.1177/09612033211043010] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 487 |
Barilaro G, Espinosa G, Cervera R. The antiphospholipid syndrome. Revista Colombiana de Reumatología 2021;28:166-176. [DOI: 10.1016/j.rcreu.2021.03.012] [Reference Citation Analysis]
|
| 488 |
Lee I, Zickuhr L, Hassman L. Update on ophthalmic manifestations of systemic lupus erythematosus: pathogenesis and precision medicine. Curr Opin Ophthalmol 2021;32:583-9. [PMID: 34545846 DOI: 10.1097/ICU.0000000000000810] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 489 |
Chanloung W, Kasitanon N, Wichainun R, Louthrenoo W. Thrombotic risk assessment in patients with systemic lupus erythematosus: Validation of the adjusted-Global Antiphospholipid Syndrome Score (aGAPSS) in Thai patients. Int J Rheum Dis 2021;24:1510-9. [PMID: 34716670 DOI: 10.1111/1756-185X.14230] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 490 |
Sant'Antonio E, Borsani O, Camerini C, Botta C, Santoro M, Allegra A, Siragusa S. Philadelphia chromosome-negative myeloproliferative neoplasms in younger adults: A critical discussion of unmet medical needs, with a focus on pregnancy. Blood Rev 2021;:100903. [PMID: 34742614 DOI: 10.1016/j.blre.2021.100903] [Reference Citation Analysis]
|
| 491 |
Rosen K, Raanani E, Kogan A, Kenet G, Misgav M, Lubetsky A, Niznik S, Schäfers HJ, Segel MJ, Agmon-Levin N. Chronic thromboembolic pulmonary hypertension in patients with antiphospholipid syndrome: Risk factors and management. J Heart Lung Transplant 2021:S1053-2498(21)02569-9. [PMID: 34836752 DOI: 10.1016/j.healun.2021.10.016] [Reference Citation Analysis]
|
| 492 |
Anunciación-Llunell A, Miró-Mur F, Esteve-Valverde E, Marques-Soares J, Pardos-Gea J, Alijotas-Reig J. Proteomics and enriched biological processes in Antiphospholipid syndrome: A systematic review. Autoimmun Rev 2021;:102982. [PMID: 34718168 DOI: 10.1016/j.autrev.2021.102982] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 493 |
Jiang D, Lim W, Crowther M, Garcia D. A systematic review of the association between anti-β-2 glycoprotein I antibodies and APS manifestations. Blood Adv 2021;5:3931-6. [PMID: 34547773 DOI: 10.1182/bloodadvances.2021005205] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 494 |
Martins FF, Campos TML. Evaluation of Frequency, Clinical Correlation, and Antibodies Confirmation Profile in Patients with Suspected Antiphospholipid Syndrome. TH Open 2021;5:e470-8. [PMID: 34693196 DOI: 10.1055/s-0041-1736289] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 495 |
Cheldieva FA, Reshetnyak TM, Cherkasova MV, Lila AM. Extra criterial antiphospholipid antibodies in patients with antiphospholipid syndrome and systemic lupus erythematosus (preliminary data). Sovremennaâ revmatologiâ 2021;15:18-25. [DOI: 10.14412/1996-7012-2021-5-18-25] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 496 |
Nurbaeva KS, Reshetnyak TM, Lila AM. Netosis in the pathogenesis of antiphospholipid syndrome and systemic lupus erythematosus. Sovremennaâ revmatologiâ 2021;15:96-102. [DOI: 10.14412/1996-7012-2021-5-96-102] [Reference Citation Analysis]
|
| 497 |
Diaz-Gallo LM, Oke V, Lundström E, Elvin K, Ling Wu Y, Eketjäll S, Zickert A, Gustafsson JT, Jönsen A, Leonard D, Birmingham DJ, Nordmark G, Bengtsson AA, Rönnblom L, Gunnarsson I, Yu CY, Padyukov L, Svenungsson E. Four Systemic Lupus Erythematosus Subgroups, Defined by Autoantibodies Status, Differ Regarding HLA-DRB1 Genotype Associations and Immunological and Clinical Manifestations. ACR Open Rheumatol 2021. [PMID: 34658170 DOI: 10.1002/acr2.11343] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 498 |
Ricard L, Laurent C, Papo M, Deriaz S, Catano J, Alamowitch S, Kayem G, Chasset F, De Moreuil C, Boffa JJ, Gerotziafas G, Elalamy I, Bornes M, Maillot F, Audemard-Verger A, Planche V, Ballot E, Fain O, Mekinian A. Clinical and prognostic significance of antinuclear antibodies in primary antiphospholipid syndrome: A multicenter retrospective study. Joint Bone Spine 2021;89:105297. [PMID: 34656751 DOI: 10.1016/j.jbspin.2021.105297] [Reference Citation Analysis]
|
| 499 |
Baleeiro C, Duran CS, Signorelli F, Balbi GG, Bonfá E, Andrade DC. Distinct features of youth-onset primary antiphospholipid syndrome. Lupus 2021;30:1888-95. [PMID: 34634966 DOI: 10.1177/09612033211038054] [Reference Citation Analysis]
|
| 500 |
Attia DH, Dorgham DA, El Maghraby AA, Alkaffas M, Abdel Kawy MA, Sherif MM, Abdel Halim RM. Autoimmune Regulator Gene Polymorphisms in Egyptian Systemic Lupus Erythematosus Patients: Preliminary Results. Int J Rheumatol 2021;2021:5546639. [PMID: 34621318 DOI: 10.1155/2021/5546639] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 501 |
Meroni PL, Borghi MO. Antiphospholipid Antibody Assays in 2021: Looking for a Predictive Value in Addition to a Diagnostic One. Front Immunol 2021;12:726820. [PMID: 34621272 DOI: 10.3389/fimmu.2021.726820] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 502 |
Gouda W, Alsaqabi F, Moshrif A, Abbas AS, Abdel-Aziz TM, Islam MA. Macrophage activation syndrome triggered by systemic lupus erythematosus flare: successful treatment with a combination of dexamethasone sodium phosphate, intravenous immunoglobulin, and cyclosporine: a case report. J Med Case Rep 2021;15:497. [PMID: 34620236 DOI: 10.1186/s13256-021-03072-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 503 |
Kwan V, Kaplovitch E, Selby R, Abdulrehman J. Effectiveness and safety of the direct oral anticoagulants in non-triple positive antiphospholipid syndrome without prior arterial thromboembolism. J Thromb Thrombolysis 2021. [PMID: 34613576 DOI: 10.1007/s11239-021-02578-1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 504 |
Radin M, Schreiber K, Cecchi I, Bortoluzzi A, Crisafulli F, Freitas C, Bacco B, Rubini E, Foddai SG, Padovan M, Gallo cassarino S, Franceschini F, Andrade D, Benedetto C, Govoni M, Bertero T, Marozio L, Roccatello D, Andreoli L, Sciascia S. Impact of the 2019 European Alliance of Associations for Rheumatology/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus in a Multicenter Cohort Study of 133 Women With Undifferentiated Connective Tissue Disease. Arthritis Care Res. [DOI: 10.1002/acr.24391] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 505 |
Siano MA, Marchetti V, Pagano S, Di Candia F, Alessio M, De Brasi D, De Luca A, Pinna V, Sestito S, Concolino D, Tartaglia M, Strisciuglio P, D'Esposito V, Cabaro S, Perruolo G, Formisano P, Melis D. Risk of autoimmune diseases in patients with RASopathies: systematic study of humoral and cellular immunity. Orphanet J Rare Dis 2021;16:410. [PMID: 34600590 DOI: 10.1186/s13023-021-02050-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 506 |
Tsonis O, Balogun S, Adjei JO, Mogekwu O, Iliodromiti S. Management of recurrent miscarriages: an overview of current evidence. Curr Opin Obstet Gynecol 2021;33:370-7. [PMID: 34419993 DOI: 10.1097/GCO.0000000000000735] [Reference Citation Analysis]
|
| 507 |
Medeiros-Ribeiro AC, Aikawa NE, Saad CGS, Yuki EFN, Pedrosa T, Fusco SRG, Rojo PT, Pereira RMR, Shinjo SK, Andrade DCO, Sampaio-Barros PD, Ribeiro CT, Deveza GBH, Martins VAO, Silva CA, Lopes MH, Duarte AJS, Antonangelo L, Sabino EC, Kallas EG, Pasoto SG, Bonfa E. Immunogenicity and safety of the CoronaVac inactivated vaccine in patients with autoimmune rheumatic diseases: a phase 4 trial. Nat Med 2021;27:1744-51. [PMID: 34331051 DOI: 10.1038/s41591-021-01469-5] [Cited by in Crossref: 103] [Cited by in F6Publishing: 104] [Article Influence: 51.5] [Reference Citation Analysis]
|
| 508 |
Jantarat A, Muangchan C. Epidemiology and clinical characteristics of systemic sclerosis overlap syndrome (SSc-OS), and the factors significantly associated with SSc-OS in Thai patients with systemic sclerosis. Mod Rheumatol 2021:roab079. [PMID: 34918144 DOI: 10.1093/mr/roab079] [Reference Citation Analysis]
|
| 509 |
Pécourt M. Highlights on HELLP syndrome. JMV-Journal de Médecine Vasculaire 2021;46:207-208. [DOI: 10.1016/j.jdmv.2021.09.001] [Reference Citation Analysis]
|
| 510 |
Pécourt M, Yelnik C, Ghesquiere L, Drumez É, Cailliau É, Hachulla É, Debarge V, Morel N, Le Guern V, Garabedian C, Costedoat-Chalumeau N, Lambert M. Is the presence of antiphospholipid antibodies a poor prognostic factor for patients with hemolysis, elevated liver enzymes, and low platelet count syndrome? Am J Obstet Gynecol 2021;225:432.e1-7. [PMID: 33812811 DOI: 10.1016/j.ajog.2021.03.039] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 511 |
Benkirane A, Devalet B, Montigny P, London F. Late-onset of primary antiphospholipid syndrome: a case report. Acta Neurol Belg 2021;121:1375-6. [PMID: 33242192 DOI: 10.1007/s13760-020-01555-4] [Reference Citation Analysis]
|
| 512 |
Hu C, Li S, Xie Z, You H, Jiang H, Shi Y, Qi W, Zhao J, Wang Q, Tian X, Li M, Zhao Y, Zeng X. Evaluation of the Diagnostic Value of Non-criteria Antibodies for Antiphospholipid Syndrome Patients in a Chinese Cohort. Front Immunol 2021;12:741369. [PMID: 34567005 DOI: 10.3389/fimmu.2021.741369] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 513 |
Chinnaraj M, Pengo V, Pozzi N. A Novel ELISA Assay for the Detection of Anti-Prothrombin Antibodies in Antiphospholipid Syndrome Patients at High Risk of Thrombosis. Front Immunol 2021;12:741589. [PMID: 34567006 DOI: 10.3389/fimmu.2021.741589] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 514 |
García Palacios JD, Puente Ruiz N, Napal Lecumberri JJ, Hernández Hernández JL. Effects of the COVID-19 pandemic on a cohort of patients with vein occlusion. Rev Clin Esp (Barc) 2021;221:587-91. [PMID: 34565709 DOI: 10.1016/j.rceng.2021.06.003] [Reference Citation Analysis]
|
| 515 |
Carvalho JF, Shoenfeld Y. Uric acid levels in primary antiphospholipid syndrome. Lupus 2021;30:2176-8. [PMID: 34569385 DOI: 10.1177/09612033211045922] [Reference Citation Analysis]
|
| 516 |
Ekici H, Imamoglu M, Okmen F, Gencosman G, Ak G, Ergenoglu M. Evaluation of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in pregnant women with systemic lupus erythematosus. J Obstet Gynaecol 2021;:1-5. [PMID: 34565265 DOI: 10.1080/01443615.2021.1946022] [Reference Citation Analysis]
|
| 517 |
Wan L, Liu T, Chen T, Chi H, Zhou Z, Tang Z, Hu Q, Teng J, Sun Y, Liu H, Cheng X, Ye J, Su Y, Lu Y, Yang C, Shi H. The high prevalence of abnormal MRI findings in non-neuropsychiatric patients with persistently positive antiphospholipid antibodies. Rheumatology (Oxford) 2021:keab649. [PMID: 34559215 DOI: 10.1093/rheumatology/keab649] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 518 |
Ranjan YS, Cheong YC. The patient with thrombophilia. Assisted Reproduction Techniques 2021. [DOI: 10.1002/9781119622215.ch8] [Reference Citation Analysis]
|
| 519 |
Khawaja M, Magder L, Goldman D, Petri MA. Loss of antiphospholipid antibody positivity post-thrombosis in SLE. Lupus Sci Med 2020;7:e000423. [PMID: 33023978 DOI: 10.1136/lupus-2020-000423] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 520 |
Petri MA, Avci M, Magder LS. Evaluation of different ways to identify persistent positivity of lupus anticoagulant in systemic lupus erythematosus. Lupus Sci Med 2020;7:e000406. [PMID: 33139453 DOI: 10.1136/lupus-2020-000406] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 521 |
Gasparini G, Canepa P, Verdiani S, Carmisciano L, Cozzani E, De Grazia D, Andrea O, Icardi G, Parodi A. A retrospective study on the prevalence of anti-phospholipid antibodies, thrombotic events and cutaneous signs of vasculopathy in 173 hospitalized COVID-19 patients. Int J Immunopathol Pharmacol 2021;35:20587384211042115. [PMID: 34541915 DOI: 10.1177/20587384211042115] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 522 |
Alessi H, Dutra LA, Maria LA, Coube PC, Hoshino K, de Abrantes FF, Lopes FC, de Souza AWS, Kayser C, Barsottini OGP. Serum BDNF and cognitive dysfunction in SLE: findings from a cohort of 111 patients. Clin Rheumatol 2021. [PMID: 34537904 DOI: 10.1007/s10067-021-05915-0] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 523 |
Lacerda MI, de Jesús GRR, Dos Santos FC, de Jesús NR, Levy RA, Klumb EM. The SLICC/ACR Damage Index (SDI) may predict adverse obstetric events in patients with systemic lupus erythematosus. Lupus 2021;30:1966-72. [PMID: 34530654 DOI: 10.1177/09612033211045061] [Reference Citation Analysis]
|
| 524 |
Otaduy C, Gobbi CA, Álvarez A, Albiero EH, Yorio MA, Alba Moreyra P. Is lupus nephritis a prognosis factor for pregnancy? Maternal and foetal outcomes. Reumatol Clin (Engl Ed) 2021:S2173-5743(21)00165-9. [PMID: 34538769 DOI: 10.1016/j.reumae.2021.02.008] [Reference Citation Analysis]
|
| 525 |
Schreiber K, Piazza G, Hunt BJ. A bridge over troubled waters: Anti-inflammatory therapy for patients with refractory obstetric antiphospholipid syndrome? Thromb Res 2021;207:55-7. [PMID: 34547612 DOI: 10.1016/j.thromres.2021.09.003] [Reference Citation Analysis]
|
| 526 |
Cheldieva FA, Reshetnyak TM, Cherkasova MV, Lila AM. Study of antiphospholipid antibodies by enzyme immunoassay and chemiluminescent methods in patients with antiphospholipid syndrome and systemic lupus erythematosus (preliminary data). Klin Lab Diagn 2021;66:546-51. [PMID: 34543533 DOI: 10.51620/0869-2084-2021-66-9-546-551] [Reference Citation Analysis]
|
| 527 |
Yamashita Y, Morimoto T, Kimura T. Venous thromboembolism: Recent advancement and future perspective. J Cardiol 2021:S0914-5087(21)00229-X. [PMID: 34518074 DOI: 10.1016/j.jjcc.2021.08.026] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 528 |
Zhou Z, You Y, Wang F, Sun Y, Teng J, Liu H, Cheng X, Su Y, Shi H, Hu Q, Chi H, Jia J, Wan L, Liu T, Wang M, Shi C, Yang C, Ye J. Urine Proteomics Differentiate Primary Thrombotic Antiphospholipid Syndrome From Obstetric Antiphospholipid Syndrome. Front Immunol 2021;12:702425. [PMID: 34489952 DOI: 10.3389/fimmu.2021.702425] [Reference Citation Analysis]
|
| 529 |
Tomasello R, Giordano G, Romano F, Vaccarino F, Siragusa S, Lucchesi A, Napolitano M. Immune Thrombocytopenia in Antiphospholipid Syndrome: Is It Primary or Secondary? Biomedicines 2021;9:1170. [PMID: 34572358 DOI: 10.3390/biomedicines9091170] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 530 |
Nagy G, Czirják L, Kumánovics G. Patients with Systemic Sclerosis with and without Overlap Syndrome Show Similar Microvascular Abnormalities. Diagnostics (Basel) 2021;11:1606. [PMID: 34573948 DOI: 10.3390/diagnostics11091606] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 531 |
Bertin D, Camoin-Jau L, Veit V, Resseguier N, Lambert M, Buffet Delmas P, Heim X, Mège JL, Morange PE, Bardin N. Single or triple positivity for antiphospholipid antibodies in "carriers" or symptomatic patients: Untangling the knot. J Thromb Haemost 2021;19:3018-30. [PMID: 34469630 DOI: 10.1111/jth.15518] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 532 |
Thomas J, Philips G, Gladson CJ. Primary Antiphospholipid Antibody Syndrome-Associated Severe Thrombocytopenia and Thrombosis Treated Successfully With "Quadruple Therapy". J Clin Rheumatol 2021;27:e208-10. [PMID: 34431809 DOI: 10.1097/RHU.0000000000000926] [Reference Citation Analysis]
|
| 533 |
Mayor Barrera V, Cajamarca Barón JH, Arteaga C, Montealegre JS, García Marmolejo JP, Corrales NM. Síndrome antifosfolípido y complicaciones hemorrágicas: revisión narrativa de la literatura. Revista Colombiana de Reumatología 2021. [DOI: 10.1016/j.rcreu.2021.07.003] [Reference Citation Analysis]
|
| 534 |
Kaneko K, Ozawa N, Murashima A. Obstetric anti-phospholipid syndrome: from pathogenesis to treatment. Immunol Med 2021;:1-15. [PMID: 34470570 DOI: 10.1080/25785826.2021.1969116] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 535 |
Peng L, Fei Y. A 31-year-old woman with painful black palms: Thrombosis or vasculitis? Rheumatology and Immunology Research 2021;2:203-205. [DOI: 10.2478/rir-2021-0026] [Reference Citation Analysis]
|
| 536 |
Benjamin LA, Paterson RW, Moll R, Pericleous C, Brown R, Mehta PR, Athauda D, Ziff OJ, Heaney J, Checkley AM, Houlihan CF, Chou M, Heslegrave AJ, Chandratheva A, Michael BD, Blennow K, Vivekanandam V, Foulkes A, Mummery CJ, Lunn MP, Keddie S, Spyer MJ, Mckinnon T, Hart M, Carletti F, Jäger HR, Manji H, Zandi MS, Werring DJ, Nastouli E, Simister R, Solomon T, Zetterberg H, Schott JM, Cohen H, Efthymiou M; UCLH Queen Square COVID-19 Biomarker Study group. Antiphospholipid antibodies and neurological manifestations in acute COVID-19: A single-centre cross-sectional study. EClinicalMedicine 2021;39:101070. [PMID: 34401683 DOI: 10.1016/j.eclinm.2021.101070] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 6.5] [Reference Citation Analysis]
|
| 537 |
Koval N, Alves M, Plácido R, Almeida AG, Fonseca JE, Ferreira JJ, Pinto FJ, Caldeira D. Direct oral anticoagulants versus vitamin K antagonists in patients with antiphospholipid syndrome: systematic review and meta-analysis. RMD Open 2021;7:e001678. [PMID: 34253684 DOI: 10.1136/rmdopen-2021-001678] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 538 |
Gerde M, Ibarra E, Mac Kenzie R, Fernandez Suarez C, Heer C, Alvarez R, Iglesias M, Balparda J, Beruti E, Rubinstein F. The impact of hydroxychloroquine on obstetric outcomes in refractory obstetric antiphospholipid syndrome. Thromb Res 2021;206:104-10. [PMID: 34454240 DOI: 10.1016/j.thromres.2021.08.004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 539 |
Heijke R, Ahmad A, Frodlund M, Wirestam L, Dahlström Ö, Dahle C, Kechagias S, Sjöwall C. Usefulness of Clinical and Laboratory Criteria for Diagnosing Autoimmune Liver Disease among Patients with Systemic Lupus Erythematosus: An Observational Study. J Clin Med 2021;10:3820. [PMID: 34501268 DOI: 10.3390/jcm10173820] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 540 |
Gao R, Zeng X, Qin L. Systemic autoimmune diseases and recurrent pregnancy loss: research progress in diagnosis and treatment. Chin Med J (Engl) 2021;134:2140-2. [PMID: 34432653 DOI: 10.1097/CM9.0000000000001691] [Reference Citation Analysis]
|
| 541 |
Demir S, Li J, Magder LS, Petri M. Antiphospholipid patterns predict risk of thrombosis in systemic lupus erythematosus. Rheumatology (Oxford) 2021;60:3770-7. [PMID: 33331921 DOI: 10.1093/rheumatology/keaa857] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 542 |
Ramirez GA, Rocca MA, Preziosa P, Bozzolo EP, Pagani E, Canti V, Moiola L, Rovere-Querini P, Manfredi AA, Filippi M. Quantitative MRI adds to neuropsychiatric lupus diagnostics. Rheumatology (Oxford) 2021;60:3278-88. [PMID: 33367829 DOI: 10.1093/rheumatology/keaa779] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 543 |
Pastori D, Menichelli D, Cammisotto V, Pignatelli P. Use of Direct Oral Anticoagulants in Patients With Antiphospholipid Syndrome: A Systematic Review and Comparison of the International Guidelines. Front Cardiovasc Med 2021;8:715878. [PMID: 34414220 DOI: 10.3389/fcvm.2021.715878] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 544 |
Tota V, Dagonnier M, Wery D, Binet L, Nagy N, Durieux V, Diaz M, Elosegi JA, Holbrechts S. Antiphospholipid syndrome-induced ischemic stroke following pembrolizumab: Case report and systematic review. Lung Cancer 2021;160:59-65. [PMID: 34411840 DOI: 10.1016/j.lungcan.2021.07.021] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 545 |
Alijotas-Reig J, Esteve-Valverde E, Ferrer-Oliveras R, Sáez-Comet L, Lefkou E, Mekinian A, Belizna C, Ruffatti A, Tincani A, Pardos-Gea J, Nalli C, Marozio L, Espinosa G, De Carolis S, Latino O, Sebastian U, LLurba E, Trespidi L, Chighizola C, Pengo V, Rovere-Querini P, Canti V, Mayer-Pickel K, Reshetnyak T, Tabacco S, Arnau A; EUROAPS Study Group. Bleeding and antithrombotic therapy during pregnancy in women with poor aPL-related obstetric outcomes: A survey of 1075 cases from EUROAPS registry∗. Eur J Anaesthesiol 2021;38:916-22. [PMID: 34397526 DOI: 10.1097/EJA.0000000000001484] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 546 |
Argyropoulou OD, Goules AV, Boutzios G, Tsirogianni A, Sfontouris C, Manoussakis MN, Vlachoyiannopoulos PG, Tzioufas AG, Kapsogeorgou EK. Occurrence and Antigenic Specificity of Perinuclear Anti-Neutrophil Cytoplasmic Antibodies (P-ANCA) in Systemic Autoimmune Diseases. Cells 2021;10:2128. [PMID: 34440897 DOI: 10.3390/cells10082128] [Reference Citation Analysis]
|
| 547 |
Chandrasekar TS, Gokul BJ, Viveksandeep TC, Yogesh KR, Sathiamoorthy S, Prasad MS. Antiphospholipid Antibody Syndrome Presenting as Subacute Abdominal Pain Due to Portomesenteric Thrombosis. Journal of Digestive Endoscopy 2022;12:e1-e1. [DOI: 10.1055/s-0040-1701397] [Reference Citation Analysis]
|
| 548 |
Faguer S, Ribes D. Early use of eculizumab for catastrophic antiphospholipid syndrome. Br J Haematol 2021. [PMID: 34396515 DOI: 10.1111/bjh.17783] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 549 |
Cheldieva FA, Reshetnyak TM, Lila AM. Assessment of the activity and organ damage in antiphospholipid syndrome. Sovremennaâ revmatologiâ 2021;15:101-106. [DOI: 10.14412/1996-7012-2021-4-101-106] [Reference Citation Analysis]
|
| 550 |
Wiest NE, Johns GS, Edwards E. A Case of Acute Pulmonary Embolus after mRNA SARS-CoV-2 Immunization. Vaccines (Basel) 2021;9:903. [PMID: 34452028 DOI: 10.3390/vaccines9080903] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 551 |
Lonati PA, Bodio C, Scavone M, Martini G, Pesce E, Bandera A, Lombardi A, Gerosa M, Franceschini F, Tincani A, Podda G, Abrignani S, Grifantini R, Cattaneo M, Borghi MO, Meroni PL. The production of anti-PF4 antibodies in anti-phospholipid antibody-positive patients is not affected by COVID-19 vaccination.. [DOI: 10.1101/2021.08.12.21261976] [Reference Citation Analysis]
|
| 552 |
Iwasaki T, Doi H, Tsuji H, Tabuchi Y, Hashimoto M, Kitagori K, Akizuki S, Murakami K, Nakashima R, Yoshifuji H, Yamamoto W, Tanaka M, Ohmura K, Morinobu A. Phenotypic landscape of systemic lupus erythematosus: An analysis of the Kyoto Lupus Cohort. Mod Rheumatol 2021:roab020. [PMID: 34894258 DOI: 10.1093/mr/roab020] [Reference Citation Analysis]
|
| 553 |
Byambajav T, Waki T, Miura K, Tanaka-Mizuno S. Association between adherence to warfarin and thrombotic events in patients with antiphospholipid syndrome in Japan: A claims-based retrospective cohort study. Pharmacoepidemiol Drug Saf 2021. [PMID: 34382707 DOI: 10.1002/pds.5343] [Reference Citation Analysis]
|
| 554 |
Frishman M, Radin M, Schreiber K. Hydroxychloroquine and antiphospholipid antibody-related pregnancy morbidity: a systematic review and meta-analysis. Curr Opin Obstet Gynecol 2020;32:351-8. [PMID: 32675702 DOI: 10.1097/GCO.0000000000000649] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 555 |
Gosselin RC. Review of coagulation preanalytical variables with update on the effect of direct oral anticoagulants. Int J Lab Hematol 2021;43 Suppl 1:109-16. [PMID: 34288452 DOI: 10.1111/ijlh.13585] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 556 |
Bernardoff I, Picq A, Loiseau P, Foret T, Dufrost V, Moulinet T, Unlu O, Erkan D, Wahl D, Zuily S. Antiphospholipid antibodies and the risk of autoimmune hemolytic anemia in patients with systemic lupus erythematosus: A systematic review and meta-analysis. Autoimmun Rev 2021;:102913. [PMID: 34371159 DOI: 10.1016/j.autrev.2021.102913] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 557 |
Cao XY, Li MT, Zhang X, Zhao Y, Zeng XF, Zhang FC, Hou Y, Zhu LX. Characteristics of Acquired Inhibitors to Factor VIII and Von Willebrand Factor Secondary to Systemic Lupus Erythematosus: Experiences From a Chinese Tertiary Medical Center. J Clin Rheumatol 2021;27:201-5. [PMID: 31815811 DOI: 10.1097/RHU.0000000000001284] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 558 |
Grossi C, Artusi C, Meroni P, Borghi MO, Neglia L, Lonati PA, Oggioni M, Tedesco F, De Simoni MG, Fumagalli S. β2 glycoprotein I participates in phagocytosis of apoptotic neurons and in vascular injury in experimental brain stroke. J Cereb Blood Flow Metab 2021;41:2038-53. [PMID: 33444093 DOI: 10.1177/0271678X20984551] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 559 |
Xi F, Cai Y, Lv M, Jiang Y, Zhou F, Chen Y, Jiang L, Luo Q. Anticardiolipin Positivity Is Highly Associated With Intrauterine Growth Restriction in Women With Antiphospholipid Syndrome. Clin Appl Thromb Hemost 2020;26:1076029620974455. [PMID: 33296221 DOI: 10.1177/1076029620974455] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 560 |
Devreese KMJ. COVID-19-related laboratory coagulation findings. Int J Lab Hematol 2021;43 Suppl 1:36-42. [PMID: 34288440 DOI: 10.1111/ijlh.13547] [Cited by in Crossref: 8] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 561 |
Barros VIPVL, Igai AMK, Oliveira ALML, Teruchkin MM, Orsi FA. Obstetric antiphospholipid syndrome. Rev Bras Ginecol Obstet 2021;43:495-501. [PMID: 34318477 DOI: 10.1055/s-0041-1732382] [Reference Citation Analysis]
|
| 562 |
O'Neal MA. Neurologic complications of medical conditions in pregnancy. Handb Clin Neurol 2020;171:215-25. [PMID: 32736752 DOI: 10.1016/B978-0-444-64239-4.00012-6] [Reference Citation Analysis]
|
| 563 |
Monahan RC, Inglese F, Middelkoop H, van Buchem M, Huizinga TW, Kloppenburg M, Ronen I, Steup-Beekman GM, de Bresser J. White matter hyperintensities associate with cognitive slowing in patients with systemic lupus erythematosus and neuropsychiatric symptoms. RMD Open 2021;7:e001650. [PMID: 34321253 DOI: 10.1136/rmdopen-2021-001650] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 564 |
Perdan-Pirkmajer K, Žigon P, Boc A, Podovšovnik E, Čučnik S, Mavri A, Rotar Ž, Ambrožič A. The Predictive Value of the aCL and Anti-β2GPI at the Time of Acute Deep Vein Thrombosis-A Two-Year Prospective Study. Biomedicines 2021;9:901. [PMID: 34440105 DOI: 10.3390/biomedicines9080901] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 565 |
Radin M, Foddai SG, Cecchi I, Roccatello D, Sciascia S. Quality of life in patients with antiphospholipid antibodies differs according to antiphospholipid syndrome damage index (DIAPS). Eur J Intern Med 2021:S0953-6205(21)00246-6. [PMID: 34330618 DOI: 10.1016/j.ejim.2021.07.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 566 |
Arantes FT, Mazetto BM, Saraiva SS, Tobaldini LQ, Dos Santos APR, Annichino-Bizzacchi J, Orsi FA. Inflammatory markers in thrombosis associated with primary antiphospholipid syndrome. J Thromb Thrombolysis 2020;50:772-81. [PMID: 32462539 DOI: 10.1007/s11239-020-02155-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 567 |
Liu T, Dai J, Yang Z, Yu X, Xu Y, Shi X, Wei D, Tang Z, Xu G, Xu W, Liu Y, Shi C, Ni Q, Yang C, Zhang X, Wang X, Chen E, Qu J. Inactivated SARS-CoV-2 vaccine does not influence the profile of prothrombotic antibody nor increase the risk of thrombosis in a prospective Chinese cohort. Sci Bull (Beijing) 2021. [PMID: 34336365 DOI: 10.1016/j.scib.2021.07.033] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 5.5] [Reference Citation Analysis]
|
| 568 |
Gil-Etayo FJ, Garcinuño S, Lalueza A, Díaz-Simón R, García-Reyne A, Pleguezuelo DE, Cabrera-Marante O, Rodriguez-Frias EA, Perez-Rivilla A, Serrano M, Serrano A. Anti-Phospholipid Antibodies and COVID-19 Thrombosis: A Co-Star, Not a Supporting Actor. Biomedicines 2021;9:899. [PMID: 34440103 DOI: 10.3390/biomedicines9080899] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 569 |
Long Y, Li W, Feng J, Ma Y, Sun Y, Xu L, Song Y, Liu C. Follicular helper and follicular regulatory T cell subset imbalance is associated with higher activated B cells and abnormal autoantibody production in primary anti-phospholipid syndrome patients. Clin Exp Immunol 2021. [PMID: 34309827 DOI: 10.1111/cei.13647] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 570 |
Assan F, de Zuttere D, Bottin L, Tavolaro S, Courvoisier DS, Barbaud A, Alamowitch S, Francès C, Chasset F. Echocardiographic features in antiphospholipid-negative Sneddon's syndrome and potential association with severity of neurological symptoms or recurrence of strokes: a longitudinal cohort study. Eur Heart J Cardiovasc Imaging 2021;22:119-28. [PMID: 31898726 DOI: 10.1093/ehjci/jez312] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 571 |
Signorelli F, Balbi GGM, Bonfá E, Borba EF, Andrade DCO. Avoiding misclassification of thrombotic primary antiphospholipid syndrome as systemic lupus erythematosus (SLE): What are the best-performing SLE classification criteria? Lupus 2021;:9612033211033978. [PMID: 34292093 DOI: 10.1177/09612033211033978] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 572 |
Rao A, Runde J, Olivas AD, Patton T. Devastating Postpartum Complications in an Adolescent Linked to New-Onset Inflammatory Bowel Disease and Antiphospholipid Antibody Syndrome. JPGN Reports 2021;2:e105. [DOI: 10.1097/pg9.0000000000000105] [Reference Citation Analysis]
|
| 573 |
Cohen H, Cuadrado MJ, Erkan D, Duarte-Garcia A, Isenberg DA, Knight JS, Ortel TL, Rahman A, Salmon JE, Tektonidou MG, Williams DJ, Willis R, Woller SC, Andrade D. 16th International Congress on Antiphospholipid Antibodies Task Force Report on Antiphospholipid Syndrome Treatment Trends. Lupus 2020;29:1571-93. [PMID: 33100166 DOI: 10.1177/0961203320950461] [Cited by in Crossref: 35] [Cited by in F6Publishing: 36] [Article Influence: 17.5] [Reference Citation Analysis]
|
| 574 |
Matthia E, Altshuler E, Naik DK, Keeley EC. Acute coronary syndrome as the first presentation of antiphospholipid antibody syndrome. BMJ Case Rep 2021;14:e242872. [PMID: 34290014 DOI: 10.1136/bcr-2021-242872] [Reference Citation Analysis]
|
| 575 |
Kwon OC, Park YB, Park MC. Effect of statins on the prevention of recurrent thrombosis in thrombotic antiphospholipid syndrome. Rheumatology (Oxford) 2021:keab410. [PMID: 34289012 DOI: 10.1093/rheumatology/keab410] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 576 |
Samuelsson I, Parodis I, Gunnarsson I, Zickert A, Hofman-Bang C, Wallén H, Svenungsson E. Myocardial infarctions, subtypes and coronary atherosclerosis in SLE: a case-control study. Lupus Sci Med 2021;8:e000515. [PMID: 34290127 DOI: 10.1136/lupus-2021-000515] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 577 |
Tripodi A. Diagnostic Challenges on the Laboratory Detection of Lupus Anticoagulant. Biomedicines 2021;9:844. [PMID: 34356908 DOI: 10.3390/biomedicines9070844] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 578 |
Menet J, Agrinier N, Dufrost V, Conart JB, Wahl D, Duprez KA, Zuily S. Ophthalmologic manifestations in patients with antiphospholipid antibodies: Beware of iatrogenic complications. Lupus 2021;:9612033211033988. [PMID: 34284674 DOI: 10.1177/09612033211033988] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
|
| 579 |
Pastori D, Ames PRJ, Triggiani M, Ciampa A, Cammisotto V, Carnevale R, Pignatelli P, Bucci T, On Behalf Of The Athero-Aps Study Group. Antiphospholipid Antibodies and Heart Failure with Preserved Ejection Fraction. The Multicenter ATHERO-APS Study. J Clin Med 2021;10:3180. [PMID: 34300346 DOI: 10.3390/jcm10143180] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 580 |
Chiriac AE, Betiu M, Podoleanu C, Stolnicu S. The Risk of Thrombotic Events in Anetoderma Affecting Young Patients. Journal of Interdisciplinary Medicine 2021;6:120-2. [DOI: 10.2478/jim-2020-0029] [Reference Citation Analysis]
|
| 581 |
Walter IJ, Klein Haneveld MJ, Lely AT, Bloemenkamp KWM, Limper M, Kooiman J. Pregnancy outcome predictors in antiphospholipid syndrome: A systematic review and meta-analysis. Autoimmun Rev 2021;20:102901. [PMID: 34280554 DOI: 10.1016/j.autrev.2021.102901] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 582 |
Zhang L, Qing P, Yang H, Wu Y, Liu Y, Luo Y. Gut Microbiome and Metabolites in Systemic Lupus Erythematosus: Link, Mechanisms and Intervention. Front Immunol 2021;12:686501. [PMID: 34335588 DOI: 10.3389/fimmu.2021.686501] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 9.0] [Reference Citation Analysis]
|
| 583 |
Szabó G, Antal-Szalmás P, Kerényi A, Pénzes K, Bécsi B, Kappelmayer J. Laboratory Approaches to Test the Function of Antiphospholipid Antibodies. Semin Thromb Hemost 2021. [PMID: 34261151 DOI: 10.1055/s-0041-1730357] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 584 |
Stelzer M, Henes J, Saur S. The Role of Antiphospholipid Antibodies in COVID-19. Curr Rheumatol Rep 2021;23:72. [PMID: 34259944 DOI: 10.1007/s11926-021-01041-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 585 |
Radin M, Barinotti A, Foddai SG, Cecchi I, Rubini E, Roccatello D, Menegatti E, Sciascia S. Cerebrovascular events in patients with isolated anti-phosphatidyl-serine/prothrombin antibodies. Immunol Res 2021;69:372-7. [PMID: 34245429 DOI: 10.1007/s12026-021-09208-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 586 |
Freire de Carvalho J, Correia de Araujo RP, Skare TL. Osteonecrosis in Primary Antiphospholipid Syndrome is Associated with Previous Glucocorticoid Use and Thrombocytopenia. Rheumatol Ther 2021;8:1255-61. [PMID: 34228316 DOI: 10.1007/s40744-021-00333-9] [Reference Citation Analysis]
|
| 587 |
Doyle AJ, Hunt BJ, Danaee A, Ling G, Desborough MJ, Luo P, Breen KA. Direct oral anticoagulant use in patients with antiphospholipid syndrome and unprovoked venous thromboembolism: a single centre experience. Br J Haematol 2021. [PMID: 34231202 DOI: 10.1111/bjh.17634] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 588 |
Kee TP, Venkatanarasimha N, Mohideen SMH, Chan LL, Gogna A, Schaefer PW, Chia GS, Choi YS, Chen RC. A Tale of Two Organ Systems: Imaging review of diseases affecting the thoracic and neurological systems. Part 1. Curr Probl Diagn Radiol 2021:S0363-0188(21)00107-9. [PMID: 34304949 DOI: 10.1067/j.cpradiol.2021.06.008] [Reference Citation Analysis]
|
| 589 |
Capozzi A, Riitano G, Recalchi S, Manganelli V, Costi R, Saccoliti F, Pulcinelli F, Garofalo T, Misasi R, Longo A, Di Santo R, Sorice M. Effect of heparanase inhibitor on tissue factor overexpression in platelets and endothelial cells induced by anti-β2-GPI antibodies. J Thromb Haemost 2021;19:2302-13. [PMID: 34107171 DOI: 10.1111/jth.15417] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 590 |
Pablo RD, Cacho PM, López-Hoyos M, Calvo-Río V, Riancho-Zarrabeitia L, Martínez-Taboada VM. Risk Factors for the Development of the Disease in Antiphospholipid Antibodies Carriers: A Long-term Follow-up Study. Clin Rev Allergy Immunol 2021. [PMID: 34216367 DOI: 10.1007/s12016-021-08862-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 591 |
Foret T, Dufrost V, Salomon Du Mont L, Costa P, Lefevre B, Lacolley P, Regnault V, Zuily S, Wahl D. Systematic Review of Antiphospholipid Antibodies in COVID-19 Patients: Culprits or Bystanders? Curr Rheumatol Rep 2021;23:65. [PMID: 34218350 DOI: 10.1007/s11926-021-01029-3] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 592 |
Grandone E, Piazza G. Thrombophilia, Inflammation, and Recurrent Pregnancy Loss: A Case-Based Review. Semin Reprod Med 2021;39:62-8. [PMID: 34215013 DOI: 10.1055/s-0041-1731827] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 593 |
Shi Y, Jiang H, Huang C, Hu C, Zhao J, Li M, Zeng X. Platelet distribution width is highly associated with thrombotic events in primary antiphospholipid syndrome. Clin Rheumatol 2021. [PMID: 34213673 DOI: 10.1007/s10067-021-05843-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 594 |
Hu C, Li S, Xie Z, You H, Jiang H, Shi Y, Qi W, Zhao J, Wang Q, Tian X, Li M, Zhao Y, Zeng X. Comparison of Different Test Systems for the Detection of Antiphospholipid Antibodies in a Chinese Cohort. Front Immunol 2021;12:648881. [PMID: 34276646 DOI: 10.3389/fimmu.2021.648881] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 595 |
Pérez-crespo A, Gutiérrez-ortiz C. Obstrucción arterial y venosa retiniana como primera manifestación de un síndrome de anticuerpos antifosfolípidos. Archivos de la Sociedad Española de Oftalmología 2021;96:380-383. [DOI: 10.1016/j.oftal.2020.06.016] [Reference Citation Analysis]
|
| 596 |
Sayar Z, Nallamilli S, Efthymiou M, Lambert J, Cohen H. Coexistent antiphospholipid syndrome and myeloproliferative neoplasm. Lupus 2021;30:1502-8. [PMID: 34192956 DOI: 10.1177/09612033211021154] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 597 |
Kleindorfer DO, Towfighi A, Chaturvedi S, Cockroft KM, Gutierrez J, Lombardi-Hill D, Kamel H, Kernan WN, Kittner SJ, Leira EC, Lennon O, Meschia JF, Nguyen TN, Pollak PM, Santangeli P, Sharrief AZ, Smith SC Jr, Turan TN, Williams LS. 2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association. Stroke 2021;52:e364-467. [PMID: 34024117 DOI: 10.1161/STR.0000000000000375] [Cited by in Crossref: 519] [Cited by in F6Publishing: 367] [Article Influence: 259.5] [Reference Citation Analysis]
|
| 598 |
Bruschi M, Moroni G, Sinico RA, Franceschini F, Fredi M, Vaglio A, Cavagna L, Petretto A, Pratesi F, Migliorini P, Locatelli F, Pazzola G, Pesce G, Bagnasco M, Manfredi A, Ramirez GA, Esposito P, Murdaca G, Negrini S, Cipriani L, Trezzi B, Emmi G, Cavazzana I, Binda V, Fenaroli P, Pisani I, Garibotto G, Montecucco C, Santoro D, Scolari F, Mosca M, Tincani A, Candiano G, Prunotto M, Volpi S, Verrina E, Angeletti A, Ravelli A, Ghiggeri GM. Serum IgG2 antibody multicomposition in systemic lupus erythematosus and lupus nephritis (Part 1): cross-sectional analysis. Rheumatology (Oxford) 2021;60:3176-88. [PMID: 33374003 DOI: 10.1093/rheumatology/keaa767] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 599 |
van Eijk LE, Binkhorst M, Bourgonje AR, Offringa AK, Mulder DJ, Bos EM, Kolundzic N, Abdulle AE, van der Voort PH, Olde Rikkert MG, van der Hoeven JG, den Dunnen WF, Hillebrands JL, van Goor H. COVID-19: immunopathology, pathophysiological mechanisms, and treatment options. J Pathol 2021;254:307-31. [PMID: 33586189 DOI: 10.1002/path.5642] [Cited by in Crossref: 52] [Cited by in F6Publishing: 51] [Article Influence: 26.0] [Reference Citation Analysis]
|
| 600 |
Enocsson H, Wetterö J, Eloranta ML, Gullstrand B, Svanberg C, Larsson M, Bengtsson AA, Rönnblom L, Sjöwall C. Comparison of Surrogate Markers of the Type I Interferon Response and Their Ability to Mirror Disease Activity in Systemic Lupus Erythematosus. Front Immunol 2021;12:688753. [PMID: 34276678 DOI: 10.3389/fimmu.2021.688753] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 601 |
Capozzi A, Riitano G, Mancuso S, Recalchi S, Manganelli V, Garofalo T, Alessandri C, Longo A, Misasi R, Conti F, Truglia S, Sorice M. Anti-vimentin/cardiolipin IgA in the anti-phospholipid syndrome: A new tool for 'seronegative' diagnosis. Clin Exp Immunol 2021;205:326-32. [PMID: 34107056 DOI: 10.1111/cei.13633] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 602 |
Ramirez GA, Mackie I, Nallamilli S, Pires T, Moll R, Pericleous C, Isenberg DA, Cohen H, Efthymiou M. Anti-protein C antibodies and acquired protein C resistance in SLE: novel markers for thromboembolic events and disease activity? Rheumatology (Oxford). 2020;. [PMID: 32964932 DOI: 10.1093/rheumatology/keaa509] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 603 |
Ogata Y, Fujieda Y, Sugawara M, Sato T, Ohnishi N, Kono M, Kato M, Oku K, Amengual O, Atsumi T. Morbidity and mortality in antiphospholipid syndrome based on cluster analysis: a 10-year longitudinal cohort study. Rheumatology (Oxford) 2021;60:1331-7. [PMID: 32944779 DOI: 10.1093/rheumatology/keaa542] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 604 |
Chezel J, Costedoat-Chalumeau N, Laouénan C, Rouzaud D, Chenevier-Gobeaux C, Le Guern V, Mathian A, Belhadi D, de Almeida Chaves S, Duhaut P, Fain O, Galicier L, Ghillani-Dalbin P, Kahn JE, Morel N, Perard L, Pha M, Saidoune F, Sarrot-Reynauld F, Aumaitre O, Chasset F, Limal N, Desmurs-Clavel H, Ackermann F, Amoura Z, Papo T, Sacre K. Highly sensitive serum cardiac troponin T and cardiovascular events in patients with systemic lupus erythematosus (TROPOPLUS study). Rheumatology (Oxford) 2021;60:1210-5. [PMID: 32901293 DOI: 10.1093/rheumatology/keaa434] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 605 |
Pregnolato F, Gerosa M, Raimondo MG, Comerio C, Bartoli F, Lonati PA, Borghi MO, Acaia B, Ossola MW, Ferrazzi E, Trespidi L, Meroni PL, Chighizola CB. EUREKA algorithm predicts obstetric risk and response to treatment in women with different subsets of anti-phospholipid antibodies. Rheumatology (Oxford) 2021;60:1114-24. [PMID: 32441742 DOI: 10.1093/rheumatology/keaa203] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 10.5] [Reference Citation Analysis]
|
| 606 |
Beckmann L, Voigtlaender M, Holstein K, Lennartz M, Schneider SW, Haddad M, Renné T, Bokemeyer C, Rolling CC, Langer F. Monocyte activation and acquired autoimmune protein S deficiency promote disseminated intravascular coagulation in a patient with primary antiphospholipid syndrome. Res Pract Thromb Haemost 2021;5:e12559. [PMID: 34263105 DOI: 10.1002/rth2.12559] [Reference Citation Analysis]
|
| 607 |
Spinillo A, Bellingeri C, Cavagnoli C, Maggio I, Riceputi G, Ruspini B, Cesari S, Beneventi F. Maternal and foetal placental vascular malperfusion in pregnancies with anti-phospholipid antibodies. Rheumatology (Oxford) 2021;60:1148-57. [PMID: 32864694 DOI: 10.1093/rheumatology/keaa499] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 608 |
Sciascia S, Radin M, Cecchi I, Bertolaccini ML, Bertero MT, Rubini E, Vaccarino A, Bazzan M, Giachino O, Baldovino S, Rossi D, Mengozzi G, Roccatello D. Identifying phenotypes of patients with antiphospholipid antibodies: results from a cluster analysis in a large cohort of patients. Rheumatology (Oxford) 2021;60:1106-13. [PMID: 31840749 DOI: 10.1093/rheumatology/kez596] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 609 |
Ferrari G, Gotelli E, Paolino S, Pesce G, Nanni L, Colombo BM, Pacini G, Schenone C, Pizzorni C, Sulli A, Smith V, Cutolo M. Antiphospholipid antibodies and anticoagulant therapy: capillaroscopic findings. Arthritis Res Ther 2021;23:175. [PMID: 34176504 DOI: 10.1186/s13075-021-02551-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 610 |
Emmenegger M, Saseendran Kumar S, Emmenegger V, Malinauskas T, Büttner T, Rose L, Schierack P, Sprinzl MF, Sommer CJ, Lackner KJ, Aguzzi A, Roggenbuck D, Frauenknecht KBM. Anti-prothrombin autoantibodies enriched after infection with SARS-CoV-2 and influenced by strength of antibody response against SARS-CoV-2 proteins.. [DOI: 10.1101/2021.06.21.449211] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 611 |
Cabrera-Marante O, Lora D, Serrano M, Rodríguez de Frías EA, Naranjo L, Pérez D, Paz-Artal E, Pleguezuelo DE, Serrano A. Antiphospholipid antibodies quantification using ALBIA technology: how to define an optimal cutoff? Clin Chem Lab Med 2021. [PMID: 34162021 DOI: 10.1515/cclm-2021-0394] [Reference Citation Analysis]
|
| 612 |
Higgins V, Augustin R, Kulasingam V, Taher J. Sample stability of autoantibodies: A tool for laboratory quality initiatives. Clin Biochem 2021:S0009-9120(21)00172-7. [PMID: 34174283 DOI: 10.1016/j.clinbiochem.2021.06.003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 613 |
Billoir P, Le Cam Duchez V, Miranda S, Richard V, Benhamou Y. [Thrombin generation assay in autoimmune disease]. Rev Med Interne 2021:S0248-8663(21)00525-7. [PMID: 34175144 DOI: 10.1016/j.revmed.2021.06.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 614 |
Martis N, Jamme M, Bagnis-Isnard C, Pouteil-Noble C, Presne C, Vigneau C, Grangé S, Burtey S, Coindre JP, Wynckel A, Hamidou MA, Kanouni T, Azoulay E, Hié M, Chauveau D, Veyradier A, Rondeau E, Coppo P; French Reference Centre for Thrombotic Microangiopathies. Systemic autoimmune disorders associated with thrombotic microangiopathy: A cross-sectional analysis from the French National TMA registry: Systemic autoimmune disease-associated TMA. Eur J Intern Med 2021:S0953-6205(21)00199-0. [PMID: 34175183 DOI: 10.1016/j.ejim.2021.05.040] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 615 |
Melamed N, Baschat A, Yinon Y, Athanasiadis A, Mecacci F, Figueras F, Berghella V, Nazareth A, Tahlak M, McIntyre HD, Da Silva Costa F, Kihara AB, Hadar E, McAuliffe F, Hanson M, Ma RC, Gooden R, Sheiner E, Kapur A, Divakar H, Ayres-de-Campos D, Hiersch L, Poon LC, Kingdom J, Romero R, Hod M. FIGO (international Federation of Gynecology and obstetrics) initiative on fetal growth: best practice advice for screening, diagnosis, and management of fetal growth restriction. Int J Gynaecol Obstet 2021;152 Suppl 1:3-57. [PMID: 33740264 DOI: 10.1002/ijgo.13522] [Cited by in Crossref: 53] [Cited by in F6Publishing: 55] [Article Influence: 26.5] [Reference Citation Analysis]
|
| 616 |
Billoir P, Miranda S, Levesque H, Benhamou Y, Le Cam Duchez V. Hypercoagulability Evaluation in Antiphospholipid Syndrome without Anticoagulation Treatment with Thrombin Generation Assay: A Preliminary Study. J Clin Med 2021;10:2728. [PMID: 34205545 DOI: 10.3390/jcm10122728] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 617 |
Samanta J, Mishra D, Chattopadhyay A, Dhir V. Comment on: EUREKA algorithm predicts obstetric risk and response to treatment in women with different subsets of anti-phospholipid antibodies. Rheumatology (Oxford) 2021;60:e109. [PMID: 32910815 DOI: 10.1093/rheumatology/keaa533] [Reference Citation Analysis]
|
| 618 |
García Palacios JD, Puente Ruiz N, Napal Lecumberri JJ, Hernández Hernández JL. [Effects of the COVID-19 pandemic on a cohort of patients with vein occlusion]. Rev Clin Esp 2021. [PMID: 34248175 DOI: 10.1016/j.rce.2021.06.001] [Reference Citation Analysis]
|
| 619 |
Shima A, Maki T, Mimura N, Yamashita H, Emoto N, Yoshifuji H, Takahashi R. A case of reversible cerebral vasoconstriction syndrome associated with anti-phospholipid antibody syndrome and systemic lupus erythematosus. eNeurologicalSci 2021;24:100351. [PMID: 34258413 DOI: 10.1016/j.ensci.2021.100351] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 620 |
Sciascia S, Radin M, Bazzan M, Montaruli B, Cosseddu D, Norbiato C, Bertero MT, Carignola R, Bacco B, Gallo Cassarino S, Roccatello D. Antiphospholipid Antibodies and Infection: Non Nova Sed Nove. Front Immunol 2021;12:687534. [PMID: 34220842 DOI: 10.3389/fimmu.2021.687534] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 621 |
Radin M, Foddai SG, Barinotti A, Cecchi I, Rubini E, Sciascia S, Roccatello D. Reducing the diagnostic delay in Antiphospholipid Syndrome over time: a real world observation. Orphanet J Rare Dis 2021;16:280. [PMID: 34134750 DOI: 10.1186/s13023-021-01906-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 622 |
Cakiroglu Y, Tiras B. Determining diagnostic criteria and cause of recurrent implantation failure. Curr Opin Obstet Gynecol 2020;32:198-204. [PMID: 32251092 DOI: 10.1097/GCO.0000000000000620] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 623 |
Favaloro EJ, Henry BM, Lippi G. Is Lupus Anticoagulant a Significant Feature of COVID-19? A Critical Appraisal of the Literature. Semin Thromb Hemost 2021. [PMID: 34130341 DOI: 10.1055/s-0041-1729856] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 624 |
Favaloro EJ, Henry BM, Lippi G. COVID-19 and Antiphospholipid Antibodies: Time for a Reality Check? Semin Thromb Hemost 2021. [PMID: 34130340 DOI: 10.1055/s-0041-1728832] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 7.5] [Reference Citation Analysis]
|
| 625 |
Croles FN, Te Boekhorst PAW, Leebeek FWG, Jansen AJG. Therapeutic plasma exchange for anticoagulant-refractory antiphospholipid syndrome with severe ischemic and necrotic skin lesions: A case series. Transfus Apher Sci 2021;:103192. [PMID: 34226147 DOI: 10.1016/j.transci.2021.103192] [Reference Citation Analysis]
|
| 626 |
Leal Rato M, Bandeira M, Romão VC, Aguiar de Sousa D. Neurologic Manifestations of the Antiphospholipid Syndrome - an Update. Curr Neurol Neurosci Rep 2021;21:41. [PMID: 34125304 DOI: 10.1007/s11910-021-01124-z] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 627 |
Zemet R, Dulitzki M, Baum M, Ofer Friedman H, Morag I, Simchen MJ. Early-onset preeclampsia - The impact of antiphospholipid antibodies on disease severity. Eur J Obstet Gynecol Reprod Biol 2021;263:79-84. [PMID: 34167038 DOI: 10.1016/j.ejogrb.2021.06.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 628 |
Erkan D. Expert Perspective: Management of Microvascular and Catastrophic Antiphospholipid Syndrome. Arthritis Rheumatol 2021. [PMID: 34114366 DOI: 10.1002/art.41891] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 629 |
Pardos-Gea J, Marques-Soares JR, Buján S, Ordi-Ros J, Alijotas-Reig J. Persistent thrombocytopenia predicts poor long-term survival in patients with antiphospholipid syndrome: a 38-year follow-up study. Rheumatology (Oxford) 2021:keab475. [PMID: 34115832 DOI: 10.1093/rheumatology/keab475] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 630 |
Nalli C, Lini D, Andreoli L, Crisafulli F, Fredi M, Lazzaroni MG, Bitsadze V, Calligaro A, Canti V, Caporali R, Carubbi F, Chighizola CB, Conigliaro P, Conti F, De Carolis C, Del Ross T, Favaro M, Gerosa M, Iuliano A, Khizroeva J, Makatsariya A, Meroni PL, Mosca M, Padovan M, Perricone R, Rovere-Querini P, Sebastiani GD, Tani C, Tonello M, Truglia S, Zucchi D, Franceschini F, Tincani A. Low Preconception Complement Levels Are Associated with Adverse Pregnancy Outcomes in a Multicenter Study of 260 Pregnancies in 197 Women with Antiphospholipid Syndrome or Carriers of Antiphospholipid Antibodies. Biomedicines 2021;9:671. [PMID: 34208130 DOI: 10.3390/biomedicines9060671] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 631 |
Lamarche MC, Alrajhi E, Wells PS. Direct oral anticoagulant use in special populations. Curr Opin Pulm Med 2021;27:311-8. [PMID: 34115699 DOI: 10.1097/MCP.0000000000000787] [Reference Citation Analysis]
|
| 632 |
Krilis M, Qi M, Ioannou Y, Zhang JY, Ahmadi Z, Wong JWH, Vlachoyiannopoulos PG, Moutsopoulos HM, Koike T, Sturgess AD, Chong BH, Krilis SA, Giannakopoulos B. Clinical relevance of nitrated beta 2-glycoprotein I in antiphospholipid syndrome: Implications for thrombosis risk. J Autoimmun 2021;122:102675. [PMID: 34098405 DOI: 10.1016/j.jaut.2021.102675] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 633 |
Tripodi A, Scalambrino E, Chantarangkul V, Paoletti O, Clerici M, Novembrino C, Boscolo-Anzoletti M, Peyvandi F, Testa S. Impact of a commercially available DOAC absorbent on two integrated procedures for lupus anticoagulant detection. Thromb Res 2021;204:32-9. [PMID: 34126321 DOI: 10.1016/j.thromres.2021.06.001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 634 |
Melnikov AP, Kashchuk MG, Ahvlediani KN, Bokarev IN. Thrombophilia in obstetric practice. jour 2021;99:15-20. [DOI: 10.30629/0023-2149-2021-99-1-15-20] [Reference Citation Analysis]
|
| 635 |
Hasbani GE, Taher AT, Sunji N, Sciascia S, Uthman I. Antiphospholipid antibodies and cerebrovascular thrombosis in the pediatric population: Few answers to many questions. Lupus 2021;30:1365-77. [PMID: 34082580 DOI: 10.1177/09612033211021488] [Reference Citation Analysis]
|
| 636 |
Hirmerová J, Seidlerová J, Šubrt I, Hajšmanová Z. Prevalence of cancer in patients with superficial vein thrombosis and its clinical importance. J Vasc Surg Venous Lymphat Disord 2021:S2213-333X(21)00285-7. [PMID: 34089942 DOI: 10.1016/j.jvsv.2021.05.006] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 637 |
Émile C. Suivi biologique du lupus systémique et du syndrome des antiphospholipides. Option/Bio 2021;32:24-26. [DOI: 10.1016/s0992-5945(21)00138-0] [Reference Citation Analysis]
|
| 638 |
Levi M. Pathophysiology of Coagulopathy in Hematological Malignancies and in COVID-19. Hemasphere 2021;5:e571. [PMID: 34095755 DOI: 10.1097/HS9.0000000000000571] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 639 |
Chaudhari D, Krishnan R, N Renjen P, Seth S. CLINICAL SIGNIFICANCE OF APTT - ANTIPHOSPHOLIPID ANTIBODY SYNDROME PRESENTING AS STROKE. ijsr 2021. [DOI: 10.36106/ijsr/2905409] [Reference Citation Analysis]
|
| 640 |
Kuwada T, Shiokawa M, Kodama Y, Ota S, Kakiuchi N, Nannya Y, Yamazaki H, Yoshida H, Nakamura T, Matsumoto S, Muramoto Y, Yamamoto S, Honzawa Y, Kuriyama K, Okamoto K, Hirano T, Okada H, Marui S, Sogabe Y, Morita T, Matsumori T, Mima A, Nishikawa Y, Ueda T, Matsumura K, Uza N, Chiba T, Seno H. Identification of an Anti-Integrin αvβ6 Autoantibody in Patients With Ulcerative Colitis. Gastroenterology 2021;160:2383-2394.e21. [PMID: 33582126 DOI: 10.1053/j.gastro.2021.02.019] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 10.5] [Reference Citation Analysis]
|
| 641 |
Zee K, Qureshi S. POTS and Antiphospholipid Syndrome: An Unlikely Association. Case Rep Rheumatol 2021;2021:9942668. [PMID: 34055446 DOI: 10.1155/2021/9942668] [Reference Citation Analysis]
|
| 642 |
Páramo JA. Microvascular thrombosis and clinical implications. Medicina Clínica (English Edition) 2021;156:609-614. [DOI: 10.1016/j.medcle.2020.12.025] [Reference Citation Analysis]
|
| 643 |
Farkh C, Ellouze S, Gounelle L, Sad Houari M, Duchemin J, Proulle V, Fontenay M, Delavenne X, Jourdi G. A Diagnostic Solution for Lupus Anticoagulant Testing in Patients Taking Direct Oral FXa Inhibitors Using DOAC Filter. Front Med (Lausanne) 2021;8:683357. [PMID: 34136510 DOI: 10.3389/fmed.2021.683357] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 644 |
Ghadiri N, Stanford M. Case of vaso-occlusive retinopathy in Kikuchi-Fujimoto and lupus overlap syndrome. BMJ Case Rep 2021;14:e240752. [PMID: 34059537 DOI: 10.1136/bcr-2020-240752] [Reference Citation Analysis]
|
| 645 |
Rawish E, Sauter M, Sauter R, Nording H, Langer HF. Complement, inflammation and thrombosis. Br J Pharmacol 2021;178:2892-904. [PMID: 33817781 DOI: 10.1111/bph.15476] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 646 |
Menozzi E, Mulroy E, Akbarian-Tefaghi L, Bhatia KP, Balint B. Movement disorders in systemic autoimmune diseases: Clinical spectrum, ancillary investigations, pathophysiological considerations. Parkinsonism Relat Disord 2021;88:116-28. [PMID: 34092506 DOI: 10.1016/j.parkreldis.2021.05.026] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 647 |
Izhar R, Ala SH, Husain S, Husain S. Anti-phospholipid antibodies in women presenting with preterm delivery because of preeclampsia or placental insufficiency. J Turk Ger Gynecol Assoc 2021;22:85-90. [PMID: 33631871 DOI: 10.4274/jtgga.galenos.2021.2020.0143] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 648 |
Sciascia S, Radin M, Cecchi I, Levy RA, Erkan D. 16th International congress on antiphospholipid antibodies task force report on clinical manifestations of antiphospholipid syndrome. Lupus 2021;30:1314-26. [PMID: 34039107 DOI: 10.1177/09612033211020361] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 649 |
Khizroeva J, Bitsadze V, Tincani A, Makatsariya A, Arslanbekova M, Babaeva N, Tsibizova V, Shkoda A, Makatsariya N, Tretyakova M, Solopova A, Gadaeva Z, Vorobev A, Khamani I, Aslanova Z, Nakaidze I, Mischenko A, Grigoreva K, Kunesko N, Egorova E, Mashkova T. Hydroxychloroquine in obstetric antiphospholipid syndrome: rationale and results of an observational study of refractory cases. J Matern Fetal Neonatal Med 2021;:1-8. [PMID: 34044735 DOI: 10.1080/14767058.2021.1908992] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 650 |
Vlasova GA, Perminova SG, Kosheleva NM. Approaches to the realization of reproductive function in women with systemic lupus erythematosus and antiphospholipid syndrome. Gynecol 2021;23:167-172. [DOI: 10.26442/20795696.2021.2.200739] [Reference Citation Analysis]
|
| 651 |
Bovenzi R, Conti M, Cerroni R, Pierantozzi M, Stefani A, Pisani A, Mercuri NB, Schirinzi T. Adult-onset sporadic chorea: real-world data from a single-centre retrospective study. Neurol Sci 2021. [PMID: 34041635 DOI: 10.1007/s10072-021-05332-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 652 |
Santamaría A. The association between coagulopathies such as thrombophilia or rare bleeding disorders with the development of gestational vascular complications. Blood Coagul Fibrinolysis 2020;31:S25-7. [PMID: 33351500 DOI: 10.1097/MBC.0000000000000987] [Reference Citation Analysis]
|
| 653 |
Al-Banaa K, Alshaikhli A, Al-Hareeri A, Abdelhalim M, Al-Hillan A, Joshi T. Arterial Dissection in Antiphospholipid Syndrome Patients: Two Case Reports and a Literature Review. Eur J Case Rep Intern Med 2021;8:002610. [PMID: 34123952 DOI: 10.12890/2021_002610] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 654 |
Liu T, Han J, Zhang R, Tang Z, Yi G, Gong W, Wan L, Hu Q, Teng J, Liu H, Cheng X, Ye J, Su Y, Sun Y, Shi Y, Gu J, Ren S, Yang C, Shi H. Characteristics of purified Anti-β2GPI IgG N-glycosylation associate with thrombotic, obstetric, and catastrophic antiphospholipid syndrome. Rheumatology (Oxford) 2021:keab416. [PMID: 34015111 DOI: 10.1093/rheumatology/keab416] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 655 |
Donnellan C, Cohen H, Werring DJ. Cognitive dysfunction and associated neuroimaging biomarkers in antiphospholipid syndrome: a systematic review. Rheumatology (Oxford) 2021:keab452. [PMID: 34003972 DOI: 10.1093/rheumatology/keab452] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 656 |
Mavromanoli AC, Barco S, Konstantinides SV. Antithrombotics and new interventions for venous thromboembolism: Exploring possibilities beyond factor IIa and factor Xa inhibition. Res Pract Thromb Haemost 2021;5. [PMID: 34027284 DOI: 10.1002/rth2.12509] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 657 |
Annous Y, Manning S, Khoujah D. Ferritin, fever, and frequent visits: Hyperferritinemic syndromes in the emergency department. Am J Emerg Med 2021;48:249-54. [PMID: 34000525 DOI: 10.1016/j.ajem.2021.04.088] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 658 |
Malinowski AK. The Pathophysiology of Hypercoagulability and Infertility. Semin Reprod Med 2021;39:34-61. [PMID: 34000740 DOI: 10.1055/s-0041-1729763] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 659 |
Pires Da Rosa G, Rodríguez-Pintó I, Cervera R, Espinosa G. Management of patients with antiphospholipid antibodies: what to do in laboratory scenarios that do not fit the guidelines. Expert Rev Hematol 2021;14:457-66. [PMID: 33909986 DOI: 10.1080/17474086.2021.1923474] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 660 |
de Laat-Kremers RMW, Wahl D, Zuily S, Ninivaggi M, Chayouâ W, Regnault V, Musial J, de Groot PG, Devreese KMJ, de Laat B. Deciphered coagulation profile to diagnose the antiphospholipid syndrome using artificial intelligence. Thromb Res 2021;203:142-51. [PMID: 34022673 DOI: 10.1016/j.thromres.2021.05.008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 661 |
Abdel-Wahab N, Tayar JH, Fa'ak F, Sharma G, Lopez-Olivo MA, Yousif A, Shagroni T, Al-Hawamdeh S, Rojas-Hernandez CM, Suarez-Almazor ME. Systematic review of observational studies reporting antiphospholipid antibodies in patients with solid tumors. Blood Adv 2020;4:1746-55. [PMID: 32337583 DOI: 10.1182/bloodadvances.2020001557] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 662 |
Brilland B, Bach-Bunner M, Gomes CN, Larochette V, Foucher E, Plaisance M, Saulnier P, Costedoat-Chalumeau N, Ghillani P, Belizna C, Delneste Y, Augusto JF, Jeannin P. Serum Interleukin-26 Is a New Biomarker for Disease Activity Assessment in Systemic Lupus Erythematosus. Front Immunol 2021;12:663192. [PMID: 34054830 DOI: 10.3389/fimmu.2021.663192] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 663 |
Li XY, Duan HJ, Liu XY, Deng XL. Change of serum B-cell activating factor level in patients with positive antiphospholipid antibodies and previous adverse pregnancy outcomes and its significance. Chin Med J (Engl) 2020;133:2287-94. [PMID: 32842014 DOI: 10.1097/CM9.0000000000000948] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 664 |
Pleguezuelo DE, Cabrera-Marante O, Abad M, Rodriguez-Frias EA, Naranjo L, Vazquez A, Villar O, Gil-Etayo FJ, Serrano M, Perez-Rivilla A, de la Fuente-Bitaine L, Serrano A. Anti-Phosphatidylserine/Prothrombin Antibodies in Healthy Women with Unexplained Recurrent Pregnancy Loss. J Clin Med 2021;10:2094. [PMID: 34068095 DOI: 10.3390/jcm10102094] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 665 |
Panova AP, Avdeev VG, Krasnova TN, Rozina TP, Pavlikova EP, Georginova OA, Filatova AL, Borisov EN, Novikov PI. Liver involvement in patients with systemic lupus erythematosus. Naučno-praktičeskaâ revmatologiâ 2021;59:164-172. [DOI: 10.47360/1995-4484-2021-164-172] [Reference Citation Analysis]
|
| 666 |
Canto MJ, Ortiz-Santamaria V, Palau J, Cuquet J, Ojeda F. Value of second-trimester uterine artery pulsatility index in pregnancies with systemic lupus erythematosus and/or antiphospholipid syndrome. J Matern Fetal Neonatal Med 2021;:1-7. [PMID: 33980112 DOI: 10.1080/14767058.2021.1918090] [Reference Citation Analysis]
|
| 667 |
Cohen H, Isenberg DA. How I treat anticoagulant-refractory thrombotic antiphospholipid syndrome. Blood 2021;137:299-309. [PMID: 32898856 DOI: 10.1182/blood.2020004942] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 668 |
Pavoni V, Gianesello L, Horton A. Antiphospholipid antibodies in critically ill COVID-19 patients with thromboembolism: cause of disease or epiphenomenon? J Thromb Thrombolysis 2021. [PMID: 33973157 DOI: 10.1007/s11239-021-02470-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 669 |
Aibar J, Schulman S. Arterial Thrombosis in Patients with Antiphospholipid Syndrome: A Review and Meta-Analysis. Semin Thromb Hemost 2021;47:709-23. [PMID: 33971678 DOI: 10.1055/s-0041-1725057] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 670 |
Truglia S, Mancuso S, Capozzi A, Recalchi S, Riitano G, Longo A, De Carolis S, Spinelli FR, Alessandri C, Ceccarelli F, De Carolis C, Misasi R, Sorice M, Conti F. "Non-criteria antiphospholipid antibodies": bridging the gap between seropositive and seronegative Antiphospholipid Syndrome. Rheumatology (Oxford) 2021:keab414. [PMID: 33970223 DOI: 10.1093/rheumatology/keab414] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 671 |
Jiang H, Wang CH, Jiang N, Li J, Wu CY, Wang Q, Li MT, Tian XP, Zhao JL, Zhao Y, Zeng XF. Clinical characteristics and prognosis of patients with isolated thrombotic vs. obstetric antiphospholipid syndrome: a prospective cohort study. Arthritis Res Ther 2021;23:138. [PMID: 33964976 DOI: 10.1186/s13075-021-02515-w] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 672 |
Elbagir S, Grosso G, Mohammed NA, Elshafie AI, Elagib EM, Zickert A, Manivel VA, Pertsinidou E, Nur MAM, Gunnarsson I, Rönnelid J, Svenungsson E. Associations with thrombosis are stronger for antiphosphatidylserine/prothrombin antibodies than for the Sydney criteria antiphospholipid antibody tests in SLE. Lupus 2021;30:1289-99. [PMID: 33957795 DOI: 10.1177/09612033211014570] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 673 |
Wirestam L, Saleh M, Svensson C, Compagno M, Zachrisson H, Wetterö J, Sjöwall C. Plasma osteopontin versus intima media thickness of the common carotid arteries in well-characterised patients with systemic lupus erythematosus. Lupus 2021;30:1244-53. [PMID: 33957796 DOI: 10.1177/09612033211013898] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 674 |
Elkhalifa M, Orbai AM, Magder LS, Petri M, Alarcón GS, Gordon C, Merrill J, Fortin PR, Bruce IN, Isenberg D, Wallace D, Nived O, Ramsey-Goldman R, Bae SC, Hanly JG, Sanchez-Guerrero J, Clarke AE, Aranow C, Manzi S, Urowitz M, Gladman DD, Kalunian K, Werth VP, Zoma A, Bernatsky S, Khamashta M, Jacobsen S, Buyon JP, Dooley MA, Vollenhoven RV, Ginzler E, Stoll T, Peschken C, Jorizzo JL, Callen JP, Lim S, Inanc M, Kamen DL, Rahman A, Steinsson K, Franks AG Jr. Anti-beta 2 glycoprotein I IgA in the SLICC classification criteria dataset. Lupus 2021;30:1283-8. [PMID: 33957797 DOI: 10.1177/09612033211014248] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 675 |
Najim M, Rahhal A, Khir F, Aljundi AH, Abu Yousef S, Ibrahim F, Amer A, Mohamed AS, Saleh S, Alfaridi D, Mahfouz A, Alyafei S, Howady F, Khatib M, Alemadi SA. Prevalence and clinical significance of antiphospholipid antibodies in patients with coronavirus disease 2019 admitted to intensive care units: a prospective observational study. Rheumatol Int 2021;41:1243-52. [PMID: 33954813 DOI: 10.1007/s00296-021-04875-7] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 676 |
Wind M, Hendriks M, van Brussel BTJ, Eikenboom J, Allaart CF, Lamb HJ, Siebelink HJ, Ninaber MK, van Geloven N, van Lith JMM, Huizinga TWJ, Rabelink TJ, Sueters M, Teng YKO. Effectiveness of a multidisciplinary clinical pathway for women with systemic lupus erythematosus and/or antiphospholipid syndrome. Lupus Sci Med 2021;8:e000472. [PMID: 33952625 DOI: 10.1136/lupus-2020-000472] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 677 |
Larosa M, Le Guern V, Morel N, Belhocine M, Ruffatti A, Silva NM, Paule R, Mouthon L, Dreyfus M, Piette JC, Souchaud-Debouverie O, Deneux-Tharaux C, Guettrot-Imbert G, Tsatsaris V, Pannier-Metzger E, Murarasu A, Doria A, Costedoat-Chalumeau N. Evaluation of the severe preeclampsia classification criterion for antiphospholipid syndrome in a study of 40 patients. Arthritis Res Ther 2021;23:134. [PMID: 33947469 DOI: 10.1186/s13075-021-02518-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 678 |
Tan Y, Bian Y, Song Y, Zhang Q, Wan X. Exosome-Contained APOH Associated With Antiphospholipid Syndrome. Front Immunol 2021;12:604222. [PMID: 34040601 DOI: 10.3389/fimmu.2021.604222] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 679 |
Naranjo L, Ostos F, Gil-Etayo FJ, Hernández-Gallego J, Cabrera-Marante Ó, Pleguezuelo DE, Díaz-Simón R, Cerro M, Lora D, Martínez-Salio A, Serrano A. Presence of Extra-Criteria Antiphospholipid Antibodies Is an Independent Risk Factor for Ischemic Stroke. Front Cardiovasc Med 2021;8:665741. [PMID: 34012984 DOI: 10.3389/fcvm.2021.665741] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 680 |
Thachil J. Doctor, Do I Have Lupus? Time to Reconsider the Lupus Anticoagulant Terminology. Semin Thromb Hemost 2021. [PMID: 33932942 DOI: 10.1055/s-0041-1728787] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 681 |
Williamson KA, Sanchez-Alvarez C, Duarte-García A. 28-Year-Old Man With Recurrent Vertigo, Syncope, and Progressive Memory Impairment. Mayo Clin Proc 2021;96:1309-14. [PMID: 33958060 DOI: 10.1016/j.mayocp.2020.08.052] [Reference Citation Analysis]
|
| 682 |
Alijotas-reig J. Does incomplete obstetric antiphospholipid syndrome really exist? Medicina Clínica (English Edition) 2021;156:515-519. [DOI: 10.1016/j.medcle.2020.12.018] [Reference Citation Analysis]
|
| 683 |
Álvarez D, Rúa C, Cadavid J ÁP. Microparticles: An Alternative Explanation to the Behavior of Vascular Antiphospholipid Syndrome. Semin Thromb Hemost 2021. [PMID: 33930895 DOI: 10.1055/s-0041-1727111] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 684 |
Sammaritano LR. Which Hormones and Contraception for Women with APS? Exogenous Hormone Use in Women with APS. Curr Rheumatol Rep 2021;23:44. [PMID: 33939022 DOI: 10.1007/s11926-021-01006-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 685 |
Yun J, Gu J, Kim HK. Double positivity of anti-β2-glycoprotein I domain I and anti-phosphatidylserine/prothrombin antibodies enhances both thrombosis and positivity of anti-ADAMTS13 antibody. J Thromb Thrombolysis 2021. [PMID: 33914240 DOI: 10.1007/s11239-021-02406-6] [Reference Citation Analysis]
|
| 686 |
Ko CJ, Gehlhausen JR, McNiff JM. Leukocytoclastic Vasculitis and Microvascular Occlusion: Key Concepts for the Working Pathologist. Surg Pathol Clin 2021;14:309-25. [PMID: 34023108 DOI: 10.1016/j.path.2021.01.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 687 |
Štok U, Čučnik S, Sodin-Šemrl S, Žigon P. Extracellular Vesicles and Antiphospholipid Syndrome: State-of-the-Art and Future Challenges. Int J Mol Sci 2021;22:4689. [PMID: 33925261 DOI: 10.3390/ijms22094689] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 688 |
Chemello D, Rosa L, de Araujo AF, de Araujo PC, Pereira LCC, Hillesheim SF, Saffi MAL. Massive thrombosis and phlegmasia cerulea dolens while taking rivaroxaban: case report and review. J Vasc Bras 2021;20:e20200036. [PMID: 34093674 DOI: 10.1590/1677-5449.200036] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 689 |
Bitsadze V, Bouvier S, Khizroeva J, Cochery-Nouvellon É, Mercier É, Perez-Martin A, Makatsariya A, Gris JC. Early ADAMTS13 testing associates with pre-eclampsia occurrence in antiphospholipid syndrome. Thromb Res 2021;203:101-9. [PMID: 33989981 DOI: 10.1016/j.thromres.2021.04.021] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
|
| 690 |
Steriade C, Titulaer MJ, Vezzani A, Sander JW, Thijs RD. The association between systemic autoimmune disorders and epilepsy and its clinical implications. Brain 2021;144:372-90. [PMID: 33221878 DOI: 10.1093/brain/awaa362] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 691 |
Magoon N, Bindu B, Sapra H. Incidental diagnosis of antiphospholipid antibody syndrome (APS) in a trauma patient with thrombocytopenia & its anesthetic management. Trauma Case Rep 2021;33:100488. [PMID: 33997231 DOI: 10.1016/j.tcr.2021.100488] [Reference Citation Analysis]
|
| 692 |
Vomstein K, Aulitzky A, Strobel L, Bohlmann M, Feil K, Rudnik-Schöneborn S, Zschocke J, Toth B. Recurrent Spontaneous Miscarriage: a Comparison of International Guidelines. Geburtshilfe Frauenheilkd 2021;81:769-79. [PMID: 34276063 DOI: 10.1055/a-1380-3657] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 693 |
Juárez-Vicuña Y, Guzmán-Martín CA, Martínez-Martínez LA, Hernández-Díazcouder A, Huesca-Gómez C, Gamboa R, Amezcua-Guerra LM, Chacon-Perez M, Amigo MC, Sánchez-Muñoz F. miR-19b-3p and miR-20a-5p are associated with the levels of antiphospholipid antibodies in patients with antiphospholipid syndrome. Rheumatol Int 2021;41:1329-35. [PMID: 33891159 DOI: 10.1007/s00296-021-04864-w] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 694 |
Berkman SA, Song SS. Ischemic Stroke in the Young. Clin Appl Thromb Hemost 2021;27:10760296211002274. [PMID: 33870763 DOI: 10.1177/10760296211002274] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 695 |
Otaduy C, Gobbi CA, Álvarez A, Albiero EH, Yorio MA, Alba Moreyra P. Is Lupus Nephritis a Prognosis Factor for Pregnancy? Maternal and Foetal Outcomes. Reumatol Clin (Engl Ed) 2021:S1699-258X(21)00091-7. [PMID: 33895099 DOI: 10.1016/j.reuma.2021.02.011] [Reference Citation Analysis]
|
| 696 |
Llorente-Chávez A, Martín-Nares E, Núñez-Álvarez C, Hernández-Molina G. Thrombosis and thrombocytopenia in antiphospholipid syndrome: their association with mean platelet volume and hematological ratios. Thromb Res 2021;203:12-7. [PMID: 33895567 DOI: 10.1016/j.thromres.2021.04.018] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 697 |
Nusbaum KB, Korman AM, Tyler KH, Kaffenberger JA, Trinidad JC, Dean S, Cataland S, Kaffenberger BH. In vitro diagnostics for the medical dermatologist. Part II: Hypercoagulability tests. J Am Acad Dermatol 2021;85:301-10. [PMID: 33852929 DOI: 10.1016/j.jaad.2021.03.108] [Reference Citation Analysis]
|
| 698 |
Salehi Omran S, Hartman A, Zakai NA, Navi BB. Thrombophilia Testing After Ischemic Stroke: Why, When, and What? Stroke 2021;52:1874-84. [PMID: 33874743 DOI: 10.1161/STROKEAHA.120.032360] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 699 |
Antovic A, Bruzelius M. Impaired Fibrinolysis in the Antiphospholipid Syndrome. Semin Thromb Hemost 2021;47:506-11. [PMID: 33878780 DOI: 10.1055/s-0041-1725098] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 700 |
Shen H, Huang X, Fan C. Clinical Characteristics and Management of Cerebral Venous Sinus Thrombosis in Patients With Antiphospholipid Syndrome: A Single-Center Retrospective Study. Clin Appl Thromb Hemost 2021;27:1076029621999104. [PMID: 33872100 DOI: 10.1177/1076029621999104] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 701 |
Deeb H, Abdul Salam O, Shaaban V, Alkhatib A, Alhalabi N, Alhalabi M. Antiphospholipid antibodies levels and potential effects on in-vitro fertilization in a large cohort of infertile Syrian women. Ann Med Surg (Lond) 2021;65:102301. [PMID: 33948172 DOI: 10.1016/j.amsu.2021.102301] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 702 |
Huang S, Ninivaggi M, Chayoua W, de Laat B. VWF, Platelets and the Antiphospholipid Syndrome. Int J Mol Sci 2021;22:4200. [PMID: 33919627 DOI: 10.3390/ijms22084200] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 703 |
Benito-Garcia F, Pires I, Lima J. Aspirin Desensitization: Implications for Acetylsalicylic Acid-Sensitive Pregnant Women. Medicina (Kaunas) 2021;57:390. [PMID: 33920569 DOI: 10.3390/medicina57040390] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 704 |
Le Ho Y, Ahmad Zaidi NA, Salleh A, Abdul Kareem BA. Aortic valve surgery for aortic regurgitation caused by Libman-Sacks endocarditis in a patient with primary antiphospholipid syndrome: a case report. J Cardiothorac Surg 2021;16:92. [PMID: 33865405 DOI: 10.1186/s13019-021-01458-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 705 |
Larosa M, Costedoat-Chalumeau N, Guettrot-Imbert G, Le Guern V, Morel N, Jesus D, Iaccarino L, Inês L, Doria A. SLE-DAS in the First Trimester of Gestation Predicts Maternal Lupus Flares Later in Pregnancy. Front Pharmacol 2021;12:660123. [PMID: 33935783 DOI: 10.3389/fphar.2021.660123] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 706 |
Alibaz-Oner F, Ergelen R, Yıldız Y, Aldag M, Yazici A, Cefle A, Koç E, Artım Esen B, Mumcu G, Ergun T, Direskeneli H. Femoral vein wall thickness measurement: A new diagnostic tool for Behçet's disease. Rheumatology (Oxford) 2021;60:288-96. [PMID: 32756998 DOI: 10.1093/rheumatology/keaa264] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 707 |
Páramo JA. [Microvascular thrombosis and clinical implications]. Med Clin (Barc) 2021;156:609-14. [PMID: 33875227 DOI: 10.1016/j.medcli.2020.12.042] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 708 |
Lalmahomed TA, Walter IJ, Lely AT, Bloemenkamp KWM, Kooiman J, Limper M. On the use of intravenous immunoglobulins for the treatment of the antiphospholipid syndrome - A systematic review and meta-analysis. Autoimmun Rev 2021;20:102828. [PMID: 33866065 DOI: 10.1016/j.autrev.2021.102828] [Reference Citation Analysis]
|
| 709 |
Pleguezuelo DE, Díaz-Simón R, Cabrera-Marante O, Lalueza A, Paz-Artal E, Lumbreras C, Serrano Hernández A. Case Report: Resetting the Humoral Immune Response by Targeting Plasma Cells With Daratumumab in Anti-Phospholipid Syndrome. Front Immunol 2021;12:667515. [PMID: 33912194 DOI: 10.3389/fimmu.2021.667515] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 710 |
Zhang J, Zhang J, Zhou Q, Lu G, You X. Association of antiphospholipid antibodies with clinical activity and renal pathological activity in patients with lupus nephritis. Lupus 2021;30:1140-5. [PMID: 33832360 DOI: 10.1177/09612033211006781] [Reference Citation Analysis]
|
| 711 |
Tannous T, Rosso C, Iannuccilli J, Tannous K, Keating M. Primary Refractory Catastrophic Antiphospholipid Syndrome Masquerading as Buerger's Disease. Cureus 2021;13:e14350. [PMID: 33972907 DOI: 10.7759/cureus.14350] [Reference Citation Analysis]
|
| 712 |
Tektonidou MG, Kravvariti E, Vlachogiannis NI, Georgiopoulos G, Mantzou A, Sfikakis PP, Stellos K, Stamatelopoulos K. Clinical value of amyloid-beta1-40 as a marker of thrombo-inflammation in antiphospholipid syndrome. Rheumatology (Oxford) 2021;60:1669-75. [PMID: 33027516 DOI: 10.1093/rheumatology/keaa548] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 713 |
Riveros Frutos A, Holgado S, Sanvisens Bergé A, Casas I, Olivé A, López-Longo FJ, Calvo-Alén J, Galindo M, Fernández-Nebro A, Pego-Reigosa JM, Rúa-Figueroa I; RELESSER Group. Late-onset versus early-onset systemic lupus: characteristics and outcome in a national multicentre register (RELESSER). Rheumatology (Oxford) 2021;60:1793-803. [PMID: 33106841 DOI: 10.1093/rheumatology/keaa477] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 714 |
Ural K, Edelson J. Antiphospholipid Syndrome and Cardiac Bypass: The Careful Balance between Clotting and Bleeding. J Extra Corpor Technol 2021;53:46-9. [PMID: 33814605 DOI: 10.1182/ject-2000040] [Reference Citation Analysis]
|
| 715 |
Reiss AB, Jacob B, Ahmed S, Carsons SE, DeLeon J. Understanding Accelerated Atherosclerosis in Systemic Lupus Erythematosus: Toward Better Treatment and Prevention. Inflammation 2021. [PMID: 33821395 DOI: 10.1007/s10753-021-01455-6] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 716 |
Ge YY, Duan HJ, Deng XL. Possible effects of chemokine-like factor-like MARVEL transmembrane domain-containing family on antiphospholipid syndrome. Chin Med J (Engl) 2021;134:1661-8. [PMID: 33813507 DOI: 10.1097/CM9.0000000000001449] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 717 |
Chan EY, Leung KFS, Soo ETL, Ma ALT. A Chinese Boy With Lupus Anticoagulant-hypoprothrombinemia Syndrome: A Case Report and Review of the Literature. J Pediatr Hematol Oncol 2021;43:e445-7. [PMID: 32287097 DOI: 10.1097/MPH.0000000000001805] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 718 |
Heras CB, Gómez AP, Hajkhan AM, Rubio ER. Síndrome antifosfolípido. Medicine - Programa de Formación Médica Continuada Acreditado 2021;13:1760-1768. [DOI: 10.1016/j.med.2021.04.003] [Reference Citation Analysis]
|
| 719 |
Alvarez AM, Gomez-Gutierrez AM, Bueno-Sánchez JC, Rúa-Molina C, Cadavid AP. Obstetric Antiphospholipid Syndrome: An Approach from Glycans of the Immunoglobulin G. J Hum Reprod Sci 2021;14:97-100. [PMID: 34084001 DOI: 10.4103/jhrs.JHRS_21_20] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 720 |
Cecchi I, Radin M, Rodríguez-Carrio J, Tambralli A, Knight JS, Sciascia S. Utilizing type I interferon expression in the identification of antiphospholipid syndrome subsets. Expert Rev Clin Immunol 2021;17:395-406. [PMID: 33686921 DOI: 10.1080/1744666X.2021.1901581] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 721 |
Yang J, Liang M. Risk factors for pregnancy morbidity in women with antiphospholipid syndrome. J Reprod Immunol 2021;145:103315. [PMID: 33845396 DOI: 10.1016/j.jri.2021.103315] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 722 |
Bollow M. [Atypical arthritis of the hands : Collagenosis-part 1]. Radiologe 2021;61:458-69. [PMID: 33779767 DOI: 10.1007/s00117-021-00840-4] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 723 |
Chayoua W, Nicolson PLR, Meijers JCM, Kardeby C, Garcia-Quintanilla L, Devreese KMJ, de Laat B, Watson SP, de Groot PG. Antiprothrombin antibodies induce platelet activation: A possible explanation for anti-FXa therapy failure in patients with antiphospholipid syndrome? J Thromb Haemost 2021;19:1776-82. [PMID: 33774918 DOI: 10.1111/jth.15320] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 724 |
Hanly JG, Inanç M. The neurology of lupus. J Neurol Sci 2021;424:117419. [PMID: 33832774 DOI: 10.1016/j.jns.2021.117419] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 725 |
Kong F, Huang X, Su L, Liao Q, Wang C, Zhao Y. Risk factors for cerebral infarction in Takayasu arteritis: a single-centre case-controlled study. Rheumatology (Oxford) 2021:keab308. [PMID: 33774663 DOI: 10.1093/rheumatology/keab308] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 726 |
Hamulyák EN, Scheres LJJ, Goddijn M, Middeldorp S. Antithrombotic therapy to prevent recurrent pregnancy loss in antiphospholipid syndrome-What is the evidence? J Thromb Haemost 2021;19:1174-85. [PMID: 33687789 DOI: 10.1111/jth.15290] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 727 |
Ugarte A, Garcia de Bustos A, Ruiz-Arruza I, Soto-Peleteiro A, Martin-Iglesias D, Gonzalez-Echavarri C, Ruiz-Irastorza G. ANTIPHOSPHOLIPID ANTIBODIES DO NOT PREDICT DAMAGE IN SLE PATIENTS IN THE XXI CENTURY. AN OBSERVATIONAL STUDY FROM THE LUPUS-CRUCES COHORT. Rheumatology (Oxford) 2021:keab307. [PMID: 33769455 DOI: 10.1093/rheumatology/keab307] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 728 |
Carvalho JF, Shoenfeld Y, Skare TL. Vitamin B12 and primary antiphospholipid syndrome. Lupus 2021;30:1025-6. [PMID: 33765900 DOI: 10.1177/09612033211004712] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 729 |
Radin M, Foddai S, Cecchi I, Rubini E, Barinotti A, Mahler M, Seaman A, Ramirez C, Casas S, Roccatello D, Sciascia S. Improving the clinical accuracy in patients with antiphospholipid antibodies using anti-phosphatidylserine/prothrombin and anti-beta2 glycoprotein I domain and particle-based multi-analyte technology. Thromb Res 2021;202:100-3. [PMID: 33798802 DOI: 10.1016/j.thromres.2021.03.019] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 730 |
May JE, Moll S. How I treat unexplained arterial thrombosis. Blood 2020;136:1487-98. [PMID: 32584955 DOI: 10.1182/blood.2019000820] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 731 |
Tektonidou MG, Papassotiriou I, Sfikakis PP. Growth Differentiation Factor 15 (GDF-15) as potential cardiovascular risk biomarker in Antiphospholipid Syndrome. Rheumatology (Oxford) 2021:keab277. [PMID: 33748838 DOI: 10.1093/rheumatology/keab277] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 732 |
Kanouchi K, Narimatsu H, Shirata T, Morikane K. Diagnostic analysis of lupus anticoagulant using clot waveform analysis in activated partial thromboplastin time prolonged cases: A retrospective analysis. Health Sci Rep 2021;4:e258. [PMID: 33738342 DOI: 10.1002/hsr2.258] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 733 |
Serrano M, Espinosa G, Lalueza A, Bravo-Gallego LY, Diaz-Simón R, Garcinuño S, Gil-Etayo J, Moises J, Naranjo L, Prieto-González S, Ruiz-Ortiz E, Sánchez B, Moreno-Castaño AB, Díaz-Pedroche C, Viñas-Gomis O, Cervera R, Serrano A; APS-COVID 19 Study Group/European Forum on Antiphospholipid Antibodies. Beta-2-Glycoprotein-I Deficiency Could Precipitate an Antiphospholipid Syndrome-like Prothrombotic Situation in Patients With Coronavirus Disease 2019. ACR Open Rheumatol 2021;3:267-76. [PMID: 33738987 DOI: 10.1002/acr2.11245] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 734 |
Tian Y, Xu J, Chen D, Yang C, Peng B. The additional use of hydroxychloroquine can improve the live birth rate in pregnant women with persistent positive antiphospholipid antibodies: A systematic review and meta-analysis. J Gynecol Obstet Hum Reprod 2021;50:102121. [PMID: 33746078 DOI: 10.1016/j.jogoh.2021.102121] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 735 |
Benhamou Y, Delluc A, Mauge L, Fischer AM, Sanchez O; pour le groupe de travail Recommandations de bonne pratique pour la prise en charge de la MVTE. [Which aetiological investigations to undertake during the progress of PE/DVT?]. Rev Mal Respir 2021;38 Suppl 1:e90-8. [PMID: 33744073 DOI: 10.1016/j.rmr.2019.05.008] [Reference Citation Analysis]
|
| 736 |
El Hasbani G, Taher AT, Sciascia S, Uthman I. Antiphospholipid syndrome: the need for new international classification criteria. Expert Rev Clin Immunol 2021;17:385-94. [PMID: 33682558 DOI: 10.1080/1744666X.2021.1900733] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 737 |
Miyamae T, Kawabe T. Non-Criteria Manifestations of Juvenile Antiphospholipid Syndrome. J Clin Med 2021;10:1240. [PMID: 33802787 DOI: 10.3390/jcm10061240] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 738 |
Yoshinaga K, Otsuka Y, Furukawa T, Amitani S, Kimura N, Sanui M. Correlation between activated clotting time monitoring and heparin concentration measurement in a patient with antiphospholipid syndrome during cardiac valve surgery: a case report. JA Clin Rep 2021;7:24. [PMID: 33715057 DOI: 10.1186/s40981-021-00427-x] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 739 |
Dieudonné Y, Guffroy A, Poindron V, Sprauel PS, Martin T, Korganow AS, Gies V. B cells in primary antiphospholipid syndrome: Review and remaining challenges. Autoimmun Rev 2021;20:102798. [PMID: 33722752 DOI: 10.1016/j.autrev.2021.102798] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 740 |
Hong SY, Kim SY, Kim JH, Hong JY, Sung JH, Choi SJ, Oh SY, Roh CR. Predictive value of quad serum markers for adverse pregnancy outcome in antiphospholipid antibody syndrome. Lupus 2021;30:981-90. [PMID: 33709835 DOI: 10.1177/09612033211001126] [Reference Citation Analysis]
|
| 741 |
Timmermans SAMEG, Damoiseaux JGMC, Reutelingsperger CP, van Paassen P. More about complement in the antiphospholipid syndrome. Blood 2020;136:1456-9. [PMID: 32462204 DOI: 10.1182/blood.2020005171] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 742 |
Li S, Lan XL, Cai HC, Zhu TN, Wang SJ, Zhao YQ. [The clinical manifestations and risk factors in primary antiphospholipid syndrome with thrombocytopenia]. Zhonghua Xue Ye Xue Za Zhi 2021;42:33-8. [PMID: 33677866 DOI: 10.3760/cma.j.issn.0253-2727.2021.01.007] [Reference Citation Analysis]
|
| 743 |
Chae HJ, Kim JW, Lee YL, Park JH, Lee SY. Mononeuropathy multiplex associated with systemic vasculitis: A case report. World J Clin Cases 2021; 9(7): 1741-1747 [PMID: 33728320 DOI: 10.12998/wjcc.v9.i7.1741] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 744 |
Gandhi AA, Estes SK, Rysenga CE, Knight JS. Understanding the Pathophysiology of Thrombotic APS through Animal Models. Int J Mol Sci 2021;22:2588. [PMID: 33806694 DOI: 10.3390/ijms22052588] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 745 |
Wind M, Gaasbeek AGA, Oosten LEM, Rabelink TJ, van Lith JMM, Sueters M, Teng YKO. Therapeutic plasma exchange in pregnancy: A literature review. Eur J Obstet Gynecol Reprod Biol 2021;260:29-36. [PMID: 33713886 DOI: 10.1016/j.ejogrb.2021.02.027] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 746 |
Spinillo A, Bellingeri C, De Maggio I, Riceputi G, Pandolfi MP, Spada C, Alpini C, Montecucco C, Beneventi F. The impact of various entities of antiphospholipid antibodies positivity on adverse pregnancy outcome. An epidemiological perspective. J Reprod Immunol 2021;145:103304. [PMID: 33677238 DOI: 10.1016/j.jri.2021.103304] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 747 |
Bettacchioli E, Le Gaffric C, Mazeas M, Borghi MO, Frostegard J, Barturen G, Makowska Z, Babei S, Lesche R, Meroni PL, Alarcon-Riquelme ME, Renaudineau Y; PRECISESADS Clinical Consortium. An elevated polyclonal free light chain level reflects a strong interferon signature in patients with systemic autoimmune diseases. J Transl Autoimmun 2021;4:100090. [PMID: 33817614 DOI: 10.1016/j.jtauto.2021.100090] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 748 |
Suárez-Pérez L, Coto-Hernández R, Suárez-Cuervo C, Caminal-Montero L. Reply to "High frequency of Antiphospholipid Antibodies in Critically ill COVID-19 patients: a Link with Hypercoagulability?". J Intern Med 2021;289:425-6. [PMID: 32909292 DOI: 10.1111/joim.13159] [Reference Citation Analysis]
|
| 749 |
Karahan S, Erol K, Yuksel RC, Artan C, Celik I. Antiphospholipid antibodies in COVID-19-associated pneumonia patients in intensive care unit. Mod Rheumatol 2021;:1-10. [PMID: 33620009 DOI: 10.1080/14397595.2021.1892257] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 750 |
Isnardi CA, Gómez G, Quintana R, Roberts K, Berbotto G, Báez RM, Maldonado FN, Castro Coello V, Graf C, Pons-estel G. Epidemiological characteristics and outcomes of SARS-CoV-2 infection in patients with rheumatic diseases: first report from the Argentine SAR-COVID registry. Rev Argent Reumatol 2021. [DOI: 10.47196/rar.v32i1.364] [Reference Citation Analysis]
|
| 751 |
Frodlund M, Walhelm T, Dahle C, Sjöwall C. Longitudinal Analysis of Anti-cardiolipin and Anti-β2-glycoprotein-I Antibodies in Recent-Onset Systemic Lupus Erythematosus: A Prospective Study in Swedish Patients. Front Med (Lausanne) 2021;8:646846. [PMID: 33732724 DOI: 10.3389/fmed.2021.646846] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 752 |
Siddiqa A, Haider A, Mehmood M, Hanif A. Erythrocytosis, embolism in a woman with antiphospholipid antibodies: A diagnostic challenge. Clin Case Rep 2021;9:2138-43. [PMID: 33936653 DOI: 10.1002/ccr3.3965] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 753 |
Castro-Gutierrez A, Young K, Bermas BL. Pregnancy and Management in Women with Rheumatoid Arthritis, Systemic Lupus Erythematosus, and Obstetric Antiphospholipid Syndrome. Med Clin North Am 2021;105:341-53. [PMID: 33589107 DOI: 10.1016/j.mcna.2020.10.002] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 754 |
Shimamura Y, Maeda T, Abe K, Ogawa Y, Takizawa H. Selective immunoglobulin M deficiency complicated by systemic lupus erythematosus and antiphospholipid syndrome: a case report and review of literature. CEN Case Rep 2021;10:435-41. [PMID: 33616883 DOI: 10.1007/s13730-021-00583-0] [Reference Citation Analysis]
|
| 755 |
Alijotas-Reig J. Does incomplete obstetric antiphospholipid syndrome really exist? Med Clin (Barc) 2021;156:515-9. [PMID: 33632509 DOI: 10.1016/j.medcli.2020.12.023] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 756 |
Vomstein K, Feil K, Strobel L, Aulitzky A, Hofer-Tollinger S, Kuon RJ, Toth B. Immunological Risk Factors in Recurrent Pregnancy Loss: Guidelines Versus Current State of the Art. J Clin Med 2021;10:869. [PMID: 33672505 DOI: 10.3390/jcm10040869] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
|
| 757 |
Cohen H, Efthymiou M, Devreese KMJ. Monitoring of anticoagulation in thrombotic antiphospholipid syndrome. J Thromb Haemost 2021;19:892-908. [PMID: 33325604 DOI: 10.1111/jth.15217] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 758 |
Ernst DM, Oporto JI, Zuñiga PA, Pereira JI, Vera CM, Carvajal JA. Maternal and perinatal outcomes of a venous thromboembolism high-risk cohort using a multidisciplinary treatment approach. Int J Gynaecol Obstet 2021;154:500-7. [PMID: 33508885 DOI: 10.1002/ijgo.13628] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 759 |
Nurbaeva KS, Cheldieva FA, Shumilova AA, Lila AM, Reshetnyak TM. Thromboembolic complications in antiphospholipid syndrome and ankylosing spondylitis (two clinical cases). Sovremennaâ revmatologiâ 2021;15:98-104. [DOI: 10.14412/1996-7012-2021-1-98-104] [Reference Citation Analysis]
|
| 760 |
Alecsandru D, Klimczak AM, Garcia Velasco JA, Pirtea P, Franasiak JM. Immunologic causes and thrombophilia in recurrent pregnancy loss. Fertil Steril 2021;115:561-6. [PMID: 33610320 DOI: 10.1016/j.fertnstert.2021.01.017] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 761 |
Cecchi I, Radin M, Rubini E, Foddai SG, Barinotti A, Roccatello D, Sciascia S. Clinical manifestations in patients with antiphospholipid antibodies: Beyond thrombosis and pregnancy loss. Lupus 2021;30:884-92. [PMID: 33593163 DOI: 10.1177/0961203321995248] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 762 |
Gomez-Flores M, Herrera-Argaez G, Vazquez-Martinez O, Herz-Ruelas M, Ocampo-Candiani J, Villarreal-Martinez A, Galarza-Delgado DA, Hernandez-Galarza I, Chavez-Alvarez S. Cutaneous manifestations of antiphospholipid syndrome. Lupus 2021;30:541-8. [PMID: 33583236 DOI: 10.1177/0961203321990100] [Reference Citation Analysis]
|
| 763 |
Chaturvedi S, Braunstein EM, Brodsky RA. Antiphospholipid syndrome: Complement activation, complement gene mutations, and therapeutic implications. J Thromb Haemost 2021;19:607-16. [PMID: 32881236 DOI: 10.1111/jth.15082] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 7.0] [Reference Citation Analysis]
|
| 764 |
Noordermeer T, Molhoek JE, Schutgens REG, Sebastian SAE, Drost-Verhoef S, van Wesel ACW, de Groot PG, Meijers JCM, Urbanus RT. Anti-β2-glycoprotein I and anti-prothrombin antibodies cause lupus anticoagulant through different mechanisms of action. J Thromb Haemost 2021;19:1018-28. [PMID: 33421291 DOI: 10.1111/jth.15241] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 765 |
Ali RA, Gandhi AA, Dai L, Weiner J, Estes SK, Yalavarthi S, Gockman K, Sun D, Knight JS. Antineutrophil properties of natural gingerols in models of lupus. JCI Insight 2021;6:138385. [PMID: 33373329 DOI: 10.1172/jci.insight.138385] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 766 |
Bradacova P, Slavik L, Ulehlova J, Skoumalova A, Ullrychova J, Prochazkova J, Hlusi A, Manukyan G, Kriegova E. Current Promising Biomarkers and Methods in the Diagnostics of Antiphospholipid Syndrome: A Review. Biomedicines 2021;9:166. [PMID: 33567576 DOI: 10.3390/biomedicines9020166] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 767 |
Ajeganova S, Hafström I, Frostegård J. Patients with SLE have higher risk of cardiovascular events and mortality in comparison with controls with the same levels of traditional risk factors and intima-media measures, which is related to accumulated disease damage and antiphospholipid syndrome: a case-control study over 10 years. Lupus Sci Med 2021;8:e000454. [PMID: 33547230 DOI: 10.1136/lupus-2020-000454] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 6.5] [Reference Citation Analysis]
|
| 768 |
Yoo JS, Kim YS, Kim HY, Kwon HS, Koh SH, Heo SH, Kim BJ, Bushnell CD, Chang DI. Comparison of patients with transient and sustained increments of antiphospholipid antibodies after acute ischemic stroke. J Neurol 2021;268:2541-9. [PMID: 33547954 DOI: 10.1007/s00415-021-10432-w] [Reference Citation Analysis]
|
| 769 |
Jiang C, Wang Z, Yuan S, Jiang Y, Ye Y. Chinese herbal medicine for immune infertility: A protocol for systematic review and meta-analysis. Medicine (Baltimore) 2021;100:e24248. [PMID: 33592866 DOI: 10.1097/MD.0000000000024248] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 770 |
You H, Zhao J, Huang C, Tian X, Li M, Zeng X. Early Initiation of Anticoagulation Improves the Long-Term Prognosis in Patients With Antiphospholipid Syndrome Associated Portal Vein Thrombosis. Front Med (Lausanne) 2021;8:630660. [PMID: 33614687 DOI: 10.3389/fmed.2021.630660] [Reference Citation Analysis]
|
| 771 |
Tung ML, Tan B, Cherian R, Chandra B. Anti-phospholipid syndrome and COVID-19 thrombosis: connecting the dots. Rheumatol Adv Pract 2021;5:rkaa081. [PMID: 33615129 DOI: 10.1093/rap/rkaa081] [Cited by in Crossref: 14] [Cited by in F6Publishing: 18] [Article Influence: 7.0] [Reference Citation Analysis]
|
| 772 |
Duan HJ, Li XY, Liu C, Deng XL. Chemokine-like factor-like MARVEL transmembrane domain-containing family in autoimmune diseases. Chin Med J (Engl) 2020;133:951-8. [PMID: 32195671 DOI: 10.1097/CM9.0000000000000747] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 6.5] [Reference Citation Analysis]
|
| 773 |
Zuo Y, Shi H, Li C, Knight JS. Antiphospholipid syndrome: a clinical perspective. Chin Med J (Engl) 2020;133:929-40. [PMID: 32265421 DOI: 10.1097/CM9.0000000000000705] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 7.5] [Reference Citation Analysis]
|
| 774 |
Muthu S, Chellamuthu G, Gopalsamy TP, Kandasamy V. Secondary Erosive Arthritis in a Young Lady - A Rare Manifestation of Primary Antiphospholipid Antibody Syndrome. J Orthop Case Rep 2021;11:15-8. [PMID: 34141662 DOI: 10.13107/jocr.2021.v11.i02.2006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 775 |
Stephan D, Cordeanu M, Mirea C, Salier G, Heitz M, Lambach H, Pianezze M, Frantz A. Maladie veineuse thromboembolique et COVID-19. La Presse Médicale Formation 2021;2:33-38. [DOI: 10.1016/j.lpmfor.2020.08.005] [Reference Citation Analysis]
|
| 776 |
Sordet C. Grossesse et maladies systémiques : risques pour la mère et l’enfant. Revue du Rhumatisme Monographies 2021;88:59-63. [DOI: 10.1016/j.monrhu.2020.11.005] [Reference Citation Analysis]
|
| 777 |
Mormile I, Granata F, Punziano A, de Paulis A, Rossi FW. Immunosuppressive Treatment in Antiphospholipid Syndrome: Is It Worth It? Biomedicines 2021;9:132. [PMID: 33535377 DOI: 10.3390/biomedicines9020132] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 778 |
Beato Merino M, Diago A, Fernandez-flores A, Fraga J, García Herrera A, Garrido M, Idoate Gastearena M, Llamas-velasco M, Monteagudo C, Onrubia J, Pérez-gonzález Y, Pérez Muñoz N, Ríos-martín J, Ríos-viñuela E, Rodríguez Peralto J, Rozas Muñoz E, Sanmartín O, Santonja C, Santos-briz A, Saus C, Suárez Peñaranda J, Velasco Benito V. Clinical and Histopathologic Characteristics of the Main Causes of Vascular Occusion — Part II: Coagulation Disorders, Emboli, and Other. Actas Dermo-Sifiliográficas (English Edition) 2021;112:103-117. [DOI: 10.1016/j.adengl.2020.12.024] [Reference Citation Analysis]
|
| 779 |
Pérez-topete SE, Miranda-aquino T, Hernández-del Río JE, Cerpa-cruz S, Gutiérrez-ureña SR, Martínez-bonilla G, González-díaz V. Left atrial strain in patients with systemic lupus erythematosus. Reumatología Clínica (English Edition) 2021;17:74-81. [DOI: 10.1016/j.reumae.2019.03.010] [Reference Citation Analysis]
|
| 780 |
Ghalib N, Pophali P, Chamorro-Pareja N, Jayarangaiah A, Kumar A. Incidental Asymptomatic Splenic Infarct in a COVID-19 Patient. Cureus 2021;13:e13065. [PMID: 33680607 DOI: 10.7759/cureus.13065] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 781 |
Pérez-Topete SE, Miranda-Aquino T, Hernández-Del Río JE, Cerpa-Cruz S, Gutiérrez-Ureña SR, Martínez-Bonilla G, González-Díaz V. Left Atrial Strain in Patients With Systemic Lupus Erythematosus. Reumatol Clin (Engl Ed) 2021;17:74-81. [PMID: 31080106 DOI: 10.1016/j.reuma.2019.03.006] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 782 |
Rosina S, Chighizola CB, Ravelli A, Cimaz R. Pediatric Antiphospholipid Syndrome: from Pathogenesis to Clinical Management. Curr Rheumatol Rep 2021;23:10. [PMID: 33511497 DOI: 10.1007/s11926-020-00976-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 783 |
Calcaterra I, Ambrosino P, Vitelli N, Lupoli R, Orsini RC, Chiurazzi M, Maniscalco M, Di Minno MND. Risk Assessment and Antithrombotic Strategies in Antiphospholipid Antibody Carriers. Biomedicines 2021;9:122. [PMID: 33513790 DOI: 10.3390/biomedicines9020122] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 784 |
Baker SA, Jin J, Pfaffroth C, Vu T, Zehnder JL. DOAC-Stop in lupus anticoagulant testing: Direct oral anticoagulant interference removed in most samples. Res Pract Thromb Haemost 2021;5:314-25. [PMID: 33733031 DOI: 10.1002/rth2.12472] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 785 |
Gavriș CM, Nedelcu LD, Pascu AM. Thrombotic risk in antiphospholipidic syndrome: From hypothesis to current evidence (Review). Exp Ther Med 2021;21:287. [PMID: 33603894 DOI: 10.3892/etm.2021.9718] [Reference Citation Analysis]
|
| 786 |
Gavriilaki E, Brodsky RA. Complementopathies and precision medicine. J Clin Invest 2020;130:2152-63. [PMID: 32310222 DOI: 10.1172/JCI136094] [Cited by in Crossref: 51] [Cited by in F6Publishing: 54] [Article Influence: 25.5] [Reference Citation Analysis]
|
| 787 |
Aringer M, Johnson SR. Classifying and diagnosing systemic lupus erythematosus in the 21st century. Rheumatology (Oxford) 2020;59:v4-v11. [PMID: 33280013 DOI: 10.1093/rheumatology/keaa379] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 12.5] [Reference Citation Analysis]
|
| 788 |
Liu Z, Sun S, Xu H, Zhang X, Chen C, Fu R, Li C, Guo F, Zhao A. Prognostic analysis of antibody typing and treatment for antiphospholipid syndrome-related recurrent spontaneous abortion. Int J Gynaecol Obstet 2022;156:107-11. [PMID: 33492662 DOI: 10.1002/ijgo.13621] [Reference Citation Analysis]
|
| 789 |
Lakota K, Perdan-Pirkmajer K, Hočevar A, Sodin-Semrl S, Rotar Ž, Čučnik S, Žigon P. COVID-19 in Association With Development, Course, and Treatment of Systemic Autoimmune Rheumatic Diseases. Front Immunol 2020;11:611318. [PMID: 33574819 DOI: 10.3389/fimmu.2020.611318] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 790 |
Madison JA, Duarte-García A, Zuo Y, Knight JS. Treatment of thrombotic antiphospholipid syndrome in adults and children. Curr Opin Rheumatol 2020;32:215-27. [PMID: 32187042 DOI: 10.1097/BOR.0000000000000702] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 791 |
Lee EE, Jun JK, Lee EB. Management of Women with Antiphospholipid Antibodies or Antiphospholipid Syndrome during Pregnancy. J Korean Med Sci 2021;36:e24. [PMID: 33496084 DOI: 10.3346/jkms.2021.36.e24] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 792 |
Svenungsson E, Gustafsson JT, Grosso G, Rossides M, Gunnarsson I, Jensen-Urstad K, Larsson A, Ekdahl KN, Nilsson B, Bengtsson AA, Lood C. Complement deposition, C4d, on platelets is associated with vascular events in systemic lupus erythematosus. Rheumatology (Oxford) 2020;59:3264-74. [PMID: 32259250 DOI: 10.1093/rheumatology/keaa092] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 793 |
Urban ML, Bettiol A, Mattioli I, Emmi G, Di Scala G, Avagliano L, Lombardi N, Crescioli G, Virgili G, Serena C, Mecacci F, Ravaldi C, Vannacci A, Silvestri E, Prisco D. Comparison of treatments for the prevention of fetal growth restriction in obstetric antiphospholipid syndrome: a systematic review and network meta-analysis. Intern Emerg Med 2021;16:1357-67. [PMID: 33475972 DOI: 10.1007/s11739-020-02609-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 794 |
Doyle AJ, Breen KA, Hunt BJ. Antiphospholipid Syndrome with Monoclonal Gammopathy-A Mechanism for Recurrent Thrombosis? Thromb Haemost 2021. [PMID: 33472254 DOI: 10.1055/a-1366-9379] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 795 |
Skeith L, Rodger MA, Bates SM, Gonsalves C, Karovitch A, Taylor TS. "Part of the Ritual": Exploring Patient and Physician Decision Making Regarding Anticoagulation Use in Obstetric Antiphospholipid Syndrome. Thromb Haemost 2021. [PMID: 33472256 DOI: 10.1055/a-1366-9261] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 796 |
Cavestro C, Degan D, Micca G, Aloi R, Mandrino S, Frigeri MC, Pistoia F, Molinari F, Sacco S. Thrombophilic alterations, migraine, and vascular disease: results from a case-control study. Neurol Sci 2021;42:3821-8. [DOI: 10.1007/s10072-020-05006-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 797 |
Prevel R, Roubaud-Baudron C, Tellier E, Le Besnerais M, Kaplanski G, Veyradier A, Benhamou Y, Coppo P; Centre National de Référence des Microangiopathies Thrombotiques. [Endothelial dysfunction in thrombotic thrombocytopenic purpura: therapeutic perspectives]. Rev Med Interne 2021;42:202-9. [PMID: 33455838 DOI: 10.1016/j.revmed.2020.12.011] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 798 |
FialovÁ L, KuchaŘ O, PetrÁČkovÁ M, Malbohan I, Zima T. Avidity of anti-phospholipid antibodies in relation to their levels. Cent Eur J Immunol 2020;45:136-43. [PMID: 33456323 DOI: 10.5114/ceji.2020.97901] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 799 |
Mena-Vázquez N, Fernández-Nebro A, Pego-Reigosa JM, Galindo M, Melissa-Anzola A, Uriarte-Isacelay E, Olivé-Marqués A, Aurrecoechea E, Freire M, Tomero E, García-Villanueva MJ, Stoye C, Salas-Heredia E, Bernal-Vidal JA, Salgado E, Blanco R, Javier Novoa F, Ibáñez-Barcelo M, Torrente-Segarra V, Narvaez J, Calvet J, Moriano Morales C, Ramon Vazquez-Rodriguez T, Garcia de la Peña P, Bohórquez C, Andreu-Sánchez JL, Cobo-Ibañez T, Bonilla G, Lozano-Rivas N, Montilla C, Toyos FJ, De la Fuente JLM, Expósito L, Ruiz-Lucea ME, Vals E, Manero-Ruiz J, Bernal-Vidal JA, Rua-Figueroa I. Hydroxychloroquine is associated with a lower risk of polyautoimmunity: data from the RELESSER Registry. Rheumatology (Oxford) 2020;59:2043-51. [PMID: 31808534 DOI: 10.1093/rheumatology/kez562] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 800 |
You Y, Shi C, Zhou Z, Wang F, Sun Y, Teng J, Liu H, Cheng X, Su Y, Shi H, Yang C, Ye J. Rituximab in thrombotic primary antiphospholipid syndrome: a pilot study from a single centre in China. Ann Rheum Dis 2021:annrheumdis-2020-219303. [PMID: 33452001 DOI: 10.1136/annrheumdis-2020-219303] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 801 |
Matus-Mayorga R, Barrera-Vargas A, Rull-Gabayet M, Aguirre-Aguilar E, Valdez-López M, Espinoza-Lira F, Ramos-Ventura C, Cano-Nigenda V, Barboza MA, Merayo-Chalico J, Arauz A. Risk factors for ischemic antiphospholipid syndrome: A case-control study. Clin Neurol Neurosurg 2021;202:106492. [PMID: 33540176 DOI: 10.1016/j.clineuro.2021.106492] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 802 |
Reshetnyak TM, Nurbaeva KS. Direct-acting oral anticoagulants in antiphospholipid syndrome. Naučno-praktičeskaâ revmatologiâ 2021;58:708-715. [DOI: 10.47360/1995-4484-2020-708-715] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 803 |
Page JM, Silver RM. Stillbirth: Evaluation and Follow-up. Obstet Gynecol Clin North Am 2020;47:439-51. [PMID: 32762929 DOI: 10.1016/j.ogc.2020.04.008] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 804 |
Zisa D, Goodman SM. Perioperative Management of Rheumatic Disease and Therapies. Med Clin North Am 2021;105:273-84. [PMID: 33589102 DOI: 10.1016/j.mcna.2020.09.011] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 805 |
Hirata H, Sakurai Y, Takeda T, Kasetani T, Morita T. Development of Acquired Factor V Inhibitor After Surgical Procedure Without the Use of Fibrin Tissue Adhesives: A Case Report. Cureus 2021;13:e12708. [PMID: 33489635 DOI: 10.7759/cureus.12708] [Reference Citation Analysis]
|
| 806 |
Nielly H, Mathian A, Cazenave M, Izzedine H, Haroche J, Cohen-Aubart F, Hie M, Miyara M, Pineton de Chambrun M, Benameur N, Hausfater P, Pha M, Boutin-Lê Thi Huong D, Rouvier P, Brocheriou I, Cluzel P, Amoura Z. Safety and effectiveness of transjugular renal biopsy for systemic lupus erythematosus and antiphospholipid antibody syndrome patients taking antithrombotics. Nephrol Dial Transplant 2020;35:1721-9. [PMID: 31157889 DOI: 10.1093/ndt/gfz085] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 807 |
Gairing SJ, Kloeckner R, Pitton MB, Baumgart J, von Auer-Wegener C, Lang H, Galle PR, Foerster F, Schattenberg JM. Multidisciplinary approach to the complex treatment for non-cirrhotic portal hypertension - case-report-based discussion. Z Gastroenterol 2021;59:43-9. [PMID: 33429449 DOI: 10.1055/a-1330-9827] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 808 |
Araújo DM, Rodrigues CEM, Gonçalves NGG, Rabelo-Júnior CN, Lobo MDP, Moreira RA, Monteiro-Moreira ACO. Proteins Involved in the Induction of Procoagulant Activity and Autoimmune Response in Patients With Primary Antiphospholipid Syndrome. Clin Appl Thromb Hemost 2020;26:1076029620905338. [PMID: 32299226 DOI: 10.1177/1076029620905338] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 809 |
El Hasbani G, Viola M, Sciascia S, Taher AT, Uthman I. Antiphospholipid Antibodies in Inflammatory and Autoimmune Rheumatic and Musculoskeletal Diseases Beyond Lupus: A Systematic Review of the Available Evidence. Rheumatol Ther 2021;8:81-94. [PMID: 33420626 DOI: 10.1007/s40744-020-00273-w] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 810 |
Canti V, Scarrone M, De Lorenzo R, Ramirez GA, Erra R, Bordoli S, Cella S, Schmit E, Rosa S, Castiglioni MT, Rovere-Querini P. Low incidence of intrauterine growth restriction in pregnant patients with systemic lupus erythematosus taking hydroxychloroquine. Immunol Med 2021;:1-7. [PMID: 33417532 DOI: 10.1080/25785826.2020.1868652] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 811 |
Grosso G, Sandholm K, Antovic A, Gunnarsson I, Zickert A, Vikerfors A, Truedsson L, Bruzelius M, Nilsson B, Nilsson-Ekdahl K, Svenungsson E. The Complex Relationship between C4b-Binding Protein, Warfarin, and Antiphospholipid Antibodies. Thromb Haemost 2021. [PMID: 33412597 DOI: 10.1055/a-1347-5655] [Reference Citation Analysis]
|
| 812 |
Rosa RF, Ugolini-Lopes MR, Gandara APR, Vendramini MBG, Campanholo KR, Dutra L, de Andrade DCO. Cognitive dysfunction and serum levels of brain-derived neurotrophic factor (BDNF) in primary anti-phospholipid syndrome (PAPS). Rheumatology (Oxford) 2021;60:179-87. [PMID: 32613245 DOI: 10.1093/rheumatology/keaa252] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 813 |
Panopoulos S, Thomas K, Georgiopoulos G, Boumpas D, Katsiari C, Bertsias G, Drosos AA, Boki K, Dimitroulas T, Garyfallos A, Papagoras C, Katsimbri P, Tziortziotis A, Adamichou C, Kaltsonoudis E, Argyriou E, Vosvotekas G, Sfikakis PP, Vassilopoulos D, Tektonidou MG. Comparable or higher prevalence of comorbidities in antiphospholipid syndrome vs rheumatoid arthritis: a multicenter, case-control study. Rheumatology (Oxford) 2021;60:170-8. [PMID: 32596727 DOI: 10.1093/rheumatology/keaa321] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 814 |
Devreese KMJ. Testing for antiphospholipid antibodies: Advances and best practices. Int J Lab Hematol 2020;42 Suppl 1:49-58. [PMID: 32543059 DOI: 10.1111/ijlh.13195] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 7.5] [Reference Citation Analysis]
|
| 815 |
de Carvalho JF, Shoenfeld Y. Aneurysms in primary antiphospholipid syndrome: a case-based review. Clin Rheumatol 2021;40:3001-6. [PMID: 33392888 DOI: 10.1007/s10067-020-05564-9] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 816 |
Zhuravleva N, Samoilova A, Karzakova L, Smirnova T, Kudryashov S, Arkhipova A, Markelova L, Gerasimova L, Sharapova O. Systemic lupus erythematosus: still a problem for doctors. Probl reprod 2021;27:102. [DOI: 10.17116/repro202127011102] [Reference Citation Analysis]
|
| 817 |
Choi MY, Fritzler MJ. Challenges and Advances in SLE Autoantibody Detection and Interpretation. Outcome Measures and Metrics in Systemic Lupus Erythematosus 2021. [DOI: 10.1007/978-3-030-73303-2_4] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 818 |
Félix C, Carrillo MP, Añón I, Malde FJ, Cáliz R, Puertas A. RESULTADOS OBSTÉTRICOS EN GESTANTES DIAGNOSTICADAS DE SÍNDROME ANTIFOSFOLÍPIDO. Revista Médica Clínica Las Condes 2021;32:128-35. [DOI: 10.1016/j.rmclc.2020.05.005] [Reference Citation Analysis]
|
| 819 |
Hedrich CM, Kallinich T. Antiphospholipid-Syndrom bei Kindern und Jugendlichen. Pädiatrische Rheumatologie 2021. [DOI: 10.1007/978-3-662-60411-3_39-1] [Reference Citation Analysis]
|
| 820 |
Jung L, Paul WM. Autoimmune disorders. Biochemical and Molecular Basis of Pediatric Disease 2021. [DOI: 10.1016/b978-0-12-817962-8.00019-6] [Reference Citation Analysis]
|
| 821 |
Bohgaki M, Koike T. Clinical manifestations. Systemic Lupus Erythematosus 2021. [DOI: 10.1016/b978-0-12-814551-7.00060-x] [Reference Citation Analysis]
|
| 822 |
Talabi MB, Clowse ME. Reproductive health. Lahita's Systemic Lupus Erythematosus 2021. [DOI: 10.1016/b978-0-12-820583-9.00045-2] [Reference Citation Analysis]
|
| 823 |
Zuo Y, Knight JS. Tissue injury—the biology. Lahita's Systemic Lupus Erythematosus 2021. [DOI: 10.1016/b978-0-12-820583-9.00021-x] [Reference Citation Analysis]
|
| 824 |
Wagner N, Haffner D, Tenbrock K, Dannecker G. Systemischer Lupus erythematodes bei Kindern und Jugendlichen. Pädiatrische Rheumatologie 2021. [DOI: 10.1007/978-3-662-60411-3_38-1] [Reference Citation Analysis]
|
| 825 |
Khamashta MA, Ugarte A, Ruiz-irastorza G. Clinical presentation of antiphospholipid syndrome. Lahita's Systemic Lupus Erythematosus 2021. [DOI: 10.1016/b978-0-12-820583-9.00026-9] [Reference Citation Analysis]
|
| 826 |
Perl A. Metabolic control of lupus pathogenesis: central role for activation of the mechanistic target of rapamycin. Systemic Lupus Erythematosus 2021. [DOI: 10.1016/b978-0-12-814551-7.00031-3] [Reference Citation Analysis]
|
| 827 |
Al-osaimi H, Althubiti A. Gestational Rheumatology. Skills in Rheumatology 2021. [DOI: 10.1007/978-981-15-8323-0_17] [Reference Citation Analysis]
|
| 828 |
Cimolai N. Untangling the Intricacies of Infection, Thrombosis, Vaccination, and Antiphospholipid Antibodies for COVID-19. SN Compr Clin Med 2021;3:2093-108. [PMID: 34179695 DOI: 10.1007/s42399-021-00992-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 829 |
Dima A, Moroti RV, Popescu DN, Berza I, Pârvu DA, Dumitrescu B. Anticardiolipin Antibodies in COVID-19 – Report of Three Cases. Internal Medicine 2021;18:59-67. [DOI: 10.2478/inmed-2021-0151] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 830 |
Qureshi F, Viswanathan V, Sane S. Tuberculosis in Catastrophic Antiphospholipid Antibody Syndrome. Indian Pediatr 2021;58:82-83. [DOI: 10.1007/s13312-021-2104-y] [Reference Citation Analysis]
|
| 831 |
Kwon EW, Lee DW. A case of pulmonary thromboembolism and splenic infarction in mycoplasma pneumonia. Allergy Asthma Respir Dis 2021;9:36. [DOI: 10.4168/aard.2021.9.1.36] [Reference Citation Analysis]
|
| 832 |
Chilaka CU, Soliman NMN, Chilaka VN. Prevention and Management of Recurrent Miscarriage. Contemporary Obstetrics and Gynecology for Developing Countries 2021. [DOI: 10.1007/978-3-030-75385-6_40] [Reference Citation Analysis]
|
| 833 |
Northup PG, Garcia-Pagan JC, Garcia-Tsao G, Intagliata NM, Superina RA, Roberts LN, Lisman T, Valla DC. Vascular Liver Disorders, Portal Vein Thrombosis, and Procedural Bleeding in Patients With Liver Disease: 2020 Practice Guidance by the American Association for the Study of Liver Diseases. Hepatology 2021;73:366-413. [PMID: 33219529 DOI: 10.1002/hep.31646] [Cited by in Crossref: 171] [Cited by in F6Publishing: 166] [Article Influence: 85.5] [Reference Citation Analysis]
|
| 834 |
Chighizola CB, Borghi MO, Meroni PL. Antibodies and diagnostic tests in antiphosholipid syndrome. Systemic Lupus Erythematosus 2021. [DOI: 10.1016/b978-0-12-814551-7.00059-3] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 835 |
Emmerich J. Congenital and Acquired Hypercoagulable States. Trauma Induced Coagulopathy 2021. [DOI: 10.1007/978-3-030-53606-0_32] [Reference Citation Analysis]
|
| 836 |
D'Mello RJ, Hsu CD, Chaiworapongsa P, Chaiworapongsa T. Update on the Use of Intravenous Immunoglobulin in Pregnancy. Neoreviews 2021;22:e7-e24. [PMID: 33386311 DOI: 10.1542/neo.22-1-e7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 837 |
Hassan R, Faruqui H, Alquraa R, Eissa A, Alshaiki F, Cheikh M. Classification Criteria and Clinical Practice Guidelines for Rheumatic Diseases. Skills in Rheumatology 2021. [DOI: 10.1007/978-981-15-8323-0_25] [Reference Citation Analysis]
|
| 838 |
Bermas BL, Sammaritano LR. Fertility and pregnancy in systemic lupus erythematosus. Systemic Lupus Erythematosus 2021. [DOI: 10.1016/b978-0-12-814551-7.00052-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 839 |
Sussman J, Davies-jones G. Neurologic Manifestations of Hematologic Disorders. Aminoff's Neurology and General Medicine 2021. [DOI: 10.1016/b978-0-12-819306-8.00025-3] [Reference Citation Analysis]
|
| 840 |
Yin D, de Groot PG, Ninivaggi M, Devreese KMJ, de Laat B. Clinical Relevance of Isolated Lupus Anticoagulant Positivity in Patients with Thrombotic Antiphospholipid Syndrome. Thromb Haemost 2021;121:1220-7. [DOI: 10.1055/a-1344-4271] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 841 |
Usuku H, Yamamoto E, Noguchi M, Komorita T, Takae M, Oike F, Yamanaga K, Ito M, Fujisue K, Sueta D, Kanazawa H, Araki S, Arima Y, Takashio S, Nakamura T, Suzuki S, Kawano H, Soejima H, Kaikita K, Matsushita K, Fukui T, Matsui H, Tsujita K. Elevated C-reactive protein is significantly associated with left ventricular dysfunction in patients with aortic regurgitation and concomitant collagen disease. Int J Cardiol 2021;328:152-7. [PMID: 33359278 DOI: 10.1016/j.ijcard.2020.12.053] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 842 |
Levi M, Iba T. COVID-19 coagulopathy: is it disseminated intravascular coagulation? Intern Emerg Med 2021;16:309-12. [PMID: 33368021 DOI: 10.1007/s11739-020-02601-y] [Cited by in Crossref: 42] [Cited by in F6Publishing: 29] [Article Influence: 14.0] [Reference Citation Analysis]
|
| 843 |
Nanjappa V, Devegowda L, Rathore A, K.s S, Nanjappa MC. Thrombosis with Thrombocytopenia - A Vascular Paradox. jebmh 2020;7:3110-3116. [DOI: 10.18410/jebmh/2020/634] [Reference Citation Analysis]
|
| 844 |
Silver RM. Antiphospholipid Syndrome. Protocols for High‐Risk Pregnancies 2020. [DOI: 10.1002/9781119635307.ch15] [Reference Citation Analysis]
|
| 845 |
Karpouzas GA, Ormseth SR, Hernandez E, Bui VL, Budoff MJ. Beta-2-glycoprotein-I IgA antibodies predict coronary plaque progression in rheumatoid arthritis. Semin Arthritis Rheum 2021;51:20-7. [PMID: 33360226 DOI: 10.1016/j.semarthrit.2020.10.003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 846 |
Ruffatti A, Tonello M, Favaro M, Del Ross T, Calligaro A, Ruffatti AT, Gervasi MT, Hoxha A. The efficacy and safety of second-line treatments of refractory and/or high risk pregnant antiphospholipid syndrome patients. A systematic literature review analyzing 313 pregnancies. Semin Arthritis Rheum 2021;51:28-35. [PMID: 33360227 DOI: 10.1016/j.semarthrit.2020.10.001] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 3.7] [Reference Citation Analysis]
|
| 847 |
Radin M, Cecchi I, Foddai SG, Rubini E, Barinotti A, Ramirez C, Seaman A, Roccatello D, Mahler M, Sciascia S. Validation of the Particle-Based Multi-Analyte Technology for Detection of Anti-PhosphatidylSerine/Prothrombin Antibodies. Biomedicines 2020;8:E622. [PMID: 33348782 DOI: 10.3390/biomedicines8120622] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 848 |
Marques C, Kakehasi AM, Gomides APM, Paiva EDS, Dos Reis Neto ET, Pileggi GCS, Provenza JR, Mota L, Xavier RM, Ferreira GA, Pinheiro MM. A Brazilian Cohort of Patients With Immuno-Mediated Chronic Inflammatory Diseases Infected by SARS-CoV-2 (ReumaCoV-Brasil Registry): Protocol for a Prospective, Observational Study. JMIR Res Protoc 2020;9:e24357. [PMID: 33156812 DOI: 10.2196/24357] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 849 |
Giacomelli R, Afeltra A, Bartoloni E, Berardicurti O, Bombardieri M, Bortoluzzi A, Carubbi F, Caso F, Cervera R, Ciccia F, Cipriani P, Coloma-Bazán E, Conti F, Costa L, D'Angelo S, Distler O, Feist E, Foulquier N, Gabini M, Gerber V, Gerli R, Grembiale RD, Guggino G, Hoxha A, Iagnocco A, Jordan S, Kahaleh B, Lauper K, Liakouli V, Lubrano E, Margiotta D, Naty S, Navarini L, Perosa F, Perricone C, Perricone R, Prete M, Pers JO, Pitzalis C, Priori R, Rivellese F, Ruffatti A, Ruscitti P, Scarpa R, Shoenfeld Y, Triolo G, Tzioufas A. The growing role of precision medicine for the treatment of autoimmune diseases; results of a systematic review of literature and Experts' Consensus. Autoimmun Rev 2021;20:102738. [PMID: 33326854 DOI: 10.1016/j.autrev.2020.102738] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 6.3] [Reference Citation Analysis]
|
| 850 |
Chezel J, Fischer Q, Nicaise Roland P, Abtan J, Faille D, Van Gysel D, Papo T, Ducrocq G, Sacre K. Primary antiphospholipid syndrome revealed by acute myocardial infarction in young adults: a prospective observational study. Thromb Res 2021;198:151-3. [PMID: 33341440 DOI: 10.1016/j.thromres.2020.12.003] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 851 |
Kim JW, Kim TW, Ryu KH, Park SG, Jeong CY, Park DH. Anaesthetic considerations for patients with antiphospholipid syndrome undergoing non-cardiac surgery. J Int Med Res 2020;48:300060519896889. [PMID: 31937174 DOI: 10.1177/0300060519896889] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 852 |
Gkrouzman E, Barbhaiya M, Erkan D, Lockshin MD. Reality Check on Antiphospholipid Antibodies in COVID‐19–Associated Coagulopathy. Arthritis Rheumatol 2021;73:173-4. [DOI: 10.1002/art.41472] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 9.7] [Reference Citation Analysis]
|
| 853 |
El Hasbani G, Taher AT, Jawad A, Uthman I. COVID-19, Antiphospholipid Antibodies, and Catastrophic Antiphospholipid Syndrome: A Possible Association? Clin Med Insights Arthritis Musculoskelet Disord 2020;13:1179544120978667. [PMID: 33328777 DOI: 10.1177/1179544120978667] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 7.7] [Reference Citation Analysis]
|
| 854 |
Miranda-Hernández D, Sánchez A, Sánchez-Briones RE, Rivas-Ruiz R, Cruz-Reynoso L, Cruz-Domínguez P, Jara LJ, Saavedra MÁ. Impact of Systemic Lupus Erythematosus on Pregnancy: Analysis of a Large 10-Year Longitudinal Mexican Cohort. J Clin Rheumatol 2021;27:S217-23. [PMID: 33264243 DOI: 10.1097/RHU.0000000000001626] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 855 |
Michele MD, Lorenzano S, Angelosanto N, Serrao A, Petraglia L, Risitano A, Toni D, Chistolini A. Role of Factor V R2 Haplotype and Common Thrombophilia Markers as Genetic Risk Factors for Ischemic Stroke. Journal of Stroke Medicine 2020;3:144-150. [DOI: 10.1177/2516608520973817] [Reference Citation Analysis]
|
| 856 |
Kim Y, Kim SY. Antiphospholipid Antibody and Recurrent Ischemic Stroke: A Systematic Review and Meta-Analysis. Stroke 2020;51:3728-32. [DOI: 10.1161/strokeaha.120.030431] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 857 |
Tsiakas S, Skalioti C, Kotsi P, Boletis I, Marinaki S. Case of an unusual diagnosis of primary antiphospholipid syndrome with multiple clinical complications. Oxford Medical Case Reports 2020;2020. [DOI: 10.1093/omcr/omaa117] [Reference Citation Analysis]
|
| 858 |
du Toit R, Herbst PG, Ackerman C, Pecoraro AJ, Claassen D, Cyster HP, Reuter H, Doubell AF. Outcome of clinical and subclinical myocardial injury in systemic lupus erythematosus - A prospective cohort study. Lupus 2021;30:256-68. [PMID: 33525979 DOI: 10.1177/0961203320976960] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 859 |
Pontara E, Cattini MG, Cheng C, Bison E, Denas G, Pengo V. Insight into the hypercoagulable state of high-risk thrombotic APS patients: Contribution of aβ2GPI and aPS/PT antibodies. J Thromb Haemost 2021;19:805-13. [PMID: 33249717 DOI: 10.1111/jth.15199] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 860 |
Barbhaiya M, Zuily S, Ahmadzadeh Y, Amigo MC, Avcin T, Bertolaccini ML, Branch DW, de Jesus G, Devreese KMJ, Frances C, Garcia D, Guillemin F, Levine SR, Levy RA, Lockshin MD, Ortel TL, Seshan SV, Tektonidou M, Wahl D, Willis R, Naden R, Costenbader K, Erkan D; New APS Classification Criteria Collaborators. Development of a New International Antiphospholipid Syndrome Classification Criteria Phase I/II Report: Generation and Reduction of Candidate Criteria. Arthritis Care Res (Hoboken) 2020. [PMID: 33253499 DOI: 10.1002/acr.24520] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 861 |
T. M. Tutchenko, O. A. Burka, V. S. Samilyk, O. V. Trokhymovych, O. I. Krotik, O. L. Gromova. Time to reduce the rate of idiopathic recurrent pregnancy losses. RE 2020. [DOI: 10.18370/2309-4117.2020.55.21-28] [Reference Citation Analysis]
|
| 862 |
Janjetovic S, Beckmann L, Holstein K, Rolling C, Thiele B, Schafhausen P, Schön G, Bokemeyer C, Langer F, Voigtlaender M. Prevalence of definite antiphospholipid syndrome in carriers of the JAK2V617F mutation. Thromb Res 2021;198:55-61. [PMID: 33290883 DOI: 10.1016/j.thromres.2020.11.027] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 863 |
Lerma LA, Chaudhary A, Bryan A, Morishima C, Wener MH, Fink SL. Prevalence of autoantibody responses in acute coronavirus disease 2019 (COVID-19). J Transl Autoimmun 2020;3:100073. [PMID: 33263103 DOI: 10.1016/j.jtauto.2020.100073] [Cited by in Crossref: 37] [Cited by in F6Publishing: 42] [Article Influence: 12.3] [Reference Citation Analysis]
|
| 864 |
Cabrera-Marante O, Rodríguez de Frías E, Serrano M, Lozano Morillo F, Naranjo L, Gil-Etayo FJ, Paz-Artal E, Pleguezuelo DE, Serrano A. The Weight of IgA Anti-β2glycoprotein I in the Antiphospholipid Syndrome Pathogenesis: Closing the Gap of Seronegative Antiphospholipid Syndrome. Int J Mol Sci 2020;21:E8972. [PMID: 33255963 DOI: 10.3390/ijms21238972] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 865 |
de Moreuil C, Hannigsberg J, Chauvet J, Remoue A, Tremouilhac C, Merviel P, Bellot C, Pan Petesch B, Le Moigne E, Lacut K, Marcorelles P. Factors associated with poor fetal outcome in placental abruption. Pregnancy Hypertens 2021;23:59-65. [PMID: 33264704 DOI: 10.1016/j.preghy.2020.11.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 866 |
Neoh KK, Tang ASN, Looi I, Anita BM. Ischemic Stroke in a Young Patient with Nephrotic Syndrome and Antiphospholipid Syndrome. Case Rep Nephrol 2020;2020:8828864. [PMID: 33294240 DOI: 10.1155/2020/8828864] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 867 |
van Dijk MM, Kolte AM, Limpens J, Kirk E, Quenby S, van Wely M, Goddijn M. Recurrent pregnancy loss: diagnostic workup after two or three pregnancy losses? A systematic review of the literature and meta-analysis. Hum Reprod Update 2020;26:356-67. [PMID: 32103270 DOI: 10.1093/humupd/dmz048] [Cited by in Crossref: 42] [Cited by in F6Publishing: 44] [Article Influence: 14.0] [Reference Citation Analysis]
|
| 868 |
Rogenhofer N, Markoff A, Ennerst X, Bogdanova N, Thaler C. Maternal and paternal carriage of the annexin A5 M2 haplotype: a possible risk factor for recurrent implantation failure (RIF). J Assist Reprod Genet 2021;38:235-42. [PMID: 33231792 DOI: 10.1007/s10815-020-01978-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 869 |
Podgórska J, Werel P, Klapaczyński J, Orzechowska D, Wudarski M, Gietka A. Liver involvement in rheumatic diseases. Reumatologia 2020;58:289-96. [PMID: 33227094 DOI: 10.5114/reum.2020.99782] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 870 |
Nauseef JT, Lim HI, DeSancho MT. Successful outcome with eculizumab treatment in a patient with antiphospholipid syndrome presenting with an unusual thrombotic storm. J Thromb Thrombolysis 2021;52:597-600. [PMID: 33222114 DOI: 10.1007/s11239-020-02343-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 871 |
Cintron D, Rodríguez-Agramonte JC, Soto-Velez LA. Altered Mental Status in a 16-Year-Old Adolescent Male. Cureus 2020;12:e11664. [PMID: 33391902 DOI: 10.7759/cureus.11664] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 872 |
Fujieda Y, Amengual O. New insights into the pathogenic mechanisms and treatment of arterial thrombosis in antiphospholipid syndrome. Eur J Rheumatol 2020. [PMID: 33226327 DOI: 10.5152/eurjrheum.2020.20058] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 873 |
Yelnik CM, Miranda S, Mékinian A, Lazaro E, Quéméneur T, Provot F, Frimat M, Morell-dubois S, Le Guern V, Hachulla E, Costedoat-chalumeau N, Lambert M. Patients with refractory catastrophic antiphospholipid syndrome respond inconsistently to eculizumab. Blood 2020;136:2473-7. [DOI: 10.1182/blood.2020007499] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 874 |
Joshi A, Sood V, Mendonca S, Dogra M, Batta G, Tiwari R, Yanamandra U. Catastrophic Antiphospholipid Syndrome in Immune Thrombocytopenic Purpura - Beyond Tenuous Concomitance! Indian J Nephrol 2020;30:424-6. [PMID: 33840964 DOI: 10.4103/ijn.IJN_188_19] [Reference Citation Analysis]
|
| 875 |
Yu X, He L. Aspirin and heparin in the treatment of recurrent spontaneous abortion associated with antiphospholipid antibody syndrome: A systematic review and meta-analysis. Exp Ther Med 2021;21:57. [PMID: 33365057 DOI: 10.3892/etm.2020.9489] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 876 |
Ghembaza A, Saadoun D. Management of Antiphospholipid Syndrome. Biomedicines 2020;8:E508. [PMID: 33212808 DOI: 10.3390/biomedicines8110508] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 877 |
Yin D, Chayoua W, Kelchtermans H, de Groot PG, Moore GW, Gris JC, Zuily S, Musial J, de Laat B, Devreese KMJ. Detection of anti-domain I antibodies by chemiluminescence enables the identification of high-risk antiphospholipid syndrome patients: A multicenter multiplatform study. J Thromb Haemost 2020;18:463-78. [PMID: 31749277 DOI: 10.1111/jth.14682] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 878 |
Shil RSK, Al Dhuhoori AA, Thomachan VM, Teir JA, Radhakrishnan R. Atypical Presentation of Anti-Phospholipid Antibody Syndrome with Seizure and Atrial Mass. Case Reports in Medicine 2020;2020:1-5. [DOI: 10.1155/2020/8877445] [Reference Citation Analysis]
|
| 879 |
Markousis-Mavrogenis G, Sfikakis PP, Mavrogeni SI, Tektonidou MG. Combined brain/heart magnetic resonance imaging in antiphospholipid syndrome-two sides of the same coin. Clin Rheumatol 2021;40:2559-68. [PMID: 33196982 DOI: 10.1007/s10067-020-05498-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 880 |
Dufrost V, Wahl D, Zuily S. Direct oral anticoagulants in antiphospholipid syndrome: Meta-analysis of randomized controlled trials. Autoimmun Rev 2021;20:102711. [PMID: 33197580 DOI: 10.1016/j.autrev.2020.102711] [Cited by in Crossref: 13] [Cited by in F6Publishing: 17] [Article Influence: 4.3] [Reference Citation Analysis]
|
| 881 |
El-Garf K, El-Garf A, Gheith R, Badran S, Salah S, Marzouk H, Farag Y, Khalifa I, Mostafa N. A comparative study between the disease characteristics in adult-onset and childhood-onset systemic lupus erythematosus in Egyptian patients attending a large university hospital. Lupus 2021;30:211-8. [PMID: 33175664 DOI: 10.1177/0961203320972778] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 882 |
Medina G, Cimé Aké EA, Vera-Lastra O, Saavedra MÁ, Cruz-Domínguez MDP, Amigo MC, Jara LJ. Damage index for antiphospholipid syndrome during long term follow-up: Correlation between organ damage accrual and quality of life. Lupus 2021;30:96-102. [PMID: 33176566 DOI: 10.1177/0961203320970651] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 883 |
Raschi E, Privitera D, Bodio C, Lonati PA, Borghi MO, Ingegno |
